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ABSTRACT OF THE DISSERTATION 
 
Low Complexity Sequences of Rbfox  
Form Higher-order Complexes with LASR  
to Regulate Alternative Splicing 
 
by 
 
Yi Ying 
Doctor of Philosophy in Molecular Biology 
University of California, Los Angeles, 2016 
Professor Douglas L. Black, Chair 
 
Alternative splicing is controlled by diverse RNA binding proteins that recognize 
elements in the pre-mRNA to alter spliceosome assembly. Separate from their RNA 
binding domains, these proteins often contain intrinsically disordered domains with 
regions of low-complexity (LC) sequences, but how LC sequences contribute to splicing 
regulation is not known. In earlier work, we found that splicing regulators of the Rbfox 
family are bound with a large complex of proteins called the Large Assembly of Splicing 
Regulators, LASR. Rbfox proteins were shown to regulate splicing in association with 
 iii 
LASR and to alter the activity of LASR components in splicing, but the nature of the Rbfox 
and LASR interaction was not clear. Here, we show that C-terminal domain of the Rbfox 
protein interacts with LASR and this interaction is essential for Rbfox activity in splicing. 
We find that an LC region within the C-terminal domain mediates assembly of Rbfox 
proteins with LASR into higher-order structures. Repetitive tyrosine residues in this 
domain are essential to the formation of the higher-order assemblies. The Rbfox LC 
domain both spontaneously aggregates in solution and forms fibrous structures and 
hydrogels over time, suggesting a mechanism for higher-order assembly similar to the 
fibril formation with FUS and other RNA-binding proteins. Exon repression and activation 
by Rbfox proteins are lost with mutations that disrupt the interaction of Rbfox and LASR. 
However, blocking higher-order assembly while retaining the Rbfox interaction with LASR, 
results in selective loss of Rbfox-dependent exon activation. These findings demonstrate 
that the LC domains of RNA-binding proteins and their self-assembly play a crucial role in 
splicing regulation. In addition to simple RNA recognition, higher-order assembly and its 
associated aggregation properties of phase separation and/or fiber formation offer 
additional mechanisms for tuning regulatory activities. 
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CHAPTER 1 
INTRODUCTION TO ALTERNATIVE PRE-MRNA SPLICING REGULATION AND 
RBFOX PROTEIN FAMILY 
 
Alternative pre-mRNA splicing regulation 
Alternative pre-mRNA splicing is the major source of proteomic complexity from a 
limited repertoire of genes in metazoans. Through this process, mRNA isoforms with 
different coding potential or stability can be generated from one identical pre-mRNA, thus 
allowing production of proteins with distinct functions or in different quantities. Near all 
human genes undergo alternative splicing to give rise to diverse protein products 
(Barbosa-Morais et al., 2012; Merkin et al., 2012).  
Pre-mRNA transcripts can undergo many different types of alternative splicing. The 
most common type is that a cassette exon can be either included or excluded in mRNA. 
One derivative type is mutually exclusive splicing where one exon or the other is included, 
but not both in the mRNA. Other types include alternative usage of 5’ terminal exons, 3’ 
terminal exons and 5' or 3' splice sites within the exons. Finally, the excision of an intron 
can be suppressed to retain intronic sequence in the mRNA (Black, 2003). Many genes 
show multiple types of alternative splicing, leading to a complex combination of exons 
and a large family of related but distinctly encoded proteins. 
The recognition of the exon-intron junctions, the removal of the intron, and the 
subsequent joining of the exons are carried out by a highly dynamic RNA-protein 
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complex called the spliceosome. Core spliceosomal components, including five small 
nuclear ribonucleoproteins (snRNPs) and numerous auxiliary proteins, are assembled 
stepwise onto each intron through recognizing the splice site sequences of a pre-mRNA 
(Wahl et al., 2009). The 5’ and 3’ splice sites sequences are located at the two ends of an 
intron, and the branch point adenosine is usually located ~15 to 50 nucleotides upstream 
of the 3ʹ  splice site, followed by a polypyrimidine tract (Black, 2003). Besides the primary 
splice site sequences, the splice site choice is modulated by multiple auxiliary regulatory 
sequences throughout the pre-mRNA. RNA elements that act positively to stimulate 
spliceosome assembly are called splicing enhancers. Conversely, RNA sequences act as 
splicing silencers or repressors to block spliceosome assembly. Splicing enhancers and 
silencers have both exonic and intronic varieties. Often these splicing enhancers and 
silencers are bound by a large number of regulatory proteins, many of which can directly 
bind to the pre-mRNA. 
Classic regulatory proteins identified include the SR protein and heterogeneous 
nuclear ribonucleoproteins (hnRNPs) families (Singh and Valcarcel, 2005). Both these 
families are usually expressed in multiple cell types. Historically, SR proteins are widely 
viewed as splicing activators that promote exon inclusion by interacting with core 
spliceosomal proteins, whereas hnRNP proteins are negative regulators that repress 
exon inclusion. However, global studies of alternative splicing regulation and RNA-protein 
mapping revealed that some hnRNP proteins act as splicing activators in a 
context-dependent and position-dependent manner. Thus, the functional distinction 
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between these two classes of proteins is blurred by discoveries that members of either 
one can activate or repress splicing in a context-dependent manner (Fu and Ares, 2014). 
Some tissue-specific RNA-binding proteins were identified as splicing factors, such as 
MBNL, CELF and Rbfox protein families. They play important roles in establishing a 
cell-type specific splicing profile to maintain cell identity (Han et al., 2013). 
The pre-mRNA sequences carry the “splicing code” that is recognized and decoded 
by spliceosomal proteins and regulatory splicing factors. To understand the “splicing 
code”, many different methods have been developed to detect the binding of splicing 
factors to regions of pre-mRNA transcripts in vitro and in vivo. SELEX (systematic 
evolution of ligands by exponential enrichment) is an in vitro approach, which allows the 
identification of high-affinity RNA motifs (Bouvet, 2001). RNA Bind-n-Seq (RBNS) 
adapted high-throughput SELEX with deep sequencing for quantitative mapping of RNA 
binding specificity. CLIP-seq (UV crosslinking and immunoprecipitation) captures 
RNA-protein recruitment sites in vivo (Ule et al., 2003). Developments in technologies 
advance our understanding of sequence specificities of RNA-binding proteins. 
Nevertheless, assigning binding sites to splicing factor solely based on primary RNA 
sequence is still very challenging. The majority of RNA-binding proteins bind to very short 
and partially degenerate RNA sequences, and one RNA sequence can be assigned to 
multiple RNA-binding proteins. Combinatorial control by multiple splicing factors on one 
pre-mRNA transcript within a cell makes it more complicated to crack the “splicing code”. 
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Much remains to be learned about the mechanisms and the regulatory networks of 
alternative splicing. 
Rbfox protein family 
Rbfox proteins belong to a family of tissue-specific splicing regulators. They consist? 
It consists of three members in mammals: Rbfox1 (also known as A2BP1) (Jin et al., 
2003; Underwood et al., 2005), Rbfox2 (also known as RBM9) (Underwood et al., 2005), 
Rbfox3 (also known as NeuN) (Kim et al., 2009). Rbfox1 is highly enriched in the brain, 
heart and skeletal muscle (Gao et al., 2016; Gehman et al., 2011; Kuroyanagi, 2009; 
Underwood et al., 2005), whereas Rbfox2 shows a broader expression pattern in multiple 
cell types, including all these three tissues as well as embryotic stem cells (Gehman et al., 
2012; Singh et al., 2014; Wei et al., 2015; Yeo et al., 2009a). Rbfox3 is exclusively 
expressed in mature neurons (Kim et al., 2009). The Rbfox proteins and particularly 
Rbfox1 have been associated with many human neurodevelopmental disorders including 
genetic generalized epilepsy (GGE), childhood focal epilepsy and autism spectrum 
disorders (Barnby et al., 2005; Bhalla et al., 2004; Martin et al., 2007; Sebat et al., 2007). 
Central nervous system-specific deletion of Rbfox1 or Rbfox2 in mice results in 
neurological defects resembling those in human diseases (Gehman et al., 2012; Gehman 
et al., 2011). While all the Rbfox proteins are expressed in neurons, they exhibit 
temporally and spatially distinct patterns of expression during neurodevelopment 
(Gehman et al., 2012), suggesting that they have distinct physiological activities besides 
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biochemical redundancy at the molecular level. Similarly, Rbfox1 and Rbfox2 showed 
different physiological functions during heart and muscle development. Rbfox2 is 
expressed in heart from embryo to adult whereas Rbfox1 is induced in postnatal heart 
(Kalsotra et al., 2008). As expected, Rbfox2 but not Rbfox1 is required for myoblast 
differentiation (Singh et al., 2014). When Rbfox1 and Rbfox2 are both expressed in 
mature heart, cardiac-specific ablation of Rbfox2 causes dilated cardiomyopathy that 
leads to heart failure (Wei et al., 2015), while Rbfox1 but not Rbfox2 is markedly 
diminished in pressure-overloaded hearts (Gao et al., 2016), suggesting that they have 
both overlapping and unique roles. As expressed in other cell types, Rbfox2 has also 
been shown to establish a splicing program involved in pluripotent stem cell 
differentiation in cooperation with another splicing factor MBNL1 (Venables et al., 2013b). 
In addition, Rbfox2 plays an important role in specifying the mesenchymal tissue-specific 
splicing profiles both in normal and in cancer tissues (Venables et al., 2013a). 
All Rbfox proteins contain a single highly conserved RNA recognition motif (RRM) 
(Auweter et al., 2006), which is identical in Rbfox1 and Rbfox2 and only slightly altered in 
Rbfox3. Despite the high conservation of RRM, one alternative exon skipping within RRM 
results in a dominant-negative isoform with decreased RNA-binding affinity, which inhibits 
Rbfox-dependent splicing activation (Damianov and Black, 2010). Increased expression 
of this dominant-negative isoform of Rbfox2 has also been found in diabetic hearts at 
early stages. By interacting with wild-type Rbfox2, dominant-negative isoform of Rbfox2 
inhibits the splicing activity of the wild-type protein (Nutter et al., 2016). 
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The flanking N and C terminal domains that are diversified through the use of 
alternative promoters and alternative splicing patterns (Damianov and Black, 2010). 
Different isoforms of Rbfox proteins show different tissue specificity. For instance, two 
mutually exclusive alternative exons B40 and M43, in the middle of C-terminal domain of 
Rbfox1 and Rbfox2, are expressed in brain and muscle respectively (Nakahata and 
Kawamoto, 2005). Variable N and C terminal domains of Rbfox proteins might affect the 
structure and potential activity of the protein.  
Inclusion of exon 19 at the 3’ region of Rbfox1 generates a protein isoform ending 
with the amino acid sequence TALVP, while skipping of this exon results in a FAPY C-tail 
which is required for proper localization into the nucleus (Lee et al., 2009). Thus, Rbfox1 
protein with TALVP tail is predominantly cytoplasmic. It has been reported that by binding 
to the 3’ UTR of mRNA transcripts, cytoplasmic Rbfox1 promotes the stability and/or 
translation of target transcripts involved in synaptic function, calcium signaling and autism 
(Lee et al., 2016). Similarly in Drosophila, the cytoplasmic Rbfox proteins regulate the 
translation of the germ cell maintenance factor pumilio by binding to its 3’ UTR, which is 
essential in maintaining normal germ cell differentiation (Carreira-Rosario et al., 2016). 
One proposed mechanism of regulating mRNA stability and translation by cytoplasmic 
Rbfox1 is through its competition with microRNA binding at the 3’ UTR (Lee et al., 2016). 
Unlike many RNA-binding proteins that have very degenerate binding sites, Rbfox 
proteins bind to RNA element GCAUG with high specificity (Jin et al., 2003). They usually 
enhance alternative exon inclusion when binding downstream of this exon, while 
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repressing exon inclusion when binding upstream or within the exon (Jin et al., 2003). 
Genome-wide analyses by RNA sequencing have revealed hundreds of targets regulated 
by Rbfox proteins. CLIP (UV crosslinking and immunoprecipitation) coupled with 
high-throughput sequencing has been used to discover the Rbfox binding sites on the 
target transcripts. Besides the exon-proximal binding sites of Rbfox proteins which are 
better studied so far, distal binding sites (>500 nucleotides from any exon) were shown to 
be active in Rbfox regulation through a conserved long-range RNA-RNA base-pairing 
interaction (Jangi et al., 2014; Lovci et al., 2013; Weyn-Vanhentenryck et al., 2014; Yeo 
et al., 2009a). Computational analyses of genome-wide CLIP and expression data 
revealed splicing regulatory networks controlled by the Rbfox proteins and provide 
insights of their roles in brain development and autism (Weyn-Vanhentenryck et al., 
2014). Rbfox2 cross-regulates alternative splicing events of other RNA-binding proteins 
to alter their expression by nonsense mediated decay, which further affects the splicing 
controlled by these RNA-binding proteins. A multilayer splicing regulatory network 
controlled by Rbfox proteins on top of many other RNA-binding proteins was revealed, 
thus offering an explanation for how regulatory splicing networks are tuned by the Rbfox 
proteins (Jangi et al., 2014). 
However, the molecular mechanisms that ensure precise regulation of alternative 
splicing in a position-dependent manner by Rbfox proteins remain poorly understood. 
Most studies to date have focused on the splicing repression by Rbfox proteins. It has 
been shown that Rbfox proteins repress the inclusion of calcitonin specific exon 4 by 
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blocking U2AF65 binding and suppressing exonic splicing enhancer in exon 4. Thus, 
Rbfox proteins block both the formation of the pre-spliceosomal E complex and its 
transition to E’ complex (Zhou et al., 2007; Zhou and Lou, 2008). Rbfox proteins also 
repress a different exon in F1γ gene via blocking the formation of pre-spliceosomal E 
complex when a weak 5’ splice site is more preferable (Fukumura et al., 2007; Fukumura 
et al., 2009). Protein partners of Rbfox proteins have also been examined to illuminate 
the molecular mechanism of Rbfox regulation. HnRNP H1 and hnRNP F were found to 
interact with Rbfox2 to repress the exon in FGFR2 minigene by antagonizing the binding 
of SRSF1 (Mauger et al., 2008). A different study reported that hnRNP H1 works together 
with RALY and TFG to specifically interact with the C-terminal domain of Rbfox proteins 
(Sun et al., 2012). However, how these protein partners are involved in Rbfox regulation 
is not well defined. In C. elegans, Rbfox proteins/ASD-1 and SUP-12 proteins 
cooperatively interact with egl-15 RNA by sandwiching a G base to form a stable complex 
where SUP-12 binds to the GUGUG sequence juxtaposed of Rbfox binding site 
(Kuroyanagi et al., 2007; Kuwasako et al., 2014). Different domains of Rbfox proteins 
were analyzed for their requirements in Rbfox activity as well. MS2-tethering assays 
showed that both RRM and C-terminus of Rbfox1 are required for exon repression when 
tethered to the upstream intron, whereas C-terminus tethered to the downstream intron is 
sufficient for exon activation (Sun et al., 2012). But the underlying molecular mechanism 
of the differential requirements of Rbfox domains in splicing activation and repression is 
not well understood.  
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The primary goal of this dissertation is to understand the molecular mechanisms by 
which Rbfox proteins regulate alternative splicing. We started with identification of Rbfox 
protein partners in the nucleus where Rbfox splicing regulation happens. Strikingly, 
nearly the entire pool of nuclear Rbfox is associated with the high molecular weight 
(HMW) material containing the chromatin. Furthermore, in this nuclear fraction the Rbfox 
proteins participate in an unexpected large protein complex which sediments in the 55S 
region in glycerol gradients. We call this large multimeric protein complex as a Large 
Assembly of Splicing Regulators, LASR. By characterizing the subunits of LASR complex 
and how LASR is involved in Rbfox-mediated splicing regulation, described by chapter 2, 
we have identified a novel mechanism that Rbfox protein affect splicing of a broader set 
of exons by interacting with RNA-binding proteins within LASR (Damianov et al., 2016). 
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SUMMARY
Rbfox proteins control alternative splicing and post-
transcriptional regulation in mammalian brain and
are implicated in neurological disease. Theseproteins
recognize the RNA sequence (U)GCAUG, but their
structures and diverse roles imply a variety of pro-
tein-protein interactions. We find that nuclear Rbfox
proteins are boundwithin a large assembly of splicing
regulators (LASR), a multimeric complex containing
the proteins hnRNP M, hnRNP H, hnRNP C, Matrin3,
NF110/NFAR-2, NF45, and DDX5, all approximately
equimolar to Rbfox.We show that splicing repression
mediated by hnRNP M is stimulated by Rbfox. Virtu-
ally all the intron-bound Rbfox is associated with
LASR, and hnRNP M motifs are enriched adjacent
to Rbfox crosslinking sites in vivo. These findings
demonstrate that Rbfox proteins bind RNA with a
defined set of cofactors and affect a broader set
of exons than previously recognized. The function of
this multimeric LASR complex has implications for
deciphering the regulatory codes controlling splicing
networks.
INTRODUCTION
Patterns of alternative pre-mRNA splicing are controlled by
specialized proteins that assemble onto the pre-mRNA and con-
trol splice site choices (Fu and Ares, 2014; Lee and Rio, 2015).
The Rbfox family of splicing regulators includes three mamma-
lian paralogs Rbfox1 (A2BP1), Rbfox2 (RBM9), and Rbfox3
(NeuN) that are all expressed in neurons and can show specific
expression in other cell types (Kuroyanagi, 2009).
Rbfox proteins affect a wide range of synaptic and neurodeve-
lopmental functions. Conditional Rbfox1 deletion in the mouse
brain leads to a seizure phenotype, whereas mice without brain
Rbfox2 exhibit cerebellar defects and ataxia (Gehman et al.,
2011, 2012). Mutations in Rbfox1 and Rbfox3 are found in human
epilepsy patients (Bhalla et al., 2004; Lal et al., 2013a, 2013b),
whereas other findings connect Rbfox1 with autism spectrum
disorders and spinocerebellar ataxias (Bill et al., 2013). Rbfox2
is also upregulated in certain cancers and controls exons during
the epithelial-mesenchymal transition (Braeutigam et al., 2014;
Venables et al., 2013). These findings have led to substantial clin-
ical interest in Rbfox protein function.
The Rbfox proteins all contain a single highly conserved RNA
recognition motif (RRM) that specifically binds the sequences
UGCAUG and GCAUG (Auweter et al., 2006; Jin et al., 2003;
Lambert et al., 2014). Alternative promoters and alternative
splicing produce multiple protein isoforms from each Rbfox
locus, with varying subcellular localization and splicing activity
(Damianov and Black, 2010; Lee et al., 2009; Nakahata and Ka-
wamoto, 2005). In addition to controlling splicing patterns, cyto-
plasmic Rbfox isoforms bind to 30 UTR targets to affect down-
stream gene expression (Lee et al., 2016). Target transcripts
for both nuclear and cytoplasmic proteins encodemany proteins
essential to neuronal development and synaptic activity (Geh-
man et al., 2011, 2012; Lee et al., 2016; Lovci et al., 2013;
Weyn-Vanhentenryck et al., 2014).
Typically, binding of Rbfox to a (U)GCAUG element down-
stream of the alternative exon promotes its splicing, whereas
binding to an upstream element, or an element within the exon,
represses exon inclusion (Jangi et al., 2014; Lovci et al., 2013;
Tang et al., 2009; Weyn-Vanhentenryck et al., 2014; Yeo et al.,
2009; Zhang et al., 2008). However, many (U)GCAUG elements
proximal to alternative exons do not affect splicing or exhibit
Rbfox binding. Conversely, (U)GCAUG elements located more
than 500 nucleotides away from a target exon can function
through base-pairing interactions that bring the bound protein
closer to the exon (Lovci et al., 2013). Moreover, some Rbfox
binding sites identified in genome-wide assays do not encom-
pass a (U)GCAUG element. Thus, the features determining
whether and how Rbfox will affect splicing are not understood.
We find that nuclear Rbfox proteins function within a large
macromolecular complex containing a distinct set of other
splicing factors that affect the recruitment of Rbfox to its targets.
RESULTS
Rbfox Proteins Engage in Distinct Protein and RNA
Interactions in Different Nuclear Compartments
To examine the portion of Rbfox protein engaged with nascent
RNA, we isolated nuclei from brain tissue followed by lysis
in Triton X-100. The majority of Rbfox proteins pelleted with
606 Cell 165, 606–619, April 21, 2016 ª2016 Elsevier Inc.
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chromatin and other high-molecular-weight (HMW) material,
with less than 10% of the protein present in the soluble nuclear
fraction (Figures 1A and 1B). Rbfox proteins could be extracted
from the pellet fraction using RNase and more efficiently with
Benzonase nuclease that cleaves both RNA and DNA (Figures
1A and 1B) and which removed more than 99% of the bulk
RNA from the fraction. We used this method to prepare subnu-
clear extracts from both mouse brain and cultured cells. Note
that this extraction differs from methods to isolate nascent
RNA, in which the chromatin is pelleted in high salt and urea to
eliminate many intermolecular interactions while maintaining
RNA polymerase association with DNA and nascent RNA (Kho-
dor et al., 2011; Pandya-Jones and Black, 2009; Wuarin and
Schibler, 1994). Our intent was to preserve protein-protein inter-
actions while eliminating interactions mediated by RNA. The
pellet fraction contains HMW material that is spun down with
chromatin but is not necessarily in direct interaction with it. The
release upon nuclease treatment indicates that a large portion
of Rbfox protein is associated with RNA (see below).
Different types of splicing regulators exhibited different parti-
tioning between the HMW fraction and the soluble nucleoplasm
(Figures 1B and S1). Similar to Rbfox, themajority of hnRNPs A1,
A2/B1, and Q/R, as well as the SR proteins, were found in the
HMW pellet and released with nuclease (Figures 1B and S1; in
Figure S1, compare the input lanes). These proteins are enriched
in nuclear speckles, indicating that nuclear speckle material also
pelleted with the HMW fraction (Misteli et al., 1998; Tripathi
et al., 2012). Unlike Rbfox, splicing factors such as PTBP2 and
hnRNP K showed approximately equal distribution between
the HMW and soluble fractions. Other proteins such as Nova
were enriched in the soluble nuclear fraction (Figures 1B and S1).
To examine Rbfox/RNA interactions in these two nuclear com-
partments, we performed individual nucleotide resolution cross-
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Figure 1. Rbfox Proteins Are Found in the
HMW Nuclear Fraction
(A) Preparation of the soluble and HMW nuclear
fractions.
(B) Immunoblot analysis of soluble and HMW
fractions from mouse brain. Rbfox1, Rbfox2, and
Rbfox3 were detected with an antibody recog-
nizing their nearly identical RRMs.
See also Figure S1.
linking immunoprecipitation (iCLIP) on
fractions of adult mouse brain (Ko¨nig
et al., 2010). UV irradiation of triturated
brain tissue did not alter the location of
the Rbfox proteins (Figure S2A). In vivo
crosslinking data were generated for
Rbfox1, Rbfox2, and Rbfox3 in the HMW
fractions of adult mouse forebrain and
hindbrain and for Rbfox1 in the soluble nu-
clear fractionof these regions.Crosslinked
Rbfox1, 2, and 3 were also isolated from
the soluble nuclear fraction of whole
mouse brain (Table S1A). Crosslinked
sequences were aligned to the mouse
genome,andsignificantclustersof iCLIP tagsweredefined (Ko¨nig
et al., 2010).Crosslinking commonlygenerates an iCLIP tag termi-
nating one nucleotide downstream. This position was frequently,
but not always,within a (U)GCAUGelement (seebelow). The iden-
tified clusters overlapped with previous maps of Rbfox binding
fromunfractionatedbrain tissue (Lovci et al., 2013;Weyn-Vanhen-
tenryck et al., 2014; Figures S2B and S2C). iCLIP clusters for
Rbfox1, 2, and 3were found adjacent to themajority of alternative
exonswhose splicingwas altered by brain-specific deletion of the
Rbfox1 or Rbfox2 genes (Gehman et al., 2011, 2012). The overlap
between Rbfox1, 2, and 3 binding sites supports the hypothesis
that functional redundancy reduces the magnitude of splicing
changes in Rbfox knockout mice.
The HMWand soluble fractions differed dramatically in the po-
sitions of Rbfox binding. In other cells, most unspliced RNA was
found in the HMW pellet even after stringent wash conditions
(Bhatt et al., 2012; Khodor et al., 2011; Pandya-Jones and Black,
2009). In agreement with this, themajority of Rbfox binding in the
soluble fraction from brain was in 30 UTR regions (Figure 2A),
whereas 90% of crosslinking events from the HMW fraction
were in introns, indicating predominant Rbfox association with
unspliced RNA in this compartment. The patterns of Rbfox bind-
ing are illustrated on the Snap25 transcript (Figure 2B), which
contains a pair of Rbfox-regulated mutually exclusive exons
(Gehman et al., 2011, 2012; Johansson et al., 2008). In the
HMW fraction, the majority of crosslinking events were in the
intron downstream of the two exons, with the 30 UTR showing
only one prominent Rbfox-binding cluster. In the soluble fraction,
intron clusters were largely absent (in keeping with the spliced
structure of the transcript), whereas the 30 UTR showed a broadly
distributed set of clusters (Figure 2B). Similar patterns of bind-
ing were seen for multiple other transcripts (see Supplemental
Information). The 30 UTR binding in the soluble nuclear fraction
Cell 165, 606–619, April 21, 2016 607
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was similar to that seen in the cytoplasm (Lee et al., 2016) and
may represent processed mRNA that is not yet exported from
the nucleus. RT-PCR measurements indicated that, unlike the
limited intron crosslinking in the soluble fraction, the lack of bind-
ing was not due to reduced amounts of 30 UTR RNA in the HMW
fraction (data not shown). The 30 UTR of Snap25mRNA was pre-
sent in both fractions, but not bound by Rbfox until release to the
soluble pool. The patterns of crosslinking indicate that more than
simple (U)GCAUG recognition determines Rbfox binding to RNA.
The Nuclear Rbfox Isoforms Are Subunits of a Much
Larger Complex of Proteins
Immunoprecipitation (IP) and mass spectrometry indicated that
the Rbfox proteins specifically associated with other proteins
in the brain HMW fraction (data not shown), but characterization
of these complexes required additional purification. To examine
Rbfox interactions in detail, we generated HEK293 cell lines
stably expressing N-terminally Flag-tagged Rbfox1, 2, or 3
(Figure 3A). Each cell line contained a single flipped-in Rbfox
transgene expressing physiological or lower levels of protein
compared to brain. The Rbfox proteins exhibited the same
enrichment in the HMW nuclear fraction of these cells as in neu-
rons (see below). We immunopurified the Rbfox proteins from
this fraction. Elution with Flag peptide yielded a defined set of
copurifying proteins seen on Coomassie-stained gels at nearly
equal stoichiometry to the tagged Rbfox protein (Figure 3A).
The pattern of copurifying bands was nearly identical for Rbfox1,
2, and 3. Multidimensional protein identification technology
B
A
chr2:
Snap25
(U)GCAUG
sequences
Conservation
136,596,000 136,599,000 136,602,000 136,605,000 136,608,000
2.1
0
Rbfox iCLIP Reads from Soluble nuclear fraction
Rbfox iCLIP Reads from HMW nuclear fractionRbfox1
Rbfox2
Rbfox3
iCLIP:
1 kb
0%
20%
40%
60%
80%
100%
Rbfox1 Rbfox2 Rbfox3
5' UTR
CDS
intron
3' UTR
S
ig
ni
fic
an
t r
ea
ds
 in
 c
lu
st
er
s
Rbfox1 Rbfox2 Rbfox3
soluble nuclear fraction HMW nuclear fraction
Figure 2. Rbfox Recruitment to Introns in the HMW Fraction and to 30 UTRs in the Soluble Nuclear Fraction
(A) Distribution of Rbfox iCLIP tags in 50 UTRs, CDS, 30 UTRs, and introns. Data for mouse brain iCLIP clusters of Rbfox1, 2, and 3with widthR2 nt are shown. See
Table S1 and Figure S2 for additional detail.
(B) Genome browser view of iCLIP reads mapped to the 30 portion of the Snap25 gene. iCLIP tracks from the soluble nuclear fraction of whole brain and the
cerebellar HMW fraction are aligned as indicated. Significant iCLIP reads from Rbfox1, 2, and 3 are colored as indicated. GCAUG motifs are shown below. See
Data S1 for additional examples.
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(MuDPIT) and immunoblots identified the major interacting part-
ners (Figures 3A and S3A). Two splicing factors, hnRNP M and
hnRNP H (which was previously shown to bind to Rbfox2;
Mauger et al., 2008), were present at slightly higher stoichiom-
etry to Rbfox. Proteins at near equal amounts to Rbfox included
matrin3, NF110/NFAR-2, NF45, and the DEAD-box helicase
DDX5/p68. Somewhat lower levels of hnRNP U-like-2 and
hnRNP C were also present, as were relatives of the above pro-
teins including MyEF2 (an hnRNP M homolog), hnRNP F, and
DDX17/p72 (Figures 3A and S3A). The same set of proteins
was found to associate with Rbfox proteins in mouse brain (Fig-
ure 3B; data not shown). Numerous other RNA-binding proteins
and splicing factors were absent from the Rbfox purifications,
including the major SR proteins, hnRNP A1/B2, A2/B1, R, Q, K,
PTBP1, and others (Figure S3A; data not shown).
Some interactions with Rbfox were specific to particular iso-
forms. NF110/NFAR-2, the largest product of the ILF3 gene,
has an extended C terminus absent from the more-abundant
NF90/NFAR-1 isoform (Saunders et al., 2001). Notably, NF90/
NFAR-1 did not copurify with Rbfox proteins (Figure S3A), impli-
cating the C-terminal domain of NF110 in this interaction (Reich-
man and Mathews, 2003). Similarly, hnRNP H1 and H2 copurify
with Rbfox more efficiently than the homologous hnRNP F (Fig-
ures 3A and S3A), whereas, for hnRNP M and hnRNP C, family
members bound with equal efficiency (Figures 3A and 3B). The
Rbfox-interacting proteins were not seen in other immuno-
precipitates, such as PTBP1, from brain or HEK293 cells. The
strikingly similar stoichiometry of the copurifying proteins, their
isoform specificity, and the absence of other RNA-binding pro-
teins in the isolate indicated that Rbfox bound with a specific
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Figure 3. Rbfox Proteins Coprecipitate from the HMW Fraction with a Distinct Set of Other RNA-Binding Proteins
(A) Immunopurification of Rbfox proteins from HEK293 nuclear fractions. Soluble and HMW nuclear extracts were prepared from cells stably expressing Flag-
tagged Rbfox1, 2, or 3. Proteins were immunoprecipitated with anti-Flag, eluted with Flag peptide, resolved on SDS-PAGE, and stained with SimplyBlue. The
major interacting proteins are indicated on the right. Flag-Rbfox bands are indicated by asterisks. (-) denotes nuclear fractions from the parental HEK293 cell line
that does not express Flag-tagged protein.
(B) Sedimentation of protein complexes frommouse brain HMWextract through 10%–50%glycerol gradients. Gradient fractions from top to bottom run from left
to right. 40S and 60S markers from a parallel gradient are indicated below. Rbfox1, Rbfox2, Rbfox3 and their binding partners are indicated on the right. MyEF2
and hnRNPMare detectedwith common antibody, as are the ILF3 gene products NF110 andNF90. The boxed area indicates a lower exposure of the same gel to
reduce the band intensities in those lanes.
See Figures S1 for additional data.
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set of interactors and was not copurifying with these proteins via
a common interaction with RNA.
Because multiple proteins were isolated in amounts equal
to the tagged Rbfox, it appeared that the Rbfox proteins associ-
ated with a single complex, rather thanmakingmultiple indepen-
dent interactions. To examine this, we immunoprecipitated Flag-
tagged hnRNPM and hnRNP H proteins transiently expressed in
HEK293T cells (Figures S3B and S3C). These overexpressed
proteins distributed between the soluble nucleoplasm and the
HMW fraction. In the HMW, but not the soluble nuclear fraction,
both hnRNP M and H copurified with the same set of proteins
found with Flag-Rbfox. These proteins were again isolated at
similar stoichiometry to each other, although in this case less
abundantly than the overexpressed hnRNP M or H (Figures
S3B and S3C). HnRNPM interacted with two additional proteins
SRSF14 and hnRNP Q/R. The proteins copurified with hnRNP
H or M in the absence of coexpressed Rbfox protein, but when
HA-tagged Rbfox3 was transfected, this protein was isolated
with Flag-hnRNP M (Figure S3B). These results indicate that
the Rbfox proteins in the HMW fraction associate with a defined
complex of other proteins that can assemble without Rbfox.
To examine the size of the Rbfox complexes, we separated
the soluble and HMW nuclear fractions from mouse brain by
sedimentation through glycerol density gradients (Figure 3B).
Interestingly, the majority of all three Rbfox proteins in the
HMW fraction sedimented as a very large protein complex with
an average size of 55S (Figure 3B; see the anti-Rbfox RRM
panel). The abundant proteins copurifying with Flag-Rbfox all
showed cosedimenting peaks, including hnRNP M/MyEF2,
hnRNP H, hnRNP C, NF110, and NF45 (Figure 3B). Unlike Rbfox,
where the majority of the protein was 55S in size, portions of the
other proteins sedimented as likely monomers (fractions 1 and 2)
and smaller complexes (fractions 4–6). In the soluble nuclear
fraction, these proteins also sedimented as free proteins and
small complexes at the top of the gradient (data not shown).
Numerous other splicing factors, including hnRNP A1, hnRNP
K, Nova, PTBP2, the SR proteins, and others that did not copur-
ify with Rbfox proteins, did not sediment in the 55S fraction but
were found as free proteins or complexes up to about 20S in
size (Figure S1). Notably NF90, containing the same N-terminal
double-stranded RNA-binding domains as NF110 but lacking
its C-terminal domain, failed to cosediment with Rbfox just as
it did not copurify with the Flag-Rbfox proteins (Figure 3B).
We also examined gradients of the HMW fraction fromHEK293
cells, probing for Rbfox1 and its interacting proteins hnRNP
H and M. Similar to brain, all the Flag-Rbfox1 was found at
!55S, accompanied by peaks of hnRNP H and M (Figure 4A).
Some hnRNP H and M were also present as smaller complexes
and apparentmonomers (Figure4A), andonly these smaller forms
were seen in the soluble nuclear fraction (Figure S3D). The 55S
peak of hnRNP H and M was also observed in HEK293 cells not
expressing an Rbfox transgene (data not shown). Because these
cells express low levels of Rbfox2, it is not clear whether Rbfox is
responsible for the highSvalueof theHandMproteins orwhether
additional complexes assemble from these proteins. The data
indicate that nearly the entire nuclear pool of Rbfox proteins is
associated with a large nuclease-resistant complex of proteins
in both the brain and HEK293 cells.
The total mass of one copy of each protein in the flag eluate is
not sufficient to yield a 55S complex, which is expected to be in
the megadalton range. To further assess the size and heteroge-
neity of these protein complexes, we analyzed each fraction
across the gradient by native protein gel and immunoblot to
identify Flag-Rbfox- and hnRNP M-containing species. Probing
these gels with anti-Flag antibody identified slowly migrating
complexes in the fractions containing Rbfox protein (Figure 4B,
top). Interestingly, these complexes increased in size in fractions
of successively higher S value. This indicates that the Rbfox
complexes are heterogeneous, with an average size of 55S.
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Figure 4. The 55S Rbfox Complex Is Present in HEK293 Cells and Is
Heterogeneous in Size
(A) Gradient sedimentation of HMW extract from HEK293T cells transiently
expressing Flag-tagged Rbfox1. Proteins detected by immunoblot are indi-
cated as in Figure 3B.
(B) Native gel analysis of complexes separated on glycerol gradients. HMW
extracts from HEK293 cells stably expressing Flag-tagged Rbfox3 were
fractionated, and protein complexes were resolved by native PAGE and pro-
bed by immunoblot. Flag-Rbfox3 (top) and hnRNPM (bottom) are indicated on
the right.
See Figure S3 for further analyses.
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Probing the gel with anti-hnRNP M antibody labeled the same
complexes containing Rbfox, a small species in fraction 2 that
is likely monomeric hnRNP M, and a complex lacking Rbfox in
gradient fractions 2–6 (Figure 4B, bottom). This complex may
be a precursor to the larger 55S population of complexes con-
taining Rbfox.
Taken together, these data indicate that the Rbfox proteins
assemble with a large complex of proteins containing hnRNP M,
hnRNP H, Matrin3, hnRNP U-like-2, hnRNP C, NF110, NF45,
and DDX5/17. We call this complex a large assembly of splicing
regulators (LASR).Wenext examinedhow the interactionofRbfox
with LASR might affect splicing.
Rbfox Can Repress Splicing through the Binding
Element for Another LASR Component hnRNP M
The iCLIP and biochemical analyses together indicate that the
intron-bound Rbfox protein is all associated with LASR and thus
likely regulates splicing as a part of this assembly. LASR compo-
nents are also found as free proteins and presumably have func-
tions in addition to their role in LASR. The LASR subunit hnRNP
M regulates splicing during the epithelial mesenchymal transition
(EMT) (Hovhannisyan and Carstens, 2007; Xu et al., 2014). Inter-
estingly, the activity, but not the expression, of hnRNP M was
found to changeduringEMT,whereasRbfox2 is upregulated dur-
ing this transition (Venables et al., 2013; Xuet al., 2014). To test the
effect of Rbfox on hnRNP M splicing activity, we created a three
exon minigene based on DUP51EK (Amir-Ahmady et al., 2005),
where the second exon contains an hnRNPM consensus binding
motif, UGGUGGUG, as defined by CLIP analysis (Huelga et al.,
2012). We mutated other potential hnRNP M binding sites and
all GCAUG motifs to create DUP-51M1. An equivalent minigene
carriedamutation in thehnRNPMsite (DUP-51DMsite;Figure5A).
In gel shift assays, purified hnRNPM bound this exon, but not the
mutant exon,whereaspurifiedRbfox2did not bindeither thewild-
typeormutant exon (FiguresS4A–S4C). Depletion of hnRNPMby
RNAi stimulated splicing of DUP-51M1 exon 2, as did mutation of
theM site, confirming that hnRNPMacts as a silencer of the exon
(Figure S4D). We also found that hnRNP M crosslinked to DUP-
51M1 pre-mRNA in vivo and that this crosslinking is reduced by
the M site mutation (Figure S4E).
DUP51M1 andDUP-51DMsite were transfected into HEK293T
cells, with and without an Rbfox3 expression plasmid. Coex-
pression of Rbfox3 strongly inhibited target exon splicing of
DUP-51M1but hadminimal effect onDUP-51DMsite (Figure 5B).
Thus, Rbfox can alter the splicing of an exon containing an
hnRNP M site. The in vivo association of Rbfox3 with this tran-
script was confirmed by crosslinking, anti-Flag IP, and RT-PCR
of the pre-mRNA (Figure 5C). The DUP-51M1 transcript was
readily detected in the RNA crosslinked to Rbfox3, and this
was strongly reduced by mutation of the M site (Figure 5C, bot-
tom panel). GAPDH RNA, which crosslinked at moderate levels
to the overexpressed Rbfox3, was used to normalize band inten-
sities. The M site mutation did not reduce the level of precursor
RNA to cause the reduced Rbfox binding (data not shown).
The crosslinking of Rbfox3 indicated close proximity to the
reporter pre-mRNA that was dependent on the M site.
To generally assess the effect of Rbfox proteins on hnRNP M
activity, we profiled exon inclusion across the transcriptome in a
modified HEK cell line where the low level of endogenous Rbfox2
was eliminated by CRISPR/Cas9 deletion of an early exon in the
Rbfox2 gene (data not shown). Rbfox1 was introduced at the
flip-in locus to yield two cell lines plus and minus Rbfox1 expres-
sion (Figure 6). HnRNPM could be efficiently depleted from both
lines by RNAi without affecting Rbfox1 expression (Figure 6A).
Profiling alternative exon use in the four conditions in triplicate
by RNA-seq and rMATS (Tables S1B and S4; Shen et al.,
2014), we identified hnRNP M-dependent exons in the presence
of Rbfox1 and Rbfox1-dependent exons in the presence of
hnRNPM (Figures 6B and 6C).We found that the effect of hnRNP
M on both exon activation and exon repression was strikingly
reduced when Rbfox1 was absent (Figure 6B). Of 225 exons
whose inclusion was increased or decreased by M depletion in
Rbfox1-expressing cells, 144 showed a 15% or greater reduc-
tion in this effect in the absence of Rbfox1. To control for bias
arising from exon selection, we carried out the reverse analysis
of hnRNPM-dependent exons defined in the absence of Rbfox1.
A significantly smaller fraction of these exons was sensitive to
Rbfox1 (two-sided p value < 2.0 3 10!5 by Fisher’s exact test).
Thus, the shift in splicing observed in Figure 6B was not due
to biased exon selection. These results confirmed that hnRNP
M activity was affected by Rbfox.
Reciprocal analyses examined the dependence of exons on
Rbfox1 in the presence and absence of hnRNP M (Figure 6C).
RNAi depletion of hnRNP M was not as stringent as Rbfox
knockout, leaving about 10% of the endogenous hnRNP M
and all of the possibly redundant paralog MyEF2 (data not
shown). Nevertheless, of 726 Rbfox1-dependent exons identi-
fied in the hnRNP M-expressing cells, 329 were less affected
by Rbfox1 when hnRNP M was absent (defining the same pa-
rameters as Figure 6B). We found that depletion of other LASR
components often inhibited cell growth and/or altered expres-
sion of Rbfox proteins. Testing the effects of these proteins on
Rbfox activity will likely require different approaches.
TheBinding of Rbfox to Its Target Element Is Affected by
Adjacent Sequence Motifs
To assess whether LASR components affect where Rbfox binds,
we analyzed sites of Rbfox crosslinking for enriched binding mo-
tifs. Among the LASR subunits, hnRNP M binds to GU-rich mo-
tifs (Huelga et al., 2012), hnRNP C to polyU sequences (Go¨rlach
et al., 1994; Ko¨nig et al., 2010; Swanson and Dreyfuss, 1988),
and hnRNP H to polyG and GGGA sequences (Caputi and Zah-
ler, 2001; Chou et al., 1999; Huelga et al., 2012). We defined
high-confidence binding sites as intronic sequences containing
overlapping iCLIP clusters for all three Rbfox proteins in either
the forebrain or hindbrain HMW fractions. These regions were
analyzed for pentamer frequencies (see Supplemental Experi-
mental Procedures; Table S2). Based on the previous CLIP
analyses (Huelga et al., 2012), we defined possible hnRNP
M-binding motifs as all pentamers containing three Gs and two
Us or three Us and two Gs but without more than two Gs or Us
in a row. This definition includes all the described binding pen-
tamers, but it is likely that some sequences within this group
bind hnRNPM better than others. HnRNP C pentamers included
U5 and all pentamers containing four continuous U nucleotides.
Similarly, hnRNP H pentamers included G5 and all pentamers
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containing four continuous Gs. Within the large set of Rbfox-
binding regions, both hnRNPM and hnRNP Cmotifs were highly
enriched, whereas hnRNP H motifs were depleted relative to a
control distribution (Figure S5).
GCAUG was the most-enriched pentamer in the high-confi-
dence binding regions, and thismotif was often aligned precisely
at the crosslink site (Figures 2B and S5). However, as seen pre-
viously, many iCLIP clusters did not contain the GCAUG motif
(Jangi et al., 2014; Lovci et al., 2013; Weyn-Vanhentenryck
et al., 2014; Yeo et al., 2009). We subdivided the intronic binding
regions into two sets: (A) those containing aGCAUG or a UGCAU
within ±40 nucleotides of the crosslink site and (B) those without
such a proximal Rbfox-binding motif. These two sets of se-
quences were analyzed for pentamer frequencies (Figures 7A
and 7B; with all motif scores in Table S3). Binding regions in
set A showed the expected enrichment of its component
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Figure 5. Rbfox3 Can Regulate Alternative Splicing through an hnRNP M Binding Site
(A) Diagram of the minigene DUP-51M1 and its mutant DUP-51DMsite. The M binding site is in bold. Arrows indicate primers used to detect DUP-51 pre-mRNA.
(B) DUP-51M1 or DUP-51DMsite were transfected into HEK293T cells with control vector (-) or Flag-Rbfox3 expression vector. Exon 2 splicing wasmeasured by
RT-PCR with primers in the flanking exons. The spliced products are indicated (top). Average exon inclusion with SD from four experiments is quantified below.
Rbfox3 expression caused a 4.6-fold decrease in DUP-51M1 exon 2 splicing. Statistical significance (red) was measured by unpaired, two-tailed, unequal
variance Student’s t test. HnRNP M, Flag-tagged Rbfox3, and U1-70K, as a loading control, are indicated (bottom).
(C) As in (B), cells expressing DUP-51 minigenes and Flag-Rbfox3 were UV irradiated in vivo and lysed under denaturing conditions to prevent copurification of
hnRNP M. RNA:protein crosslinks were immunoprecipitated with anti-Flag. HnRNP M, Flag-Rbfox3, and GAPDH in the lysates (lanes: input) and immunopre-
cipitates (lanes: Flag IP) were measured by immunoblot (top). The boxed area indicates a lower exposure of the same gel to reduce the band intensities in those
lanes. DUP-51 pre-mRNA and GAPDH mRNA were detected by RT-PCR (bottom). Amounts of coprecipitated RNA normalized to the Rbfox3 protein over three
experiments are graphed, with means, SD, and p value as in (B).
See Figures S4 and S6 for additional analyses.
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GCAUG and UGCAU pentamers (Figure S5). In the set B binding
regions, U pentamers were the most-enriched motifs and were
more common than in set A (compare Figures 7A and 7B). Similar
to the entire high-confidence set of iCLIP clusters (Figure S5), GU
pentamers were highly enriched in both subsets of binding re-
gions. These data indicate that binding sites for other LASR com-
ponents are commonly found adjacent to sites of Rbfox binding.
To examine the positions of particular motifs relative to the
crosslink sites, we further refined two smaller groups of intronic
Rbfox iCLIP clusters. Group 1 contained a GCAUG within five
nucleotides upstream or downstream of the crosslinking site
defined as position 0 (orange lines in Figure 7C). As seen previ-
ously (Jangi et al., 2014; Weyn-Vanhentenryck et al., 2014), the
GCAUG pentamer most frequently began at either position !4
or 0, consistent with crosslinking to the second or the first gua-
nine of a GCAUG motif (Figure 7C, top). The second group of
clusters (red lines in Figure 7C) contained crosslink sites more
than 100 nt away from the nearest GCAUG. In group 2 clusters,
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(A) Immunoblot of hnRNPM and Rbfox1 in Rbfox2-null HEK293 cells. Rbfox2-knockout cells and derivative cells with Flag-Rbfox1 at the Flp-in locus were grown
in doxycycline, transfected with control or hnRNP M-targeted shRNA plasmids and harvested 84 hr post-transfection. Relative protein expression over three
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(B) Comparison of hnRNP M splicing activity in cells expressing Flag-Rbfox1 to that in cells not expressing Rbfox proteins. hnRNP M-regulated exons on this
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Rbfox crosslinking is presumably determined by other interac-
tions than GCAUG recognition, although it is possible that
secondary structure brings a distal GCAUG motif close to the
crosslinked region. The U5 motif was strongly enriched precisely
at the crosslink sites of the group 2 clusters (red line, Figure 7C,
bottom), with the most-frequent crosslink at U2. This motif
showed no enrichment at particular positions adjacent to the
GCAUG crosslink sites (orange line).
IndividualGUpentamerswere enrichedat particular positions in
bothgroupsofcrosslinkingsites (Figure7Cshows theGUpentam-
erswith the topZ scores). In group1clusters, theseGUpentamers
were enriched at upstream and downstream positions directly
abutting the crosslinked GCAUG, as well as further upstream of
the GCAUG motif. Because all the Rbfox is assembled with
LASR, the common position of these pentamers presumably re-
flects the binding of another LASR protein—most likely hnRNP
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Figure 7. Enrichment of Sequence Motifs near Sites of Rbfox Binding
Histogram of pentamer enrichment Z scores within 40 nucleotides of the crosslink sites. iCLIP clusters showing overlap for all three Rbfox paralogs in forebrain or
hindbrain HMW fractions were analyzed.
(A and B) Motif enrichments were calculated for crosslink sites less than 40 nucleotides from the nearest GCAUG motif (A) or for sites more than 40 nt from this
motif (B). The top 10% of Z scores is shaded darker gray. The Rbfox-binding GCAUG, UGCAU (red), and similar pentamers (orange) are indicated as dots below
and sorted by Z score above. Motifs recognized by hnRNP M (blue), hnRNP C (green), and hnRNP H (gray) are similarly shown.
(C) Motif distribution near the crosslink sites. The fraction of sequences with an individual motif aligning at each nucleotide relative to the crosslink site is plotted.
Smaller groups of the cluster subsets A and B were analyzed: (1) those containing a GCAUG sequence within five nucleotides of the crosslink site (orange lines)
and (2) those with a crosslink >100 nt away from the nearest GCAUG (red lines).
(D) WebLOGO plots of the sequence adjacent to (U)GCAUG motifs (Crooks et al., 2004). (Top) Intronic sequences containing a GCAUG motif within 5 nt of an
Rbfox crosslink site are shown. (Middle) Sequences containing UGCAUG from introns with Rbfox iCLIP clusters but >100 nt away from the nearest crosslink site
are shown. (Bottom) Mean PhyloP placental conservation scores of the WebLOGO sequences are shown (blue line, no Rbfox crosslinking; orange line,
crosslinked to Rbfox).
See Figures S5 and S6 for additional information.
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M.Thegroup 2 clusters showeddifferent patterns ofGUpentamer
placement (Figure 7C, red lines), with peaks very close to the
crosslinksite, anddispersedenrichment in theadjacent sequence.
The most-enriched GU-rich pentamer in these group 2 clus-
ters was UGUUG. To examine the activity of this element in
splicing, we made a new splicing reporter with the duplicated
element UGUUGUGUUG in the exon (DUP-50M1; diagramed
in Figure S6A). This fused element also contains a UGUGU pen-
tamer that is enriched in group 2 clusters. Purified hnRNPM, but
not Rbfox2, bound this exon in vitro, and theM binding was elim-
inated by mutation of the element (Figures S4A–S4C). This
element, but not its mutant, rendered the exon repressible by
Rbfox3 and stimulated crosslinking of Rbfox3 to the transcript
in vivo (Figures S6B and S6C), similar to the hnRNP M element
defined by CLIP (Figures 5B and 5C).
For every GCAUG sequence within an iCLIP cluster, there can
be dozens of exact UGCAUG sequences within the same tran-
script that do not exhibit crosslinking and presumably do not
bind Rbfox. To examine the contribution of adjacent nucleotides
to Rbfox binding, we aligned the central GCAUGmotifs from the
group 1 clusters and plotted the nucleotide frequency at adja-
cent positions. The highest probability sequence flanking the
GCAUG from position !15 to position +15 consisted of alter-
nating G and U nucleotides (Figure 7D, top). This pattern was
compared to UGCAUG hexamers from introns containing iCLIP
clusters but which did not generate a cluster themselves. Nucle-
otides adjacent to these non-Rbfox-binding hexamers exhibited
a different pattern of A and U enrichment (Figure 7D, middle).
GCAUG motifs bound by Rbfox were also more conserved
than the unboundmotifs, with PhyloP conservation scores peak-
ing within the GCAUG and extending into adjacent nucleotides
(Figure 7D, bottom). These data indicate that the surrounding
nucleotide context of a (U)GCAUG element contributes to its
recruitment of an Rbfox protein.
DISCUSSION
A Large Protein Assembly for Rbfox Proteins
Much of splicing occurs in conjunction with transcription, and
splicing factors are concentrated adjacent to active loci in
nuclear speckles thought to consist of dense networks of inter-
molecular interactions. After nuclear lysis, unspliced RNA re-
mains associated with chromatin and other HMW assemblies.
However, biochemical analyses of pre-mRNA splicing usually
employ proteins and RNPs eluted from intact nuclei at moderate
salt that may not engage in all interactions defining their function.
To assess the contacts of splicing regulators in compartments
more immobile than the soluble nucleoplasm, we lysed nuclei
under mild conditions and examined how proteins partition
between the pellet and the supernatant upon centrifugation.
The Rbfox proteins were largely found in the HMW pellet, con-
taining chromatin, nuclear speckle components, and unspliced
RNA. Splicing regulators were associated with RNA in this frac-
tion, and extraction of the pellet with Benzonase released them in
soluble form. In this preparation, the Rbfox proteins were asso-
ciated with a multimeric complex, the LASR. It will be interesting
to examine other regulators in these fractions and perhaps find
other new interactions.
The Rbfox protein in the HMW extract was entirely associated
with LASR. Isolation of LASR via a tagged Rbfox protein or
tagged hnRNP M or H yielded approximately equal quantities
of hnRNPM, hnRNP H, and tagged Rbfox and only slightly lower
amounts of Matrin3, hnRNP U-like-2, hnRNP C, NF110, NF45,
and DDX5. The near equimolar stoichiometry of the components
when isolated with different tagged subunits indicated that LASR
assembled via specific protein-protein interactions and was not
a random aggregation of proteins released by the nuclease.
Similarly, the absence of other RNA-binding proteins in the com-
plex, and its resistance to extensive nuclease treatment, indi-
cated that the LASR subunits were not held together by binding
to a common RNA. This nuclease resistance distinguishes LASR
from previously characterized RNP assemblies such as the 40S
hnRNP particle, the DBIRD complex, and the higher-order exon
junction complex (Close et al., 2012; Singh et al., 2012; Walker
et al., 1980).
LASR subunits were present as free proteins, small complexes
that contain components other thanRbfox, and large 55Sassem-
blies that contain Rbfox. The 55S complexes were heteroge-
neous in size yet still yielded equivalent stoichiometries of all
the components, indicating that they may be higher-order as-
semblies of a unit complex. The unit LASR complex is present
in cells without Rbfox (Figures 4BandS3C). Thismaymultimerize
to create the 55S formsor interact with amuch larger but substoi-
chiometric structure to yield its high S value. Given that all of the
Rbfox is in this larger form, it is possible that Rbfox itselfmediates
themultimerization. In thebrain, nuclearRbfox1 andRbfox3were
almost entirely associated with the 55S complex. Rbfox2 bound
this complex but was also in light fractions, indicating a possible
functional difference of Rbfox2. It will be interesting to identify
interactions that hold the LASR subunits together, that allow
recruitment ofRbfox, and thatmediate its higher-order assembly.
The components of LASR engage in a variety of other inter-
actions. LASR shares several components with one of two
described microprocessor complexes, including NF45, DDX5,
DDX17, hnRNP M, and hnRNP H (Gregory et al., 2004). Instead
of Rbfox, the microprocessor contains Drosha and DGCR8
that carry out miRNA processing. Other described Rbfox inter-
actions include with U1C, hnRNP K, Sam68, RALY, PSF, TFG,
and Ataxin2, as well as the aforementioned hnRNP H contact
(Huang et al., 2012; Kim et al., 2011; Mauger et al., 2008; Shibata
et al., 2000; Sun et al., 2012). Recombinant Rbfox added to an
in vitro splicing extract inhibited assembly of a pre-spliceosomal
E-complex on an Rbfox-repressed exon (Fukumura et al., 2007;
Zhou and Lou, 2008). This activity will be interesting to assess for
involvement of the LASR complex.
Rbfox Regulation of Splicing in the Context of LASR
Wefind that the expression of Rbfox altered the activity of hnRNP
M in controlling splicing and that M binding sites increased the
crosslinking of Rbfox to a reporter RNA in vivo. Thus, the hnRNP
M component of LASR can apparently allow Rbfox to alter
splicing through an indirect interaction with the RNA. In exam-
ining what constitutes a functional binding site, we found that
sequences adjacent to Rbfox-crosslinked GCAUG pentamers
were enriched for motifs that potentially bind hnRNP M.
We further found that atypical non-(U)GCAUG sites of Rbfox
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crosslinkingwere enriched forMandCmotifs, possibly indicative
of LASR-mediated recruitment of Rbfox. Although additional
work is needed to confirm this mechanism, such an hnRNP
M/Rbfox interaction can explain how the activity, but not the
expression of hnRNP M, increases during the EMT (Venables
et al., 2013; Xu et al., 2014).
The multiple RNA-binding domains within LASR raise ques-
tions regarding the optimal arrangement of regulatory motifs
and how the architecture of the complex might enforce co-
recognition of certain motifs. The enrichment of GU-rich motifs
adjacent to GCAUG-binding elements may derive from the
hnRNP M in the LASR contacting the RNA simultaneously with
Rbfox. However, other GU-binding proteins cannot be ruled
out. In C. elegans, an Rbfox family member can cooperatively
assemble with the Sup12 protein binding to an adjacent GU-rich
motif (Kuwasako et al., 2014). It is not clear whether mammalian
Sup12-like proteins also cooperate with Rbfox or bind LASR.
Substantial efforts are being directed at understanding a
‘‘splicing code’’ that would predict the splicing pattern of a
pre-mRNA from its sequence (Barash et al., 2010; Zhang et al.,
2010). A group of splicing regulators acting within a common
complex provides a mechanistic explanation for the co-occur-
rence of certain binding motifs.
The non-RRM domain proteins of LASR also have interesting
features. The double-stranded RNA-binding protein NF110/
NFAR2 and the helicase DDX5 were shown to interact and to
affect transcriptional regulation (Fuller-Pace, 2013; Ogilvie
et al., 2003; Reichman and Mathews, 2003; Saunders et al.,
2001). DEAD-box proteins like DDX5 often have lower RNA heli-
case activity than the DEAH-box family and may instead act as
switches to control assembly steps, with ATP hydrolysis toggling
the protein between conformational or binding states (Singh
et al., 2015). Studies demonstrate DDX5 involvement in splicing
of particular exons, where it may alter assembly of pre-mRNP
complexes (Guil et al., 2003; Kar et al., 2011; Liu, 2002).
Most attention has focused on the RNA recognition properties
of splicing regulators, but these proteins also engage in complex
protein/protein interactions. An Rbfox splice variant lackingmost
of the RNA-binding domain, but retaining the N- and C-terminal
domains can block splicing activation, but not splicing repres-
sion, by full-length Rbfox (Damianov and Black, 2010). The
C-terminal domain is required for both splicing repression and
activation by an MS2-tethered Rbfox protein (Sun et al., 2012).
The significance of the Rbfox1 and Rbfox3 C-terminal domains
is underscored by their mutation in familial epileptic syndromes
(Lal et al., 2013a, 2013b). Elucidating the consequences of these
mutations, as well as understanding Rbfox1 roles in autism
spectrum disorders and spinal cerebellar ataxia, will require a
clearer description of Rbfox interactions in nuclear and cyto-
plasmic mRNA metabolism.
EXPERIMENTAL PROCEDURES
Cell Culture and Tissue Isolation
Stable HEK293 lines expressing HA-Flag-tagged Rbfox1, 2, or 3 proteins were
prepared using the Flp-In T-REx System (Life Technologies). An Rbfox2-defi-
cient clone derived from this cell line was obtained by CRISPR/Cas9-guided
deletions in the first constitutive Rbfox2 exon. Brain tissue was obtained from
6-week-old C57BL/6J male mice (Charles River Laboratories). Transfection
of HEK293 cells was as described (Damianov and Black, 2010). For transient
expression of recombinant proteins, cells were harvested 48 hr post-transfec-
tion or post-induction with 0.5 mg/ml doxycycline. For RNAi, hnRNPMwas tar-
geted with short hairpin RNAs (shRNAs) as described in the Supplemental
Experimental Procedures. All experiments were approved by the UCLA Institu-
tional Animal Care and Use Committee (ARC# 1998-155-53).
RT-PCR
Total RNA was extracted with TRIzol (Life Technologies) from cells or tissues.
DNA was removed with RQ1 DNase. Reverse transcription was carried out
with SuperScript III (Life Technologies) and gene-specific reverse primers.
Minigene and GAPDH products were amplified for 15–18 PCR cycles and
detected as described (Damianov and Black, 2010). Primer and minigene
sequences are listed in Supplemental Experimental Procedures.
RNA-Protein Crosslinking In Vivo
Monolayer HEK293T cultures were irradiated with UV (254 nm) at 75 mJ/cm2
on ice in a Stratalinker 1800 (Stratagene). Mouse brain samples were triturated
in ice-cold HBSS solution and UV irradiated at 600 mJ/cm2.
Preparation of Whole-Cell Lysates for Reporter Experiments
UV-irradiated HEK293T cells were lysed 5 min on ice with ten packed cell vol-
umes of buffer (20 mM HEPES-KOH [pH 7.5], 150 mM NaCl, 0.5 mM DTT,
1 mM EDTA, 0.6% Triton X-100, 0.1% SDS, and 50 mg/ml yeast tRNA) and
centrifuged at 20,000 3 g for 5 min at 4!C. The supernatants were 53 diluted
with buffer (20 mM HEPES-KOH [pH 7.5], 150 mM NaCl, 0.5 mM DTT, 1 mM
EDTA, 1.253 cOmplete protease inhibitors [Roche], and 50 mg/ml yeast
tRNA). Lysates were spun for 10 min at 20,000 3 g, 4!C prior to IP.
Subcellular Fractionation
Nuclei from cell cultures or tissues were purified as described (Grabowski,
2005), resuspended in ten volumes of buffer (10 mM HEPES-KOH [pH 7.6],
15mMKCl, 1mMEDTA, 0.15mMspermine, 0.5mMspermidine), and pelleted
at 1,0003 g for 5 min at 4!C. Nuclei were lysed for 5 min in ten volumes of ice-
cold lysis buffer (20 mM HEPES-KOH [pH 7.5], 150 mM NaCl, 1.5 mM MgCl2,
0.5 mM DTT, 1.253 protease inhibitors, and 0.6% Triton X-100). Soluble and
HMW fractions were separated by centrifugation at 20,000 3 g for 5 min
at 4!C. Samples for iCLIP are described in the Supplemental Information. To
extract nuclease-resistant protein complexes, the soluble fraction was
removed and an equal volume of lysis buffer added to the HMWpellet. Soluble
and HMW fractions were incubated at 25!C on a rotator with 5 U/ml of Benzo-
nase (Sigma) until the HMW pellet was resuspended and then cleared by
centrifugation for 10 min at 20,000 3 g, 4!C.
Immunoprecipitation
Nuclear fractions or whole-cell lysates were incubated overnight at 4!C with
5- to 7.5-ml-packed M2 FLAG agarose beads (Sigma). For nuclear fractions,
beads were washed four times with wash buffer (20 mM HEPES-KOH
[pH 7.5], 150mMNaCl, and 0.05% Triton X-100). For whole-cell lysates, beads
were washed five times with wash buffer containing 1M NaCl and twice with
standard wash buffer. Flag-tagged proteins were eluted from beads over
2 hr at 4!C in 50–100 ml of elution buffer (20 mM HEPES-KOH [pH 7.5],
100 mMNaCl, and 150 ng/ml of 33FLAG peptide [Sigma]). RNA-protein cross-
links were eluted with elution buffer plus 5 mg of yeast tRNA.
Protein Analysis
Immunoprecipitated proteins were subjected to MuDPIT as described
(Sharma et al., 2014) and analyzed by SDS-PAGE with immunoblotting or pro-
tein staining as described (Damianov and Black, 2010). Protein complexes
were resolved on 10%–50% glycerol gradients (20 mM HEPES-KOH
[pH 7.5], 150 mM NaCl, 0.5 mM DTT, and 13 protease inhibitor) in 14 3
89 mm tubes (Beckman Coulter Genomics). Extracts (250 ml) were loaded
and spun in a SW41Ti rotor (Beckman Coulter) at 32,0003 RPM for 12 hr at
4!C. Gradients were fractionated top to bottom into 24 3 500 ml fractions.
Fractions were analyzed by immunoblot or resolved on 3%–12% NativePAGE
Novex Bis-Tris Gels (Life Technologies). Primary antibodies are listed in Sup-
plemental Experimental Procedures.
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iCLIP
iCLIP libraries were prepared following Ko¨nig et al. (2010), with changes to
allow for the differing RNA content of the cellular fractions. iCLIP libraries
were sequenced on a HiSeq2000 (Illumina). Data analyses were performed
as in Ko¨nig et al. (2010), with few modifications. In brief, PCR duplicate iCLIP
reads were removed using random barcodes. Unique reads were mapped to
mouse genome mm9/NCBI37 using Bowtie, allowing two mismatches (Lang-
mead et al., 2009). Mapped reads were assigned to the longest transcripts in
the Known Gene table (Hsu et al., 2006) and divided into 50 UTR, CDS, intron,
and 30 UTR regions. Motif enrichment and the modified iCLIP protocol are
described in the Supplemental Experimental Procedures.
Genome-wide Splicing Analysis
Total TRIzol-extracted RNA was treated with TURBO DNase (Ambion) and
polyA plus RNA isolated on Oligo-dT. cDNA libraries were prepared using
TruSeq Kits (Illumina). Read properties are shown in Table S1B. Alternative
splicing was analyzed by rMATS (Shen et al., 2014) and expressed as changes
in percent-spliced-in values (DPSI). Exons showing splicing change (jDPSIj >
10 with false discovery rate [FDR] less than 0.5) between control and hnRNP
M-depleted samples from Flag-Rbfox1-expressing cells were considered
hnRNPM regulatory targets. Similarly, Rbfox1-dependent exons were defined
in cells expressing hnRNP M.
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Figure S1. Splicing Factors Not Coprecipitating with Rbfox Proteins Do Not Cosediment in the 55S Glycerol Gradient Fraction, Related to
Figures 1 and 3
The soluble nuclear fraction and the HMW extract from mouse brain were subjected to sedimentation through 10%–50% glycerol gradients as in Figure 3B. The
proteins detected by immunoblotting are indicated on the right. 40S and 60S markers (arrows) were obtained by sedimenting a HeLa S100 extract in parallel.
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Figure S2. iCLIP Analyses, Related to Figure 2
(A) The Rbfox proteins from mouse brain remain in the nuclear HMW fraction after trituration and UV-irradiation. Immunoblot analysis of the soluble nuclear
fraction and the HMW extract from mouse brain, after trituration and irradiation at 600 mJ per cm2 from a 254 nm ultraviolet light source. Rbfox1, Rbfox2, and
Rbfox3 are detected with specific antibodies or simultaneously with an antibody recognizing their common RRM.
(B) Comparison of Rbfox iCLIP clusters with previous CLIP studies (Lovci et al., 2013; Weyn-Vanhentenryck et al., 2014). The iCLIP datasets show strong
correlation with the previously published data. The number of reads per cluster in our data were plotted against the same values in two other datasets. Correlation
plots are shown with R2 value for Rbfox1.
(C) Correlation matrix for comparing all the Rbfox pairs of datasets.
(D) Intersection matrix for comparing all the Rbfox pairs of datasets. The number of common clusters divided by the union in each pair of datasets.
See Figure 2.
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Figure S3. Analyses of Proteins Copurifying with LASR, Related to Figures 3 and 4
(A) Immunoblot validation of Rbfox interacting proteins. Nuclear HMW extracts were prepared from HEK293T cells transfected with control vector (-), or tran-
siently expressing Flag-tagged Rbfox1, Rbfox2, or Rbfox3 proteins. Proteins copurifying with Rbfox proteins were subjected to immunoblot analysis. Aliquots of
HMW extracts (input) and anti-Flag precipitates (Flag IP) were analyzed in parallel as indicated on the top. The proteins were probed with specific antibodies as
shown on the right.
(B and C) Proteins coprecipitating with hnRNP M and hnRNP H from HEK293T HMW extracts. Anti-Flag immunopurification from nuclear soluble and HMW
fractions prepared from human HEK293T cells expressing Flag-tagged hnRNP M, hnRNP H1, or hnRNP H2 as indicated, or transfected with control vector
(lanes ‘‘-’’). The major interacting proteins are indicated on the right. (B) Immunopurification of hnRNP M and interacting proteins. The HEK293T cells in this
experiment expressed HA-tagged Rbfox3 in addition to Flag-hnRNP M. The proteins were resolved by SDS-PAGE and stained with SimplyBlue safestain. (C)
Immunopurification of hnRNP H and interacting proteins. The HEK293T cells in this experiment did not express ectopic Rbfox proteins. The immunoprecipitated
proteins were resolved by SDS-PAGE and silver-stained. Note that the IP of hnRNP H2 was inefficient due to the low expression of this protein, but the same
pattern of bands was visible in this lane of the gel.
(D) hnRNP M and hnRNP H present in the soluble nuclear fraction do not participate in large protein complexes. Soluble nuclear fractions were prepared from
HEK293T cells transiently expressing Flag-tagged Rbfox1 and were sedimented through 10%–50%glycerol gradients. Sedimentation of HMWextract, prepared
in parallel from these cells is shown in Figure 4A. The proteins were detected by immunoblot, indicated on the right as in Figure 4A.
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Figure S4. hnRNP M Is Recruited to the DUP-51M1 Pre-mRNA to Regulate Splicing, Related to Figure 5
(A–C) hnRNPM, but not Rbfox2 binds in vitro to the GU-rich sequences in exon 2 of DUP-51 and DUP-50. (A) Coomassie staining of immunopurified Flag-tagged
Rbfox2 and hnRNP M. These proteins were transiently expressed in HEK293T cells, immunoprecipitated from whole cell lysates, washed with buffer containing
1M NaCl, and eluted with 3xFlag peptide. Rbfox2 was used because Rbfox3 protein purified this way contained traces of other protein components of the LASR
complex (data not shown). (B) Exon 2 of DUP-51 and DUP-50 minigenes. These sequences were transcribed in vitro with internal radiolabel. A version of DUP-51
exon 2, in which the GU-rich site was converted to UGCAUG, was also synthesized. The GU-motifs in DUP-51M1 and DUP-50M1 are boxed in black. (C)
Electrophoretic mobility shift assays of the radiolabeled RNAs shown in panel B, after incubation with either Rbfox2 (top) or hnRNP M protein (bottom). 4.5 nM
(legend continued on next page)
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RNA was incubated with the indicated molar excess of protein, and in the presence of tRNA and spermidine to reduce non-specific binding. The RNA and
RNA:protein complexes were resolved on 7% acrylamide gels (29:1 acrylamide:bis acrylamide ratio) containing 25 mM Tris, 112.5 mM Glycine buffer (pH 8.3).
(D and E) HEK293 cells were cotransfected with either the DUP-51M1 or DUP-51DMsite minigene along with either a hnRNP M-targeted shRNA vector or a
control vector. (D) Exon 2 splicing was analyzed by RT-PCR with primers in the flanking exons (top). The percentage of exon 2 inclusion is indicated below each
lane. hnRNPM and U1-70K, which served as a loading control, were detected by immunoblot (bottom). The relative level of hnRNPM in each lane, normalized to
U1-70K, is indicated. Note that a lower level of basal exon inclusion is observed in this experiment compared to Figure 5. This is due to the longer cell culture time
needed to carry out the double transfection of shRNA and reporter plasmids. This results in a greater level of cell confluency at time of assay, which is seen to
reduce exon inclusion in the Dup plasmids. (E) HEK293T cells expressing DUP-51 minigenes and the hnRNP M or control shRNAs, as in D, were UV-irradiated
in vivo, lysed under denaturing conditions, and immunoprecipitated with anti-hnRNP M antibody. The levels of hnRNP M and MyEF2 in the lysates (input) and
post-IP (hnRNP M IP) were measured by immunoblot (top). Co-precipitated DUP-51 pre-mRNA was detected by RT-PCR (bottom). See also Figure 5.
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Figure S5. Enrichment of Sequence Motifs near Intronic Crosslink Sites from the Total Set of Overlapping Rbfox1, Rbfox2, and Rbfox3 iCLIP
Clusters from Mouse Forebrain or Hindbrain Nuclear HMW Fractions, Related to Figure 7
Histograms of pentamer Z-scores indicating motif enrichment in the Rbfox iCLIP clusters are shown as in Figure 7.
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Figure S6. GU-Rich Motifs Enriched in Rbfox Binding Regions Can Confer Rbfox-Dependent Regulation on an Exon, Related to Figure 7
(A) Diagram of the minigenes DUP-50M1 DUP-50DMsite.
(B and C) The effect of Rbfox3 on exon 2 splicing (B) and crosslinking to DUP-50 pre-mRNA (C) are analyzed and shown as in Figure 5.
Cell 165, 606–619, April 21, 2016 S7
 39 
 
 
 
 
 
 
 
 
 
 
 
Tissue Significantreads
iCLIP
clusters
Rbfox1 206,419 27,420 0.3 0.7 92.6 6.4
Rbfox2 183,165 21,522 0.2 0.9 92.9 5.9HMW 
Rbfox3 153,504 20,456 0.3 0.8 91.8 7.1
Forebrain 
Soluble 527,355 20,875 0.8 7.1 15.4 76.6
Rbfox1 335,818 36,746 0.2 0.7 94.3 4.8
Rbfox2 246,515 27,583 0.1 1.0 92.7 6.1HMW 
Rbfox3 346,986 38,192 0.1 0.7 92.6 6.6
Hindbrain 
Soluble 303,936 17,378 0.4 3.4 28.7 67.5
Rbfox1 7,080 0.2 3.5 20.3 76.0
Rbfox2 3,345 0.2 3.9 20.8 75.0Brain Soluble 
Rbfox3 3,667 0.1 1.1 15.7 83.0
136,483
77,137
170,240
Protein /
antibodyFraction
Rbfox1 
Rbfox1 
Significant reads in gene regions, %
CDS regions5' UTRs 3' UTRsintrons
A
B
-Rbfox, -hnRNP M +Rbfox, -hnRNP M
Library ID
replicate 1 replicate 2 replicate 3 replicate 1 replicate 2 replicate 3 replicate 1 replicate 2 replicate 3 replicate 1 replicate 2 replicate 3
Number of input reads 29,505,514 27,163,511 23,977,861 20,449,200 20,407,845 21,719,496 31,069,868 32,560,985 30,223,076 39,214,977 23,586,357 32,109,927
Uniquely mapped reads number 26,672,600 24,598,904 16,444,741 16,884,619 18,028,381 19,175,947 27,578,312 29,321,413 26,426,555 34,763,688 15,451,350 29,130,368
Uniquely mapped reads, % 90.40% 90.56% 68.58% 82.57% 88.34% 88.29% 88.76% 90.05% 87.44% 88.65% 65.51% 90.72%
Number of splices, total 7,711,379 7,148,062 4,967,171 5,119,525 5,311,401 5,565,996 8,164,354 8,765,408 7,976,808 9,970,133 4,699,521 9,027,587
Number of splices, sjdb annotated 7,611,822 7,057,173 4,907,062 5,047,202 5,235,023 5,485,171 8,078,355 8,673,291 7,893,654 9,846,061 4,644,933 8,920,595
-Rbfox, +hnRNP M +Rbfox, +hnRNP M
1
Table S1: Sequencing and mapping data for iCLIP and TruSeq libraries. Related to Fig. 2 and Fig. 6.
(A) Rbfox iCLIP experiments from mouse brain nuclear fractions.
Numbers of iCLIP clusters with width of at least two nucleotides are shown for each experiment. The 
numbers of significant reads (with FDR less than 0.01) within these clusters are also indicated. The 
percentages of these reads mapping to 5' untranslated regions (5' UTRs), coding DNA sequence 
(CDS), introns, and 3' untranslated regions (3' UTRs) of the longest transcripts from known genes are 
shown for each experiment. See Fig. 2.
(B) TruSeq libraries from 293 Flp-In cells. Read numbers and mapping data from the STAR algorithm 
are indicated for each library. See Fig. 6
Supplemental material
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crosslink sites from overlapping clusters 
all
Forebrain 3,600 84,861 25,397 3,815 59,464
HMW
extract
Hindbrain 4,410 163,702 87,855 15,766 75,847
intronic
Rbfox 1,2,3
iCLIP
overlapping
clusters
containing
GCAUG
or UGCAU
± 40nt from
crosslink
site
containing
GCAUG
± 5nt from
crosslink
site
lacking
GCAUG
and UGCAU
± 40nt from
crosslink
site
Table S2: Overlapping Rbfox 1, Rbfox2, and Rbfox3 iCLIP clusters on introns in HMW 
nuclear fractions. Related to Fig. 2 and Fig. 7.
The numbers of iCLIP clusters from HMW nuclear fraction from forebrain and hindbrain, 
overlapping by at least one nucleotide, and the crosslinking sites within these clusters are 
indicated. These crosslink sites are further split into groups based on their proximity to the 
nearest GCAUG or UGCAU pentamers as described. See Fig. 2 and 7.
2
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Extended Experimental Procedures 
 
Cell culture and tissue isolation 
 HEK293T and Flp-In™ T-REx™ 293 cells were grown according to ATCC 
protocols. For transient transfection, cells were grown in 6-well plates and 
transfected as described (Damianov and Black, 2010). For transient expression 
of recombinant proteins cells were harvested 48 hours post-transfection or post-
induction with 0.5 µg /ml doxycycline.  For RNAi, hnRNP M was targeted at the 3' 
UTR sequences GCATCTTGTTGACATCGAAT and 
AGATTGCAATGTGCGCAATT with shRNAs expressed from the plasmid pBlsH1 
(Gencheva et al., 2010). ShRNA plasmids were first transfected in suspension, 
followed by transfection in monolayer 36 hours later, and harvested after an 
additional 48 hours. Stable HEK293 lines expressing HA-Flag-tagged Rbfox1, 2, 
or 3 proteins were prepared using the Flp-In™ T-REx™ System (Life 
Technologies). An Rbfox2 deficient clone derived from this cell line was obtained 
by CRISPR/Cas9-guided deletions in the first constitutive Rbfox2 exon. Forebrain 
and hindbrain tissues were obtained from 6 week old C57BL/6J male mice 
(Charles River). All experiments were approved by the UCLA Institutional Animal 
Care and Use Committee. 
 
Antibodies 
Primary antibodies used for immunoblot assays: FLAG (F3165-1MG, Sigma), 
Rbfox1 (1D10, (Gehman et al., 2011)), Rbfox2 (A300-864A, Bethyl), Rbfox3 
(MAB377, Millipore), RbfoxRRM (Damianov and Black, 2010), hnRNP M 
(NB200-314, Novus Biologicals), MyEF2 (HPA004883-100UL, Sigma), hnRNP H 
(Chou et al., 1999), hnRNP F (Min et al., 1995), hnRNP C (ab75822, Abcam), 
Matrin3 (A300-591A, Bethyl), hnRNP U-like2 (ab104042, Abcam), hnRNP U 
(A300-689A, Bethyl), ILF3 (NF110 and NF90 proteins, NBP1-40682, Novus 
Biologicals), NF45 (ab28772, Abcam), DDX5 (ab10261-100, Abcam), DDX17 
(ab24601-100, Abcam), ELAVL1/HuR (ab14371, Abcam), Nova (Buckanovich 
and Darnell, 1997), hnRNP A2/B1 (ab6102, Abcam), hnRNP K (ab52600, 
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Abcam), hnRNP Q/R (R5653-200UL, Sigma), hyperphosphorylated SR proteins 
(mAb104, (Roth et al., 1990)), PTBP1 (Markovtsov et al., 2000), PTBP2 and U1-
70K (Sharma et al., 2005), GAPDH (AM4300, Ambion), Histone H3 (ab1791-100, 
Abcam). 
 
Minigene Sequences 
Exon 1: 
CTTACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTCAAACAGACACCATCCAA
GGTGCACCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGTCGAACG
TGGATGAAGTTGCTGTCGAGGCCCTGGGCAG 
 
Intron 1: 
gttggtatcaaggttacaagacaggtttaaggagaccaatagaaactggccaagtggag
acagagaagactcttgggtttctgatagggcccactgactctctctgcctattggtcta
ttttcccacccttag 
 
Exon 2 of DUP51-M1: 
 GCTGCTGGGCAAGGTGAACGTGGATGAAGTTGGTGGTGCGGCCGTGGGCAG 
 
Exon 2 of DUP-51∆Msite: 
 GCTGCTGGGCAAGtcGAACGTGGATGAAGTTGcTGtcGCGGCCGTGGGCAG 
 
Exon 2 of DUP50-M1: 
 GCTGCTGGGCAAGTCGAACGTGGATGATGTTGTGTTGCGGCCGTGGGCAG 
 
Exon 2 of DUP-50∆Msite: 
 GCTGCTGGGCAAGTCGAACGTGGATGAaGaTcTGTcGCGGCCGTGGGCAG 
 
Intron 2: 
gttggtatcaaggtaccaagacaggtttaaggagaccaatagatctggccaagtggaga
cagagaagactcttgggtttctgataggcactgactctctctgcctattggtctatttt
cccacccttag 
 
Exon 3: 
GCTGCTGGTGGTCTACCCTTGGACCCAGAGGTTCTTTGAGTCCTTTGGGGATCTGTCCA
CTCCTGATGCTGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGT
GCCTTTAGTGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAG
TGAGCTGCACTGTGACAAGCTGCACGTGGATCCTTGAGCATCTGGATTCTGCCT 
 
Primers 
Gene RT-PCR product Forward primer Reverse primer 
spliced RNA GACACCATCCAAGGTGCAC CTCAAAGAACCTCTGGGTCCAAG DUP-51 
minigenes unspliced RNA TTGGGTTTCTGATAGGCACTG CTCAAAGAACCTCTGGGTCCAAG 
human GAPDH mRNA TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
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Motif analyses and comparisons with published Rbfox CLIP studies 
 Crosslink sites, defined as one nucleotide upstream of each iCLIP read 
were evaluated for significance using the False Discovery Rate (FDR) method as 
described (König et al., 2010). Crosslink sites with FDR ≤ 0.01 were used for 
clustering and downstream analyses. Sites with genomic locations within 20 
nucleotides were clustered.  
 The binding regions, defined as including 40 nucleotides upstream and 40 
nucleotides downstream of each crosslinking site, were analyzed for enrichment 
of nucleotide pentamers. To control for nucleotide frequency biases, pentamer 
frequencies in the binding regions were compared to the distribution of pentamer 
frequencies in a large set of 81-nucleotide genomic intervals randomly chosen 
from the introns containing iCLIP clusters. GCAUG and UGCAU, the two 
pentamer derivatives of the UGCAUG motif, were the most enriched motifs in the 
binding regions (red dots, z-score > 645, Fig. S5). Several other near matches to 
the UGCAUG motif including CAUGU, GUAUG, UGUAU, GUGCA, CAUGC 
(orange dots, Fig. S5) were also highly enriched. Some of these partial matches 
were previously shown to bind Rbfox2 (Lambert et al., 2014).  
 Within the distribution of pentamer z-scores we examined binding motifs 
for hnRNP’s M, C, and H. Based on the previous CLIP analyses (Huelga et al., 
2012), we defined possible hnRNP M binding motifs as all pentamers containing 
3 G’s and 2 U’s or 3 U’s and 2 G’s but without more than 2 Gs or Us in a row. 
HnRNP C pentamers included U5 and all pentamers containing 4 continuous U 
nucleotides. Similarly, hnRNP H pentamers included G5 and all pentamers 
containing 4 continuous G’s. Most of the potential hnRNP M binding pentamers 
were enriched in the Rbfox binding regions, with 8 pentamers having Z-scores 
above 50 (Fig. S5, blue dots), placing them among the 10% most enriched 
motifs. Since UV-induced RNA-protein crosslinking is biased towards uridines 
(Sugimoto et al., 2012), motifs with high U content might be overrepresented at 
iCLIP crosslink sites. To rule out the possibility that the hnRNP M pentamers 
were enriched simply due to their uridine content, we compared them to 
equivalent motifs with C or A substituted for G. All of these CU-rich and AU-rich 
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motifs had lower Z-scores than the corresponding GU-rich motif, with most 
having negative values (data not shown). Thus, the enrichment of these GU 
motifs was not simply due to their uridine content.  
 We also found that the hnRNP C binding pentamers were enriched in the 
Rbfox binding regions (Fig. S5, green dots). Since hnRNP C elements are highly 
uridine-rich, we could not distinguish whether their enrichment resulted from 
direct Rbfox recognition, recruitment of Rbfox by hnRNP C binding, or simply 
enhanced crosslinking to those elements. The G-rich pentamers that potentially 
bind hnRNP H were depleted relative to the average pentamer in the intronic 
Rbfox binding regions (Fig. S5, gray dots). It is possible that the exclusion of 
hnRNP H binding sites from the sequence immediately adjacent to Rbfox binding 
is a consequence of the structural relationship of the two proteins within LASR. 
 To compare the iCLIP data with previous CLIP studies, replicates were 
combined to create one data set per study. The reads were collapsed into 
clusters and the read number per cluster was determined. For clusters 
intersecting between two data sets the reads per cluster were plotted. The 
correlation matrix shows the r2 measure of correlation for all pairs of data sets. 
For the intersection matrix, the number of clusters overlapping between each pair 
of CLIP data sets was determined and divided by the number of clusters in the 
union set for that pair. 
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Modified iCLIP protocol 
This follows the original iCLIP protocol developed by the Ule lab (König et al., 
2010) with the following differences: 
 
- Sample preparation is modified for compatibility with nuclear fractions. 
- Partial digestion of RNA is carried out post immunoprecipitation with 
Micrococcal nuclease (MNase), similar to the Yeo lab CLIP protocol (Yeo et al., 
2009). 
- The immunoprecipitated RNA is fragmented in presence of yeast tRNA in 
predetermined ratio to the MNase, which allows one to skip the titration step. 
- The 3' hydroxyl end of the synthetic RNA linker is blocked by a biotin group, and 
the protein:crosslinked RNA:linker products are then purified on Monomeric 
Avidin Agarose prior to separation by electrophoresis. 
  
Materials: 
Tubes and tips: 
Use original Eppendorf 1.5 ml tubes. Tubes from other manufacturers may have 
lower quality lids. Barrier pipette tips are highly recommended. All plasticware 
should be RNase-free. 
Buffers: 
WB150 : 20 mM HEPES-KOH pH 7.5, 150 mM NaCl, 0.1% Triton-X100 
WB750 : 20 mM HEPES-KOH pH 7.5, 750 mM NaCl, 0.1% Triton-X100 
PNK buffer: 20 mM HEPES-KOH pH 7.5, 10 mM MgCl2, 0.2% Tween-20 
EGTA buffer : 20 mM HEPES-KOH pH 7.5, 150 mM NaCl, 20 mM EGTA, 0.1% 
Triton X-100 
TE buffer: 10 mM Tris-HCl pH 7.5, 1 mM EDTA. 
Prepare these buffers with DEPC-treated MilliQ-H2O. Keep all of them except the 
TE buffer on ice. 
Oligonucleotides: 
L3 linker (RNA): /Phos/-UGAGAUCGGAAGAGCGGUUCAG-Biotin 
 
 46 
 
 8 
Primers for reverse transcription: 
RTclipGTT: /Phos/-nnnnAACnnnnAGATCGGAAGAGCGTCGTggatccTGAACCGC  
RTclipGCC: /Phos/-nnnnGGCnnnn... 
RTclipATC: /Phos/-nnnnGATnnnn... 
The barcodes are underlined. Order RT primers with different barcodes in such a 
way that no single nucleotide substitution should convert one barcode to another. 
cut_oligo: GTTCAggatccACGACGCTCTTCaaaa 
P5solexa: AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTT 
CGATCT 
P3solexa: AAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTC 
TCCGATCT 
 
Magnetic beads: Dynabeads Protein G (Life Technologies, Cat# 10004D). 
These beads are very tiny and work efficiently with diluted, large volume 
samples.  
Because of their small size, not all beads will migrate to the sidewall of the tube 
next to the magnet when placed on a magnetic stand - some will remain on the 
lid of the tube or will be trapped in the foam layer on the top. To minimize the loss 
of beads with each wash step, gently invert the magnetic rack with the tubes to 
allow the trapped beads to find their way to the magnet. Let the samples rest for 
several seconds, then repeat until the foam layer becomes completely clear. 
These beads also require rather vigorous shaking to break up the clumps after 
removal from the magnetic rack. Make sure to completely resuspend the beads 
at the beginning of each wash step. After resuspending the beads in wash buffer, 
we typically invert the tubes about 50-60 times. 
Do not centrifuge these beads. 
 
Procedure: 
1. Preparation of samples: 
Sample types: 
- HMW nuclear pellet 
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- Soluble nuclear fraction, in buffer containing 20 mM HEPES-KOH pH 7.5, 150 
mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT, 1x Complete protease inhibitors, 0.6% 
Triton X-100 
- Whole cells 
Triturate brains from 6-week old C57BL/6J male mice in ice-cold HBSS solution 
as described (Ule et al., 2005) and UV-irradiate at 600 mJ/cm2 (four pulses of 
150 mJ/cm2 each, gently mixing the sample between irradiations), at 4 ˚C in a 
Stratalinker 1800.  
For cells in monolayer culture, irradiate at 450 mJ/cm2, at 4 ˚C, and harvest with 
1x PBS or HBSS, and pellet at 700x g for 2 min at 4 ˚C. 
These UV doses were determined experimentally as described (Darnell, 2012). 
 
Prepare HMW nuclear pellet and soluble nuclear fraction as described (see the 
fractionation protocol), but do not treat samples with Benzonase nuclease or 
RNases. 
 
Add 10-15 volumes of buffer containing 20 mM HEPES-KOH pH 7.5, 150 mM 
NaCl, 0.6% Triton X-100, 0.1% SDS, 1 mM EDTA, and 0.5 mM DTT to the HMW 
pellet or the cell pellet. Mix immediately by pipetting if this is a cell pellet.  
Add 20% SDS and 0.5 M EDTA to soluble nuclear fraction or cytosol, to final 
concentrations of 0.1% and 2 mM, respectively. 
 
Sonicate all samples in a Bioruptor (Diagenode) at 4 ˚C with 30 pulses of 30 sec 
each. Make sure the chromatin is completely resuspended. 
Centrifuge at 20,000 x g, 4 ˚C for 5 min. Transfer the supernatants to fresh tubes. 
Dilute with five volumes of buffer containing 20 mM HEPES-KOH pH 7.5, 150 
mM NaCl, 0.5 mM DTT, 1.25x Complete protease inhibitors EDTA-free (Roche), 
and 50 µg/ml yeast tRNA. Mix briefly and centrifuge again at 20,000 x g, 4 ˚C for 
10 min. 
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2. Immobilization of antibodies: 
Transfer an appropriate amount of Dynabeads to a 1.5 ml tube. We use 
approximately 10 µl of packed beads per sample. Wash the beads three times in 
1000 µl of WB150. Add about 5-50 µg of IgG per 10 µl of packed beads, add 700-
1000 µl of WB150 and rotate overnight at 4 ˚C or for a few hours at room 
temperature. 
Wash the beads three times with WB750 and once with WB150. Transfer the beads 
in fresh tube(s) using WB150. 
 
3. Immunoprecipitation: 
Add each supernatant to Dynabeads loaded with IgG and rotate overnight at 4 
˚C. Transfer the beads to fresh tubes with WB150. Wash five times with 1 ml of 
WB750 and two times with PNK buffer. If using more than 10 µl of beads, at this 
point all samples should be split into aliquots containing 10 µl of packed beads 
each. 
 
4. RNA fragmentation: 
Collect the Dynabeads at the bottom of the tube using a magnet (not to the 
sidewall on magnetic rack stand), then completely remove the buffer on top of 
the beads. Remove the buffer the same way prior to all other enzymatic steps of 
this protocol. 
Add 100 µl of 1x MNase buffer (NEB) containing 5.0 µg of yeast tRNA. 
Place on Thermomixer (Eppendorf) and determine the minimum shaking speed 
at which the beads completely resuspend in the buffer. Set the Thermomixer at 
37 ˚C, 15 sec shaking/15 sec rest, and equilibrate the samples at this 
temperature. Add 50 µl of 1x MNase buffer containing 60 gel units/ml (6 Kunz 
units/ml) of MNase (NEB, cat# M0247S). Incubate for exactly 5 min and stop the 
reaction with 500 µl of EGTA buffer. 
This ratio of RNA to MNase routinely produces suitable partial digestion at the 
given incubation conditions. 
Wash four times with EGTA buffer and two times with PNK buffer. 
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5. Dephosphorylation of RNA: 
Add 100 µl of 1x FastAP buffer (Fermentas) containing 0.15 U/µl of Fast alkaline 
phosphatase (Thermo Scientific, cat# EF0651) and 0.2 U/µl of RNaseOUT (Life 
Technologies, cat# 10777-019). Incubate in a Thermomixer for 90 min at 37 ˚C, 
15 sec shaking/20 sec rest. This long incubation is required for removal of the 3' 
phosphate groups from MNase-cleaved RNA. The reaction is less efficient than 
dephosphorylation of 5' ends. 
Wash four times with WB750 (the high salt buffer is required to wash away the 
phosphatase) and two times with PNK buffer. 
 
6. L3 linker ligation: 
Add 40 µl of 0.75x T4 RNA ligase1 buffer (NEB) containing 1 mM ATP, 25% 
PEG4000 (Sigma, cat# 202398), 0.5 U/µl T4 RNA ligase1 (NEB, cat# M0204S), 
0.5 U/ul RNaseOUT, and 6.0 µM L3 linker. 
Incubate in Thermomixer overnight at 16 ˚C, 15 sec shaking/4 min rest. 
Wash four times with WB150 and two times with PNK buffer. 
 
7. 32P labeling by phosphorylation of the 5' ends: 
Add 16 µl of 1x PNK buffer (NEB) containing 150 µCi of γ[32P] ATP, 10 units of 
T4 Polynucleotide Kinase (NEB, cat# M0201S), and 1U/µl of RNaseOUT. Add 24 
µl of PNK wash buffer. 
Incubate in Thermomixer for 20 min at 37 ˚C, 15 sec shaking/20 sec rest. Wash 
three times with WB150. 
 
8. Elution from Dynabeads: 
Add 50 µl of buffer containing 100 mM Tris-HCl pH 7.5, 0.6% SDS, 5 mM EDTA, 
50 mM DTT, and 50 ng/ul yeast tRNA. Incubate in Thermomixer for 10 min at 85 
˚C while shaking continuously. Transfer the eluted material in a fresh tube. 
Rinse the Dynabeads with 1200 µl of buffer containing 50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 1.25x Complete protease inhibitors, 50 ng/ul yeast tRNA, and 
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0.1% Triton X-100. Add the supernatant to the eluted material from the previous 
step and mix briefly. 
Centrifuge at maximum speed for five minutes at 4 ˚C. Transfer the supernatant 
to a fresh tube. This centrifugation helps to completely remove the Dynabeads. 
 
9. Binding on Monomeric Avidin beads: 
This is an additional purification designed to remove the IgG heavy chains, which 
comigrate or run slightly above the Rbfox proteins on SDS-PAGE. We find that 
this helps to get cleaner results with other proteins as well. The L3 linker must 
have a 3' biotin residue. 
Wash Immobilized Monomeric Avidin Agarose (Thermo Scientific, cat# 20228) 
three times with WB150. Pellet the beads after each washing step at 500-1,000 x 
g, 4 ˚C for 1 min, using a swinging bucket rotor not a fixed rotor. This helps 
minimize the loss of beads. 
Remove the supernatant and add one packed-bead volume of WB150. Add 15 µl 
of resuspended beads to each sample. Incubate on a rotator for 3-4 hours at 4 
˚C. 
Wash the beads three times with WB150 and once with EGTA buffer. After 
removing the last wash buffer, centrifuge again and carefully remove the 
remaining 5-20 µl of supernatant using a P10 pipette. 
 
10. Elution from Monomeric Avidin beads: 
Add 30 µl of buffer containing 100 mM Tris-HCl pH 7.5, 10% Glycerol, 2.2% 
SDS, and 5 mM EDTA. Incubate in Thermomixer for 10 min at 85 ˚C while 
shaking. 
Centrifuge in fixed rotor at 10,000 x g for 1 min. Carefully remove 25 µl of 
supernatant and transfer to a fresh tube. Add 5 µl of 1x LDS sample buffer (Life 
Technologies, 4x stock cat# NP0007) containing 300 mM DTT. 
Store at -20 ˚C or proceed with the next step. 
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11. NuPAGE electrophoresis: 
Incubate the samples at 90 ˚C for 10 min. 
Prerun a 10% NuPAGE Bis-Tris Gel (Life Technologies, cat# NP0307) with 1x 
MOPS SDS running buffer (Life Technologies, 20x stock cat# NP0001) for 10-15 
min at 75 V. Remove the foam from the running buffer on top of the gel, and 
rinse the wells by pipetting. Load 30 µl of sample per preparative lane. Load 7.5 
µl of Novex sharp pre-stained protein standards (Life Technologies, cat#57318) 
in the analytical lane. Run for 10-20 min at 75 V, then increase the voltage to 
110-120 V and continue the electrophoresis as necessary. 
 
12. Electrotransfer: 
Equilibrate the gel for 5 min in transfer buffer (25 mM Bis-Tris, 25 mM Bicine,1 
mM EDTA, pH 7.2, 10% Methanol, 0.02% SDS). Rinse a piece of Protran BA-85 
nitrocellulose membrane (0.45 µM pore size, Whatman GmbH cat#10104594) 
with milliQ-H2O and then equilibrate in transfer buffer. Equilibrate a sheet of 
extra-thick blot paper (Bio-Rad, cat# 1703969) in transfer buffer and place it over 
the cathode of a Semi-Dry Electrophoretic Transfer Cell (Bio-Rad cat# 170-
3940). Place the membrane over the paper, then place the gel over the 
membrane. Avoid trapping air bubbles. Cover the gel with another sheet of extra-
thick blot paper soaked in buffer. Transfer for 60-75 min at 400 mA, not 
exceeding 15 V. 
Briefly rinse with MilliQ-H2O and wrap the membrane in saran wrap. 
 
13. Size selection of RNA crosslinked to the immunoprecipitated protein: 
Expose an X-ray film or a Phosphoimager screen to the membrane. Use 
appropriate guides to align the image with the membrane. Excise regions from 
the preparative lanes 20-40 kDa above the protein of interest. Transfer each cut 
piece of membrane to a separate 1.5 ml tube. 
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14. Elution of RNA by deproteinization: 
Add 300 µl of buffer containing 100 mM Tris-HCl ph 7.5, 50 mM NaCl, 10 mM 
EDTA, and 2 µg/µl proteinase K and completely submerge the membrane. 
Incubate for 30 min at 55 ˚C while shaking continuously. Preincubate buffer 
containing 100 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM EDTA, 7 M Urea, and 
0.5 µg/µl proteinase K for 2 min at 55 ˚C. Add 300 µl of this buffer to each tube 
and continue the incubation for another 30 min. 
Transfer the solution to a fresh tube, add equal volume (600 µl) of Phenol: 
Chloroform 5:1, pH 4.5), and vortex for 30 sec. Centrifuge at maximum speed for 
5 min and carefully transfer the aqueous phase to a fresh tube. Add 0.5 µl of 15 
µg/µl GlycoBlue (Life Technologies, cat# AM9516), and 60 µl of 3M sodium 
acetate pH 5.4. Mix briefly, add 660 µl of isopropanol, mix thoroughly, and 
incubate overnight at -20 ˚C. 
Centrifuge at 20,000 x g, 4 ˚C for 30 min. Wash the pellet with 1 ml of 75% 
Ethanol. Completely remove the ethanol, and air dry the pellet for a maximum of 
2 min. 
Add 5.70 µl DEPC treated MilliQ-H2O and let the tube sit on ice for 5-10 minutes. 
 
15. Reverse transcription: 
Add 0.5 µl of 10 mM dNTP mix and 0.5 µl of 2 µM RT primer to a PCR tube. Add 
5.5 µl of RNA sample and mix 5-10 times by pipetting. Incubate in a PCR 
machine for 5 min at 70 ˚C with lid heating. Take the tube from 70 ˚C and place it 
directly on ice for at least 1 min. Set the PCR heat block at 25 ˚C. Equilibrate the 
tube at this temperature for 30-60 sec and add 3.5 µl of a mix containing 2 µl of 
5x First strand buffer, 0.5 µl  of 100 mM DTT, 0.5 ul of 100 U/µl SuperScript III 
Reverse Transcriptase (Life Technologies, cat# 18080-044), and 0.5 µl of 40 U/µl 
RNaseOUT. Mix 10 times by pipetting. Incubate the sample at 25 ˚C for 5 min, 
then for 20 min at 42 ˚C, and for another 20 min at 48 ˚C. 
Transfer the reverse transcription reaction to a 1.5 ml tube, add 100 µl of TE 
buffer and 320 µl of Ethanol:3M sodium acetate pH 5.4 (25:1), mix and incubate 
overnight at -20 ˚C. Centrifuge at 20,000 x g, 4 ˚C for 30 min. Wash the pellet 
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with 1 ml of 75% Ethanol. Remove the ethanol completely and dissolve the pellet 
in 5.0 µl of MilliQ-H2O. 
Add 7.5 µl of Formamide containing 10 mM EDTA, Bromophenol Blue and 
Xylene Cyanol tracking dyes. 
 
16. Size selection of cDNA: 
Prepare molecular weight marker in the following way: Mix 2.0 µl of GeneScan 
500 LIZ marker (Life Technologies, cat# 4322682), 3.0 µl of MilliQ-H2O, and 15 µl 
of Formamide containing 10 mM EDTA, but not tracking dyes. 
Thoroughly clean electrophoretic glass plates and cast a 5.5% 
acrylamide:bisacrylamide (19:1) / 1xTBE / 50% Urea gel using 0.4-0.5 mm 
spacers. Let the gel polymerize for an additional 30-60 min after becoming solid. 
Attach a metal plate to one of the glass plates for uniform heat dissipation. Pre-
run the gel with 1x TBE running buffer for 15 min at 21 W. Denature the samples 
and the marker for 5 min at 85 ˚C and then place them immediately on ice for at 
least one minute. Rinse the wells of the gel by pipetting to remove the urea that 
migrated there during the pre-run. Load 12.5 µl of sample per lane, then load 10 
µl of marker on the left hand side of the first sample and the right hand side of the 
last sample. Run the electrophoresis for 15-20 min at 21 W. 
Rinse with Milli-Q water and wipe/dry the outer surface of the glass plates, but do 
not remove them from the gel. Scan the gel in a Typhoon scanner, Cy5 channel, 
+3 mm focal plane to detect the bands of the marker. Print this image in actual 
size and also print a mirror image. Remove one of the glass plates, put the 
corresponding printout under the remaining glass plate, align it with the gel and 
use it as a guide to excise a gel slice from each lane, containing cDNA in the 
range of 70-120 nt (cDNA length = 56 nt + RNA fragment length). 
Chop each piece of gel into 15-25 smaller pieces, transfer them to a 1.5 ml tube, 
and add 700 µl of TE buffer. Keep on a rotator at room temperature for several 
hours or overnight. 
Centrifuge for 1 min at maximum speed, then carefully transfer the TE buffer into 
a fresh tube. We use 200 µl flat tips to avoid transferring small acrylamide pieces 
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with the buffer. Add 0.5 µl of 15 µg/µl GlycoBlue, 75 µl of 3M sodium acetate pH 
5.4, and mix. Add 750 µl of isopropanol, mix again, and store overnight at -20 ˚C. 
Centrifuge for 30 min at 20,000 x g, 4 ˚C. Wash the pellets with 1 ml of 75% 
Ethanol. Remove the ethanol completely, air dry the pellet for a maximum of 2 
min. Add 6.70 µl DEPC treated MilliQ-H2O and let the tube sit on ice for 5-10 
minutes. 
 
17. Circularization of the cDNA: 
Add 1.5 µl of the following mix in a PCR tube: 0.8 µl of 10x Circligase II buffer, 
0.4 µl of 50 mM MnCl2, and 0.3 µl of 100 U/µl CircLigase II ssDNA ligase 
(Epicentre, cat# CL9021K). Add 6.5 µl of cDNA solution and mix by pipetting. 
Incubate in a PCR machine at 60 ˚C for 60 min with lid heating. 
 
18. Linearization at the BamHI site: 
Add 30 µl of the following mix: 4 µl of 10x FastDigest buffer, 0.9 µl of 10 µM 
cut_oligo, and 25.1 µl of MilliQ- H2O. Incubate for 4 min at 95 ˚C, then decrease 
the temperature by 1 ˚C every 60 sec until reaching 37 ˚C. Add 2 µl of FastDigest 
BamHI (Thermo Scientific, cat# FD0054), mix and incubate for 30 min at 37 ˚C. 
Transfer the sample to 1.5 ml tube, add 200 µl of TE buffer, add 700 µl of 
Ethanol:3M sodium acetate pH 5.4 (25:1), and mix and incubate overnight at -20 
˚C. Centrifuge at 20,000 x g, 4 ˚C for 30 min. Wash the pellet with 1 ml of 75% 
Ethanol. Remove the ethanol completely, dry the pellet briefly, and dissolve in 22 
µl of MilliQ-H2O. 
 
 
19. Analytical PCR to determine the optimum number of cycles for 
preparative amplification: 
Prepare 42 µl of PCR reaction mix containing 2 µl of single stranded DNA 
template, 1x Pfu buffer, 0.2 mM dNTP mix, 0.2 µM of each P5solexa and 
P3solexa primers, and 0.5 units of Pfu polymerase. Split this mix into four 
aliquots of 10 µl each in PCR tubes. 
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Prepare a negative control the same way, adding water instead of template. 
Amplify one aliquot from each PCR mix for 20, 24, 28, and 32 cycles using the 
following parameters: initial denaturation: 94 ˚C for 3 min, cycle (denaturation 94 
˚C for 30 sec, annealing 63.5 ˚C for 15 sec, extension 72 ˚C for 30 sec), final 
extension for 7 min at 72 ˚C, cool down to 4 ˚C. 
Using a separate set of pipettes and a separate bench if available, run these 
samples on a 2% agarose gel containing 0.5x TBE and 0.5 µg/ml Ethidium 
bromide. For each sample, calculate the number of cycles that will produce about 
50-200 ng of PCR product from the rest of the template. 
 
20. Preparative PCR: 
Prepare 30 µl of PCR reaction mix the same way as above, using 20 µl of single 
stranded DNA template. Amplify by PCR using the parameters described above 
and the number of cycles determined at the analytical step.Run the PCR 
reactions on a 2% agarose gel and excise gel bands containing products ranging 
from 150 to 210 bp (PCR product length = 132 bp + RNA fragment length). 
Extract DNA from the agarose gel slice using a Zymoclean Gel DNA recovery kit 
(Zymo Research, cat# D4007). Elute DNA from the column with 10 µl of EB 
buffer (Qiagen, cat# 19086). 
Determine the concentration of DNA by Qubit using the dsDNA BR Assay Kit 
(Life technologies, cat# Q32850). Prepare 5-20 µl of sequencing library, 
containing 10 nM DNA and 0.1% Tween-20 in buffer EB. Multiple PCR products 
can be mixed together if they were prepared with RT primers bearing different 
barcodes. 
Sequence in Illumina HiSeq2000 single end 100 nt. 
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Table S3. Complete Motif Enrichment Scores near Rbfox iCLIP Crosslink Sites, 
Related to Figure 7. 
 
Enrichment of sequence motifs within the region from -40 to +40 nucleotides 
relative to intronic crosslink sites of overlapping Rbfox1, Rbfox2, and Rbfox3 
iCLIP clusters in the HMW nuclear fraction 
  Rbfox binding motif 
  Similar to Rbfox binding motif 
  hnRNP M binding motif 
  hnRNP C binding motif 
  hnRNP H binding motif 
  all sites 
sites less than 40 
nucleotides away 
from the nearest 
GCAUG or UGCAU 
sites more than 40 
nucleotides away 
from the nearest 
GCAUG or UGCAU 
rank motif Z-score motif Z-score motif Z-score 
1 GCAUG 648.4 GCAUG 1038.0 UUUUU 358.0 
2 UGCAU 645.4 UGCAU 904.3 UUUUG 216.4 
3 CAUGU 412.5 CAUGU 592.3 UGUUU 208.9 
4 GUAUG 411.3 AUGUG 496.7 CUUUU 195.6 
5 AUGUG 405.4 UGUAU 455.7 UUUGU 191.6 
6 UGUAU 392.6 GUGCA 430.4 UUUUC 176.0 
7 UAUGU 361.7 GUAUG 430.0 AUUUU 168.3 
8 UGUGC 336.5 UGUGC 414.7 GUUUU 166.1 
9 UGUUU 299.4 UAUGU 408.4 UUGUU 162.9 
10 UGUGU 295.6 AUGCA 377.7 UUUUA 154.3 
11 GUGCA 289.4 CAUGC 359.0 UGCUU 143.4 
12 GUGUA 279.5 GUGUA 285.0 UAUUU 135.9 
13 UUUUU 279.4 UGUGU 278.5 UCUUU 129.8 
14 UUUGU 268.5 AUGUA 269.1 UAUGU 122.1 
15 AUGUA 247.4 UUGCA 267.1 UUUAU 121.9 
16 GUUUU 220.6 UAUGC 218.8 UUUCU 120.3 
17 CAUGC 206.2 AUAUG 209.8 GUUUG 117.2 
18 UUUUG 205.4 GUGUG 192.9 UGUAU 116.8 
19 GUUUG 200.3 CUGCA 178.2 UUGCU 115.7 
20 AUGCA 198.8 UUUGC 174.8 GUAUG 114.9 
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21 GUGUG 196.8 GUAUA 169.7 CUGUU 110.8 
22 UUGUU 188.6 AUGUU 163.1 UGUUG 106.6 
23 UUUGC 177.9 CAUGA 157.2 UGUCU 103.7 
24 UUGCA 176.6 CAUGG 153.4 UUAUU 99.5 
25 UUUUC 171.9 UUGUG 146.6 UUCUU 99.3 
26 UCUGU 164.1 AGCAU 140.1 GCUUG 97.5 
27 UGUCU 163.5 UGUAC 138.5 UCUGU 92.6 
28 AUGUU 161.9 UGUUU 137.7 GCUUU 87.6 
29 CUUUU 159.8 ACAUG 136.5 UGAUG 83.5 
30 UGCUU 159.4 UGCAC 128.8 GUGUU 79.5 
31 UUUUA 149.0 AUGUC 128.0 UGCCU 76.1 
32 AUAUG 147.2 GCAUU 126.9 UUGUG 74.2 
33 UAUGC 147.1 GCAUA 126.2 CUUUG 72.2 
34 GUGUU 145.3 UGUCU 126.1 UGAUU 70.3 
35 AUUUU 145.2 GUGUU 125.6 CUUGU 70.2 
36 GUAUA 141.2 UUUGU 121.3 GUUGU 69.1 
37 UUGUG 141.1 GUUUG 121.2 CUGUG 68.9 
38 UGUAC 139.3 CUGUG 119.8 GUGUA 68.6 
39 UGUUG 138.6 CGCAU 115.3 UGUGU 68.4 
40 AUGUC 138.4 AUGCU 111.2 UUUGA 67.6 
41 UAUUU 132.7 UGCUU 102.8 UUGUA 67.3 
42 UUUAU 129.1 GGCAU 102.1 UUUAA 67.2 
43 CUGUG 128.0 GUCUG 101.9 UGUGC 66.6 
44 GUCUG 123.8 CAUAU 101.4 GUUUA 66.5 
45 UUGCU 121.3 UGCGU 90.8 GGUUU 66.0 
46 GCUUG 119.0 GCUUG 89.8 GCUGU 65.8 
47 UUGUA 106.1 GAAUG 88.2 UGCUG 62.9 
48 UUUCU 105.4 UCUGU 86.5 UGGUU 61.4 
49 UGCAC 101.4 UUUUG 83.2 AUGUG 61.3 
50 UGCCU 101.0 UACAU 82.8 UUUCG 61.1 
51 UUAUG 94.7 UUAUG 81.6 GAUUU 60.9 
52 AUGCU 94.7 CGUGU 79.1 UUCUG 60.7 
53 UCUUU 94.2 UGUGA 77.5 GUCUG 60.5 
54 GUAUU 94.1 GUGUC 76.8 UGUAC 59.5 
55 CAUGA 93.9 AUGCG 76.3 ACUUU 58.4 
56 CUUGU 92.6 UAUAU 75.9 UUUGG 58.4 
57 UGUGA 89.7 GUACA 74.6 UUGUC 58.4 
58 GAAUG 86.4 UGAAU 73.6 UUUGC 58.4 
59 UUAUU 86.0 UGUUG 73.4 AUGUU 58.2 
60 CUGUU 84.8 AUGCC 73.0 UUAUG 56.7 
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61 CUGCA 83.9 AUUGC 72.5 GUAUU 56.3 
62 CGUGU 83.7 UUGUA 68.2 UUUCC 55.6 
63 GUUGU 83.4 CGUGC 66.6 UUGAU 55.6 
64 AGCAU 82.4 GCACG 66.2 GUCUU 54.6 
65 GUGUC 81.4 GUUUU 66.1 CGUUU 54.1 
66 GCCUG 80.9 UUUAU 64.8 UUUAC 54.0 
67 UUGUC 80.7 AAUGC 63.5 CUGAU 53.0 
68 GCUUU 80.1 UCAUG 62.5 UUUAG 52.0 
69 UGAAU 78.9 GCGUG 60.9 CCUUU 51.7 
70 UGCUG 78.7 UUUUU 60.4 CUUGC 51.1 
71 CGCAU 78.0 UGAGU 60.3 GUGUC 50.9 
72 GCUGU 77.2 GCAUC 59.6 AUGAU 49.7 
73 CAUGG 76.9 GUAUU 59.4 UUGGU 49.4 
74 ACAUG 76.8 UGUGG 58.1 GCCUG 49.2 
75 UUCUU 75.5 CUUGC 53.7 AUGCU 47.2 
76 UGCGU 73.8 UGCCU 53.3 GUUUC 47.0 
77 UAUAU 70.6 CUUGU 52.7 UUCGU 45.0 
78 GUGCU 66.7 AUUUU 52.5 CUAUU 44.6 
79 GUUGC 64.9 GUGCU 52.4 UCUUG 44.6 
80 CUUGC 64.2 GCCUG 52.0 UUCGC 44.4 
81 UGAUU 63.9 UUGUU 51.4 AUGUA 44.3 
82 UGAUG 63.5 UCUGC 49.5 AAUUU 44.1 
83 AUGCG 63.3 AGUGU 49.1 UUACU 42.2 
84 UGUUC 62.3 AUGAA 49.0 UAUCU 42.0 
85 CUUUG 62.3 UAUUG 48.7 GUGCU 41.7 
86 AUUGU 62.0 CACGU 48.3 AGUUU 40.7 
87 UAUUG 60.9 AUGGC 47.9 UGAAU 40.4 
88 AAUGU 60.7 GUGCG 46.8 AUUGU 40.3 
89 GUUUA 59.2 AUGAU 46.4 UGUUC 40.0 
90 AUUGC 59.0 UGUUC 45.8 CGCUU 39.2 
91 AUGAU 58.0 AUUUG 45.2 UGCUA 39.1 
92 UCGCU 57.9 UGCGC 44.9 GUUGC 39.1 
93 GCGUG 57.6 AUGAG 44.6 GAAUG 38.6 
94 GCACG 57.4 UAUGA 44.1 UUCUC 38.3 
95 UGUGG 56.4 AUUGU 44.1 UGUUA 38.0 
96 UUUGG 54.1 UUGCU 43.7 UAAUU 37.6 
97 CAUAU 53.7 AAUGU 42.6 AAUGU 37.6 
98 GCAUU 53.5 UGCUG 41.9 UCGCU 37.0 
99 UGCGC 53.1 ACGUG 41.7 CUGCU 36.7 
100 GAUUU 53.0 UCGCU 41.1 GUGUG 36.6 
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101 GCUGC 52.0 UAUUU 41.0 UACUU 36.3 
102 UACAU 51.6 GUUGU 40.8 GUUCU 35.8 
103 UGGUU 51.5 CAUUU 40.1 CUUAU 35.6 
104 UUCGC 51.3 GUUGC 40.0 UUAAU 35.4 
105 GUCUU 51.2 GCUGU 40.0 CCUGU 35.1 
106 CUGUA 49.8 GGUAU 40.0 CUGUA 35.0 
107 CGUGC 49.4 UUUUA 39.2 UGGCU 34.6 
108 UUCUG 49.4 GCGCA 38.8 UUUCA 34.3 
109 GCAUA 49.4 GUUUA 38.7 CGUGU 34.1 
110 GUACA 49.2 UUGUC 37.9 UCUAU 33.9 
111 UUUCG 48.7 GAUGU 37.8 UAGUU 33.4 
112 CGUUU 48.2 UACGU 36.9 GUUAU 33.4 
113 CACGU 47.8 CACAU 36.8 UUGCC 32.7 
114 UGCUA 47.3 GUACG 36.6 UCGUU 32.4 
115 UACGU 46.8 UGUAA 36.6 AUUUA 31.8 
116 UCAUG 46.6 GCUGC 36.1 CUGCC 31.6 
117 AGUGU 45.8 CUGUA 36.0 AUGUC 31.6 
118 GUGCG 45.6 ACGCA 35.7 CUUUA 31.0 
119 GGUUU 45.6 UCGCA 34.4 UAUUG 30.6 
120 UGUUA 45.4 UGUUA 34.1 GAUUG 30.5 
121 UUUAC 44.8 GUCAU 33.8 UACGU 30.5 
122 GAUGU 44.8 GAGUG 33.6 UGACU 29.4 
123 CGUAU 44.5 UGGCA 33.6 GAUGU 29.3 
124 CCUGU 43.0 GUCGC 33.5 UUAUA 28.9 
125 CCUGC 43.0 CCUGC 33.3 UGUGA 28.6 
126 AAUGC 42.3 CUAUG 32.7 GUAUA 28.6 
127 UCUAU 42.3 UGUCG 32.1 GCUAU 28.5 
128 AUGCC 42.0 GUGCC 32.0 UACCU 28.3 
129 UGAGU 40.9 GCACA 31.7 UAUAU 28.1 
130 AUUUG 40.9 CCUGU 31.3 UUCCU 27.6 
131 UAUGA 40.8 UUUUC 30.7 CCUGC 27.5 
132 UUCGU 40.2 CUCGU 30.5 UAUUC 27.4 
133 UGGCU 40.1 UGACU 30.4 CUGUC 27.2 
134 UUGCC 39.9 GUAUC 30.3 CGUAU 27.0 
135 UCUGC 39.3 UUCAU 29.8 GUUGA 26.8 
136 GUACG 38.5 UGAUU 29.4 ACUGU 26.7 
137 CUGAU 38.4 CUUUG 28.5 UUGAA 26.4 
138 UUGAU 38.3 AUGGU 28.4 CCCGU 26.1 
139 CAUUU 38.0 GAUUG 28.4 UUGAC 25.3 
140 UUCAU 37.3 UUCGC 27.9 AUAUU 25.1 
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141 UGUCG 36.8 CGUUU 27.7 GGCUG 25.1 
142 UAUCU 36.8 UGUCA 27.3 CGUCU 24.9 
143 UGACU 36.3 UGUAG 26.5 GUACG 24.5 
144 GUUAU 36.2 AGUGC 25.9 GUGCG 24.3 
145 UUGGU 35.8 GGUGU 25.9 CCGUU 24.3 
146 CGCUU 35.8 UUAUU 25.8 UUGCG 24.2 
147 CUAUG 35.8 UGCCG 25.8 CUUCU 24.1 
148 GAUUG 35.2 ACUGC 25.7 UCCUU 24.0 
149 GGUGU 34.6 CCGUG 25.6 UGCGU 24.0 
150 GUAUC 33.8 CUGUU 25.3 UGCGC 23.9 
151 UCUUG 33.4 CUUUU 25.2 UUCGG 23.6 
152 UACUU 33.1 UGCUA 24.9 CUAUG 23.3 
153 GGUAU 32.8 CGUAU 24.4 UUCCG 23.3 
154 UUUAA 32.3 CGCUG 24.1 UCGCG 22.8 
155 CUUAU 31.8 UCGUG 23.9 ACGUU 22.7 
156 UUUGA 31.5 AGUAU 23.4 CUUUC 22.4 
157 GUCUA 31.3 CAUUG 23.4 AUUUC 22.3 
158 UUACU 30.7 UGAGC 22.8 UUAUC 22.2 
159 CUAUU 30.4 ACGUC 22.6 GCACG 22.1 
160 CUGUC 30.3 GUCUA 22.5 GUGAU 22.0 
161 AGUAU 30.3 UUGCC 22.5 UAUGA 21.8 
162 GUGAU 29.7 UGUCC 22.2 UAAUG 21.4 
163 UCGUU 29.5 AUAUA 21.5 UCUGA 21.1 
164 GCGUU 29.4 GAUGC 21.4 UGAUA 21.1 
165 UCGCA 29.2 UGGGU 21.1 UCCGU 21.1 
166 UUUCC 29.2 GCGUU 21.0 GCUGC 20.6 
167 ACUUU 29.1 UCUUU 20.3 CCUAU 20.6 
168 GUGCC 29.1 GCUUU 20.2 AGUGU 20.3 
169 ACUGU 29.1 UGAUG 20.0 GGUGU 20.1 
170 CCUUU 29.0 CACGC 20.0 UAUGC 19.9 
171 CCGUG 28.9 AUGAC 19.9 UUAAC 19.8 
172 UCCGU 28.4 AUGGG 19.8 GCGUU 19.8 
173 AGUUU 27.9 CGUCA 19.5 GGAUU 19.8 
174 UGUCC 27.8 AUCGC 19.5 UGUGG 19.7 
175 CUGCU 27.7 CUGCG 19.2 UGUCG 19.7 
176 ACGUU 27.6 UGCGA 18.9 AUUCG 19.5 
177 GUUUC 27.2 ACACG 18.4 UUACG 19.1 
178 GCGCA 27.1 GUUAU 17.7 UUCAU 19.0 
179 GCUAU 27.0 UAUGG 17.6 GUACU 18.9 
180 UUGCG 27.0 UGGAU 17.2 GCUUA 18.9 
 63 
181 CGCUG 26.8 UAUCU 17.2 GAUGA 18.7 
182 ACGUG 26.8 UUUAC 17.2 CAUUU 18.6 
183 UGUAA 26.1 GUGAU 16.9 UGUCC 18.5 
184 CUCGU 25.0 UGGCU 16.7 GUCUA 18.4 
185 UCGUG 24.4 AUCUG 16.7 AUCUU 18.3 
186 CGUCU 24.4 GCUCG 16.7 GUUCG 18.2 
187 UGUAG 24.3 CUGUC 16.4 GUCCG 18.2 
188 GUCAU 24.3 UCUAU 16.3 CGUUA 18.1 
189 GGCAU 24.2 CAUCU 16.2 CUAUC 18.1 
190 UGUCA 24.0 UCCGU 15.6 GCUUC 18.0 
191 GAUGC 23.9 GUGAG 15.5 ACGCG 18.0 
192 UUAUA 23.7 UUUCU 15.0 UGCAC 18.0 
193 ACGUC 23.6 CGUUG 14.8 UUAGU 17.9 
194 GUCGC 22.3 UGCUC 14.8 CGGAA 17.9 
195 UGCGA 22.3 UUGCG 14.3 CACGU 17.8 
196 UACCU 22.3 GGUGC 14.2 AUUCU 17.8 
197 GUUCU 22.0 UCGUC 14.0 AGUAU 17.7 
198 ACGCA 21.0 UCGUU 13.9 CCGGU 17.5 
199 AUAUU 21.0 CCAUG 13.7 UAUUA 17.4 
200 GUACU 20.9 UGAUC 13.5 CUAGU 17.4 
201 UUCUC 20.9 UAGCA 13.5 CGCGA 17.3 
202 GUUCG 20.5 GUUCA 13.4 UGACG 17.2 
203 UAAUG 20.4 GGUCG 13.4 UCGGU 16.8 
204 UUACG 20.0 UAUAC 13.2 ACGUA 16.7 
205 AUGGC 19.9 CGGCA 12.9 ACUAU 16.7 
206 AAUUU 19.8 CUACG 12.5 UACUG 16.6 
207 AUGAC 19.7 ACGUU 12.4 UCUUA 16.5 
208 AUGGU 19.7 CGCUU 12.2 AUUUG 15.7 
209 UGGGU 19.6 CGUGA 12.1 UAGUG 15.2 
210 UUUAG 19.4 GUCGU 12.0 UUGGC 15.0 
211 ACGUA 19.3 UACGC 11.9 GGCUU 14.7 
212 CUGCG 19.1 GCCGU 11.5 CCGUG 14.7 
213 CGUCA 18.9 UAAUG 11.3 CUUCG 14.5 
214 AUGAG 18.2 CUCGC 11.1 AUAGU 14.4 
215 CGUUG 18.1 ACGUA 10.9 CGUUC 14.3 
216 UACGC 18.0 CGCGU 10.8 AGCUU 14.2 
217 UUAAU 18.0 UCUCG 10.7 CUCUU 14.0 
218 GUCGU 17.9 UAUCG 10.7 CCGUC 13.8 
219 CCCGU 17.8 UGGUU 10.4 ACGUC 13.8 
220 UAGUU 17.6 ACGCG 10.1 GUAGU 13.8 
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221 AUCUG 17.6 GCACU 10.0 GUAUC 13.6 
222 UGACG 17.4 ACUGU 9.9 CGCGG 13.5 
223 CCGUU 17.3 GUUCG 9.4 UUACC 13.4 
224 GCAUC 17.2 UUACG 9.2 UCGUG 13.2 
225 AUCGC 16.9 GUCUU 9.0 GUCGU 13.1 
226 GGCUG 16.9 CGCAA 8.9 UAGUA 13.1 
227 ACGCG 16.8 UGACG 8.9 UCAUG 13.1 
228 AUGAA 16.8 UAAGU 8.7 GUGGU 13.0 
229 AUCUU 16.6 UCGGC 8.7 UGCGA 12.6 
230 UGAUC 16.6 CGUCG 8.6 UUCUA 12.6 
231 UUGGC 15.3 GUACU 8.4 CUAUA 12.2 
232 GCUCG 15.2 UCGUA 8.1 UUCCC 12.1 
233 UGGAU 15.1 UACUU 8.1 GAUGC 11.8 
234 UAAUU 14.8 GGGUG 7.8 UUAAG 11.7 
235 GUCCG 14.7 UGCAA 7.7 CGAGU 11.5 
236 CGUUA 14.7 UUCGU 7.6 CUGGU 11.4 
237 UACUG 14.4 GUGAA 7.5 AUUGC 11.1 
238 UUCGG 14.4 UUGGC 7.2 AUAUG 11.1 
239 UCGUC 14.1 CGUCU 7.2 UGGUA 11.1 
240 UCGUA 14.1 UACGA 7.2 CGUUG 10.9 
241 ACACG 14.1 AUACG 7.2 AACUU 10.9 
242 UAUUC 13.5 CGAAU 7.1 UACGC 10.8 
243 UUGAC 13.5 CUUAU 7.1 UCGGA 10.8 
244 AUUCG 13.4 AUCUU 6.7 AUGCG 10.5 
245 CGCAA 13.3 GCGAU 6.6 CUGCG 10.4 
246 CGUUC 13.2 AUCGU 6.6 GUGCC 10.3 
247 GCCGU 13.2 CAUCG 6.5 UCUUC 10.3 
248 UGCCG 13.2 UAGCG 6.5 AUCUG 10.2 
249 GACUG 13.0 CUCUG 6.4 UCGUA 10.2 
250 CCUAU 12.9 UCGAU 6.4 GGUAU 9.9 
251 UUAUC 12.8 GACUG 6.2 GACUG 9.8 
252 CAUUG 12.6 GCUAU 6.0 UACUA 9.8 
253 CGCGG 11.9 CGUAC 6.0 UGGAU 9.7 
254 GUUGA 11.9 AUCCG 5.9 CUUGA 9.6 
255 UCGCG 11.8 CAUAC 5.9 UCGAC 9.4 
256 CACGC 11.7 CGGAU 5.9 UGAGU 9.3 
257 AUUUA 11.5 CGUUC 5.5 UUAGC 9.2 
258 UUCCG 11.5 UCAUA 5.4 UCCAU 9.1 
259 CGCGU 11.5 GUCCG 5.4 AUUAU 9.0 
260 GCUUA 11.3 UCUUG 5.3 UGUAG 9.0 
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261 UAAGU 11.3 GCGUA 5.3 CCUUG 8.9 
262 UAUCG 11.3 CCGCA 5.1 UUGGG 8.8 
263 CUUCG 11.2 AUUCG 4.6 AGAUU 8.7 
264 CUAUC 10.9 CGCGG 4.4 UAAGU 8.7 
265 CGUAC 10.9 GUCUC 4.3 CGAUG 8.7 
266 GCGAU 10.8 GAUCG 4.2 GCGUG 8.6 
267 AUAUA 10.7 GGGUA 4.2 GCCGU 8.4 
268 CUGCC 10.5 CGAUU 4.0 CGCAA 8.3 
269 CCAUG 10.5 GCGCG 4.0 ACGGA 8.0 
270 UCUCG 10.4 AUGGA 3.8 CCCCU 7.9 
271 CGAGU 10.2 CGCCU 3.8 UGUCA 7.8 
272 UGAUA 10.0 GUAGC 3.7 GACUU 7.8 
273 UAUAC 10.0 UUUCG 3.6 UCCUA 7.8 
274 CGCGA 9.9 CCGCG 3.5 GUAAU 7.7 
275 CUUUA 9.8 UUCUG 3.5 CAUGU 7.7 
276 UUAAC 9.6 GUCGA 3.5 CGCGU 7.5 
277 UUUCA 9.4 CCUCG 3.5 UCAUU 7.5 
278 UAUGG 9.4 UCCAU 3.3 CGUAC 7.4 
279 UAGCG 9.4 UAUAG 3.0 UGAUC 7.4 
280 UCCAU 9.3 AUAUU 3.0 UAGCG 7.3 
281 UGGUA 9.2 ACUUG 2.9 GUACC 7.3 
282 CUCGC 9.0 UGGUA 2.9 CGGAC 7.2 
283 GAGUG 8.9 GUACC 2.9 GCCUU 7.0 
284 GCUUC 8.9 GUAAG 2.7 UAACG 6.8 
285 CAUCG 8.7 CCGUU 2.5 CCGUA 6.7 
286 GUGAA 8.7 CGCAC 2.5 AUGAC 6.6 
287 UUCCU 8.4 UACCU 2.3 UAUCG 6.6 
288 CUACG 8.0 CGAGU 2.3 ACGAC 6.6 
289 UACGA 7.5 GAGCA 2.2 CUUGG 6.6 
290 GUACC 7.5 UUUGG 2.1 GCGAU 6.5 
291 GUGGU 7.4 CCGUA 2.0 AUCGC 5.9 
292 CGUGA 7.4 GUCGG 2.0 CGGUG 5.9 
293 CUAUA 7.0 CCCGU 1.8 AUCUA 5.8 
294 ACUGC 6.6 CGCGC 1.8 CGUCA 5.6 
295 CGUCG 6.5 CAACG 1.4 CGGUU 5.6 
296 UCGGU 6.4 UACUG 1.4 GUUCC 5.5 
297 GUAAU 6.3 CGCUA 1.3 CCCUU 5.5 
298 CCGUA 5.9 CGUUA 1.2 ACGAU 5.5 
299 GGUCG 5.8 GCGAA 1.2 GUCGC 5.4 
300 CCGCA 5.8 ACGAG 1.1 CUGAC 5.2 
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301 GCGUA 5.8 UUAUA 1.1 GCGCU 5.0 
302 UGGCA 5.7 GACGU 0.9 UCGUC 4.9 
303 AUUAU 4.7 GUAAU 0.7 CCUAC 4.9 
304 UAUUA 4.7 GAUAU 0.0 UGUAA 4.7 
305 CGAUG 4.2 AGCGU 0.0 CAUCG 4.5 
306 ACUAU 4.2 CUUCG -0.3 ACCUU 4.5 
307 AUUUC 4.2 GUAAC -0.3 UUCGA 4.5 
308 GUAGU 4.1 UUGGU -0.4 ACUUA 4.4 
309 CGAUU 4.0 AUCAU -0.4 UGACA 4.2 
310 UUAGU 4.0 UGGCG -0.4 GAUAU 4.1 
311 CAUCU 3.9 AACGC -0.7 GUUGG 4.1 
312 UAGUG 3.7 UGCCC -0.7 GUGAA 4.0 
313 GCACU 3.7 UACGG -1.0 CAGUU 3.9 
314 AUACG 3.6 ACGCU -1.4 CUUAA 3.9 
315 UCGAC 3.6 GCUUA -1.5 UCCCG 3.8 
316 UGCAA 3.6 CAUAG -1.7 GCUCG 3.8 
317 CCGCG 3.4 UGGUG -1.7 CUCGU 3.6 
318 UUACC 3.3 GUGGC -1.8 UCCGA 3.6 
319 UCAUA 3.1 AUCGA -1.9 CGCUG 3.5 
320 GAUAU 3.1 UUCUU -2.0 CUACU 3.5 
321 CACAU 3.0 CGAUC -2.1 UGGUG 3.4 
322 UCGAU 2.9 CGAGA -2.1 UACGA 3.4 
323 CUCUG 2.6 CUAUA -2.1 CGUAA 3.4 
324 CGGCA 2.5 CGACG -2.2 CCGCA 3.4 
325 AUCGU 2.4 CUGAU -2.2 GCGUC 3.2 
326 AGCGU 2.3 GGCUG -2.3 GUCAU 3.1 
327 GGAUU 2.2 GCGCU -2.5 UGCGG 3.0 
328 CUUUC 2.2 CUAUC -2.6 AGCGU 2.9 
329 CGGAU 2.1 GCGCC -2.7 GGUUG 2.8 
330 AUCCG 2.0 CGUAG -2.7 UGGGU 2.6 
331 CGCUA 2.0 UUACU -2.8 UCUCG 2.6 
332 AUCUA 1.8 UCGAC -2.9 CGGCU 2.6 
333 UCAUU 1.7 GACGC -2.9 CCAUG 2.6 
334 AUAGU 1.6 GUGGU -2.9 CUAAC 2.5 
335 UCCUU 1.6 GCGUC -3.0 CGAUU 2.4 
336 GUCGA 1.4 CGAUG -3.0 GCUGA 2.3 
337 CGAAU 1.4 GCCGC -3.1 AACGU 2.3 
338 GCGCG 1.2 UCACG -3.2 UAUCA 2.1 
339 GCGCU 1.1 GCGGC -3.5 GCGUA 2.1 
340 GAUCG 1.1 UUCUC -3.6 UCUGC 2.0 
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341 AUUCU 1.0 AUACA -3.6 CUGGC 1.9 
342 UCGGA 1.0 AUUAU -3.7 UUAGA 1.9 
343 UGGUG 1.0 CUGCU -3.8 CGUGC 1.8 
344 UGAGC 0.9 GAGCG -3.8 CCGCG 1.8 
345 CCGGU 0.6 CGGCU -3.8 CUCGC 1.8 
346 GCACA 0.6 GUUAC -3.9 CGCUA 1.8 
347 ACGAU 0.5 CGUAA -3.9 AUAUC 1.7 
348 CGGUU 0.5 GUGGG -4.0 UUGGA 1.6 
349 CGUAA 0.3 AUCUA -4.0 CCGGC 1.6 
350 GACGU 0.2 GCCCG -4.1 GAUUA 1.3 
351 UACUA 0.0 ACAUA -4.3 ACUCU 1.3 
352 GUUCA 0.0 UGCCA -4.4 UAUAC 1.3 
353 ACGCU 0.0 GAGUA -4.5 AAUGA 1.2 
354 UAACG 0.0 GAUUU -4.5 UCUAC 1.0 
355 GCGUC 0.0 CGCGA -4.6 ACCGU 1.0 
356 UAGUA 0.0 GGCCG -4.6 CGAUA 0.9 
357 AGCUU -0.2 GAUCU -4.8 ACGCU 0.9 
358 UGCUC -0.4 CGGUU -4.8 GUACA 0.7 
359 AGUGC -0.5 UUCGG -4.9 UCUCU 0.7 
360 UAUAG -0.8 GUUCU -5.0 CCGAU 0.7 
361 GUCUC -1.2 UUAUC -5.1 UCGCA 0.7 
362 CGGCU -1.2 CGCAG -5.2 CGUCG 0.6 
363 ACGAC -1.3 GCGAC -5.3 ACACG 0.6 
364 GAUGA -1.3 UCAUU -5.3 UCGAG 0.3 
365 UCGGC -1.3 UCGGU -5.4 AUGGU 0.2 
366 CUAGU -1.4 UAUCA -5.7 CUACC 0.2 
367 CCUAC -1.7 CCUAU -5.8 GAGUU 0.1 
368 CGAUC -1.8 CCGGC -5.9 CACGA 0.1 
369 CGGAC -1.8 UAACU -5.9 ACAUU 0.0 
370 AUCGA -1.9 AGCGA -6.2 UCCGG 0.0 
371 GCGAA -2.0 ACGAU -6.4 UCCCC 0.0 
372 CCUUG -2.1 AGCGC -6.4 CGUGA 0.0 
373 UAUCA -2.1 UAAGC -6.4 GACGA -0.1 
374 CUUCU -2.3 UUGAC -6.6 CCAUU -0.1 
375 CGCGC -2.3 AACGU -6.7 UAACU -0.1 
376 UCUGA -2.3 ACCCG -6.8 GCCCG -0.2 
377 AACGU -2.4 CAUUC -6.8 AAUGC -0.2 
378 UUCGA -2.5 CGGCC -6.9 GAUUC -0.2 
379 GUUAC -2.7 GCUUC -7.0 ACUGA -0.3 
380 CCGGC -2.7 CGAAC -7.1 CGAUC -0.3 
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381 UCACG -2.9 UACCG -7.1 AUCGA -0.4 
382 UCCGA -3.0 GGCGU -7.2 CGGUC -0.4 
383 GCCCG -3.1 UUGAU -7.2 GCGGA -0.4 
384 GUUGG -3.1 CGACA -7.4 GUUAC -0.5 
385 CUUGA -3.4 CCUAC -7.4 UCAGU -0.5 
386 GUAAC -3.7 UGAUA -7.4 GAUAC -0.6 
387 UUAGC -3.7 AGUUU -7.5 UGGUC -0.6 
388 GUGGC -3.9 UCGCG -7.5 CUACG -0.7 
389 GGUGC -4.0 UCGAA -7.5 CGGGU -0.7 
390 GGCUU -4.0 UUCCG -7.6 UACAU -0.8 
391 GAGUA -4.2 CCGAA -7.7 CCGAA -0.8 
392 GUAGC -4.3 ACGGC -7.7 AUACU -0.8 
393 CGGUG -4.3 AUAGC -7.7 AUAAU -0.8 
394 GCCGC -4.4 UCGGA -8.1 UUCAC -0.9 
395 UAACU -4.4 UUCGA -8.2 GAGUA -0.9 
396 UUGAA -4.6 AUAUC -8.3 UCGAU -1.0 
397 AUAUC -4.6 AACGA -8.3 GACGU -1.0 
398 CGCAC -4.7 GGAUG -8.4 CGACU -1.0 
399 UCCCG -4.7 CUCGG -8.4 UUAGG -1.1 
400 GUCGG -4.7 UAACG -8.6 UCAUA -1.2 
401 ACUUG -5.0 GUGAC -8.7 GUCGA -1.2 
402 AACGC -5.0 AUACU -8.7 GACGG -1.3 
403 CCGUC -5.2 CCGCU -8.8 CGCAU -1.4 
404 UACGG -5.2 CGGAC -8.8 AUACG -1.5 
405 GGUUG -5.5 UCCGA -9.0 GUCCU -1.6 
406 CGCCU -5.5 GGUUU -9.0 UACCC -1.6 
407 GGGUA -5.5 UUAAC -9.1 GCGGG -1.7 
408 GGGUG -5.6 UUACC -9.1 UCACG -1.7 
409 UCUUA -5.6 UCGCC -9.2 GCGCA -1.7 
410 CGGAA -5.7 GUUGG -9.2 GCAAU -1.8 
411 CUGAC -5.8 UACAC -9.2 GUGAC -1.9 
412 CCGAA -5.9 AGUCG -9.4 UGCAA -1.9 
413 GCCUU -5.9 CGGUG -9.5 ACCUG -1.9 
414 CGAUA -6.0 GCCUA -9.5 CGUCC -1.9 
415 CAACG -6.2 UCAUC -9.6 UUGAG -1.9 
416 UGACA -6.3 ACGAC -9.7 GCGCG -2.2 
417 UCUCU -6.4 CGAUA -9.7 CGGAU -2.2 
418 CGUAG -6.5 CCUUG -9.7 UAGUC -2.3 
419 CCUCG -6.6 AUCGG -9.7 GCCUA -2.5 
420 GACGA -6.6 UCCGC -9.8 CCUGA -2.6 
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421 AUCAU -6.7 GCGGU -9.9 UCACU -2.7 
422 UCUAC -6.8 GGAUA -9.9 UUCAG -2.7 
423 CGAGA -6.8 CGGCG -10.0 ACGUG -2.8 
424 CUGGU -6.9 UAGAU -10.1 AUCCG -2.8 
425 GGCGU -6.9 UAACC -10.1 GGCGU -2.9 
426 CGGUC -6.9 GUUUC -10.2 GAAUU -2.9 
427 AUACU -7.0 UCUCU -10.3 AUUGA -3.0 
428 CGCAG -7.1 UUAAU -10.3 GAUCG -3.1 
429 GUGAC -7.2 GUCCA -10.4 GCGAG -3.1 
430 GACGC -7.2 AAUCG -10.5 AUCGU -3.2 
431 UUGGG -7.2 UCCCG -10.5 GCCGC -3.2 
432 CGAAC -7.2 ACCGA -10.6 UAUAA -3.2 
433 UGGUC -7.3 GCAAU -10.7 UAGAU -3.2 
434 GUGAG -7.6 UGGUC -10.8 UAUAG -3.3 
435 CGGCG -7.7 ACGCC -10.8 GUGGC -3.3 
436 UGCCA -7.7 GUAGU -10.8 CGGCG -3.4 
437 ACAUU -7.8 CCCGC -10.9 CUCUG -3.4 
438 GCGGA -8.0 GUCCU -11.0 GCGAA -3.4 
439 ACGAG -8.0 GCGGA -11.0 GGGUU -3.5 
440 GCAAU -8.1 ACGGU -11.1 CCUUA -3.5 
441 GGCCG -8.1 ACUCG -11.1 CAUUG -3.6 
442 UACCG -8.3 CGGUC -11.1 UAACA -3.6 
443 CUUGG -8.5 CUCCG -11.2 CCCCG -3.7 
444 GUCCA -8.6 CGCUC -11.4 CGAAC -3.7 
445 CUACU -8.7 CUCAU -11.4 CUUAG -3.7 
446 ACGGA -8.7 AAGUG -11.4 GGUUC -3.8 
447 CGACA -8.8 CGACC -11.4 GUCCA -3.9 
448 UCGAG -8.8 CGAGC -11.5 CGAAU -4.0 
449 CGACG -8.8 AAGCG -11.6 AGGUU -4.0 
450 CUAAC -9.0 UAUUC -11.7 UAUGG -4.1 
451 ACCGU -9.0 GGCGC -11.7 GGUCG -4.2 
452 CGACU -9.0 ACAUU -11.7 GCACU -4.2 
453 ACGGC -9.1 CUCGA -11.8 UACCG -4.3 
454 GCCUA -9.2 ACUAU -11.8 AUUAC -4.4 
455 UAGCA -9.4 AGACG -11.9 UACUC -4.5 
456 AUCGG -9.5 UGCAG -12.0 ACGGC -4.5 
457 UGCGG -9.5 UCUAC -12.1 UAGCU -4.5 
458 GUCCU -9.8 GCUAC -12.1 UGCCG -4.6 
459 UCCGG -9.8 GACGG -12.2 AGUUG -4.8 
460 UAGAU -9.8 CGUGG -12.2 CUCAU -4.8 
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461 GUAAG -10.0 GGUUG -12.3 CGACA -5.0 
462 GCUGA -10.0 GCGAG -12.3 CGACC -5.0 
463 UCCGC -10.3 UAAUU -12.4 UGCCA -5.2 
464 GUUCC -10.4 GACAU -12.4 AUCGG -5.2 
465 UGCCC -10.4 ACUUU -12.5 AUAUA -5.3 
466 GCGGC -10.4 AACCG -12.5 CGCAG -5.4 
467 CACGA -10.7 UAGUU -12.6 UAACC -5.5 
468 CUGGC -10.8 UGAAC -12.6 GUAAC -5.6 
469 AGCGA -10.9 CGAAA -12.7 CGCGC -5.6 
470 GAGCG -11.0 CUACA -12.7 GAACG -5.7 
471 GCGCC -11.0 CAUUA -12.9 UCCGC -5.8 
472 CAUAG -11.0 UAGGU -12.9 AAUUC -5.8 
473 CGACC -11.1 GACGA -12.9 ACCUA -5.9 
474 GACGG -11.2 ACCGC -13.0 AUGCC -6.0 
475 GAUCU -11.2 GUUAG -13.1 AAAUU -6.1 
476 CUCAU -11.3 UCCGG -13.2 UUAAA -6.1 
477 CCGAU -11.4 GAACG -13.2 CGAGA -6.1 
478 ACGCC -11.5 CGACU -13.2 ACCGG -6.2 
479 UGGCG -11.5 UACUA -13.3 CACUU -6.3 
480 ACCUU -11.7 CCUUU -13.3 UACGG -6.4 
481 UAACC -11.9 GCCUU -13.5 GUCUC -6.4 
482 GACUU -11.9 ACCGU -13.5 GACGC -6.5 
483 ACCGA -12.0 UAUUA -13.6 AACGC -6.5 
484 GCGAC -12.0 UAGUG -13.9 GGUAG -6.6 
485 GCGAG -12.0 CCGAG -14.0 UCUGG -6.6 
486 GAUAC -12.2 GGCGG -14.0 ACGCC -6.7 
487 UAUAA -12.2 AUUAC -14.0 UGAAC -6.8 
488 ACCUA -12.2 CCGAC -14.1 AGCGA -6.8 
489 AUGGG -12.3 CACGG -14.2 GGCCG -6.8 
490 UGAAC -12.5 UCGAG -14.2 GUUAG -7.1 
491 UCGCC -12.7 CCGGU -14.5 CACGG -7.2 
492 UACCC -13.0 CUGAC -14.5 CACCU -7.2 
493 AGUCG -13.0 CAUCC -14.6 CGUAG -7.2 
494 UCAUC -13.2 GCCGG -14.6 CUGAA -7.3 
495 UAGGU -13.3 GACCG -14.6 CACGC -7.6 
496 AACGA -13.3 CUUUA -14.7 UAAAU -7.6 
497 CGGGU -13.3 CGGUA -14.8 ACGAA -7.7 
498 CGUGG -13.5 CACCG -14.8 ACCGA -7.8 
499 UCUUC -13.5 GUUAA -15.1 AAGUU -7.9 
500 AUUGA -13.6 UUAGC -15.1 UCUAA -7.9 
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501 UUCUA -13.6 AUAGU -15.2 UAGGU -7.9 
502 AACUU -13.6 CUAUU -15.3 GAUCA -8.1 
503 GAACG -13.8 AAUUG -15.3 GCUGG -8.1 
504 AUUAC -14.0 CGCCG -15.4 CGAAG -8.2 
505 CACGG -14.1 UGACA -15.5 ACAUG -8.2 
506 AAUCG -14.1 UCGGG -15.5 CUAAU -8.2 
507 GUUAG -14.2 AUACC -15.5 CGGUA -8.4 
508 GAUUA -14.2 UGCGG -15.5 CGCCU -8.7 
509 CGGUA -14.3 AGCUU -15.8 CCCAU -8.7 
510 GGAUG -14.6 CUAAC -15.9 CUUAC -8.7 
511 UUGAG -14.7 UAGUA -15.9 GUCAA -8.9 
512 UCCUA -14.8 AAGCA -16.1 UCAUC -8.9 
513 ACCUG -15.0 UAUCC -16.2 CGUGG -8.9 
514 CACCG -15.2 AAUAU -16.4 GUUAA -8.9 
515 CCCUU -15.3 ACCGG -16.5 AGUCG -9.0 
516 UAGCU -15.3 CUGGC -16.5 GGUAA -9.0 
517 CGGCC -15.4 CGGGU -16.5 GGACG -9.1 
518 ACCGG -15.5 AAUUU -16.5 CACUA -9.1 
519 UCGAA -15.5 GAAUA -16.6 UAAAC -9.1 
520 CUCGA -15.8 AUUUA -16.7 AGACG -9.1 
521 AGACG -15.8 ACCUA -16.7 CUCUA -9.1 
522 UUCAC -15.9 GAUCA -16.8 CAAUU -9.2 
523 ACGGU -15.9 CCCUG -16.8 GAUCU -9.2 
524 CUCGG -16.0 CUACU -16.9 CUCCG -9.3 
525 AACCG -16.0 GAUAC -16.9 UCGCC -9.3 
526 AAUGA -16.1 CCGAU -16.9 UGACC -9.3 
527 GGUUC -16.3 UAGCU -16.9 GUCGG -9.4 
528 UCAGU -16.4 UAUAA -17.0 AUCAU -9.4 
529 GGCGC -16.5 UUAGU -17.1 ACUUG -9.4 
530 CCCGC -16.5 ACGGG -17.1 GACAU -9.5 
531 CUCUU -16.6 UUACA -17.1 AGUUA -9.6 
532 GACAU -16.7 GCUAA -17.2 CGGCA -9.6 
533 CUAAU -16.7 GUAGG -17.3 GUAGC -9.6 
534 CGUCC -16.8 CAAUG -17.4 CGCAC -9.7 
535 CGCUC -16.8 ACGAA -17.5 GUAGG -9.7 
536 ACUCG -17.2 CAGCG -17.5 CACCG -9.9 
537 UAGUC -17.2 CCGGA -17.7 CGAAA -9.9 
538 AUAAU -17.3 CUUGA -17.7 CAUCU -10.0 
539 CUACC -17.4 AAACG -17.7 AGUCU -10.0 
540 CGAAA -17.4 GGGGU -17.8 UAAUC -10.0 
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541 ACCCG -17.5 GGACG -17.8 CAAUG -10.2 
542 UUGGA -17.6 CCCGA -17.8 UCGGC -10.2 
543 GAUCA -17.6 CCCAU -18.0 GAAAU -10.2 
544 GCGGG -17.6 GCCGA -18.0 CUCGA -10.2 
545 AUACA -17.7 CGAAG -18.1 GGUCU -10.5 
546 UACAC -17.8 GGAUU -18.1 CAACG -10.7 
547 CGAGC -18.0 GACUA -18.3 UGAAA -10.8 
548 CUCCG -18.1 CAGCA -18.3 GCUAA -10.8 
549 GGAUA -18.1 AUUGA -18.3 AGUUC -10.9 
550 CCCCU -18.2 ACGGA -18.4 CAGCG -11.0 
551 CCAUU -18.2 CAAGC -18.5 AACCG -11.0 
552 CAUAC -18.3 GUGGA -18.5 CGACG -11.1 
553 ACGAA -18.3 GUUGA -18.5 UCUCC -11.1 
554 CGAAG -18.4 CCAUA -18.7 UAGAC -11.1 
555 AGCGC -18.4 CAUAA -18.8 GAGCG -11.1 
556 GUUAA -18.4 CUUGG -19.3 GCGGC -11.2 
557 CCCAU -18.5 GGUAA -19.4 CCCGA -11.2 
558 UUAAG -19.1 CGGGC -19.5 ACGAG -11.3 
559 UAACA -19.2 GCUGA -19.6 CGCUC -11.3 
560 CGCCG -19.3 AGGCG -19.6 GACCG -11.3 
561 GGACG -19.3 CCGUC -19.7 GGAUG -11.3 
562 AGAUU -19.3 CGGGA -19.7 ACGGU -11.7 
563 GAGUU -19.4 CAUCA -20.1 GUCAC -11.8 
564 GAAUU -19.4 CUAGU -20.1 UAAUA -11.8 
565 AAUUG -19.4 GGCGA -20.2 ACUUC -11.9 
566 ACUUA -19.5 UGGGC -20.4 CUCGG -11.9 
567 GGUAA -19.5 GCAGU -20.4 CCACG -11.9 
568 UAAGC -19.9 AUAAU -20.5 CCUCG -11.9 
569 GUAAA -19.9 CAGUG -20.5 CACUG -11.9 
570 GCGGU -19.9 ACCUG -20.5 AUUCC -12.0 
571 AAGCG -20.1 GUAAA -20.5 AGCGG -12.0 
572 UUCCC -20.1 UACCC -20.7 GCUAG -12.1 
573 GUAGG -20.3 AUUUC -20.7 UCCCU -12.2 
574 AGUUG -20.3 GCACC -20.8 UCUAG -12.2 
575 CCGAG -20.5 AUUCU -20.8 GCCAU -12.2 
576 GGGCG -20.7 UUGGG -20.9 CAUAU -12.2 
577 GCUAA -20.7 UUCCU -20.9 CCCCC -12.3 
578 GACCG -20.9 UUGAG -21.0 GUAAA -12.3 
579 GUGGG -21.0 CCACG -21.0 UCGAA -12.3 
580 GAUUC -21.4 UCAGU -21.1 ACUCG -12.3 
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581 CCACG -21.5 ACCUU -21.2 AAUUG -12.4 
582 GCCGG -21.6 AUUCA -21.2 CGAGC -12.4 
583 UAUCC -21.7 AUAAG -21.2 AAUCG -12.4 
584 CAGUU -21.7 UCCUG -21.2 AACGG -12.4 
585 CCCUG -21.7 CACGA -21.2 UCAAC -12.4 
586 CCCCG -21.8 CGGAG -21.3 GAUAA -12.5 
587 ACGGG -21.9 GGUUC -21.4 CUUCA -12.5 
588 GCUAC -21.9 CUGGU -21.4 ACUAC -12.6 
589 CGCCA -22.1 CUAAU -21.6 GUUCA -12.6 
590 CCCGA -22.4 CUGCC -21.6 GGGCG -12.6 
591 GUCAA -22.6 GAUUA -21.7 GGGUA -12.6 
592 GACUA -22.8 CGCCC -21.8 GCGCC -12.6 
593 AUGGA -22.9 AACUG -22.1 CGCCA -12.7 
594 GGCGG -22.9 GGUAC -22.1 AACGA -12.7 
595 CAGCG -22.9 ACAUC -22.2 ACGCA -12.8 
596 CAAUG -23.0 UUUAG -22.2 GCGAC -12.9 
597 GGGUU -23.3 GGCUU -22.2 CACCC -13.0 
598 GAAUA -23.5 GGAAU -22.3 UAUCC -13.1 
599 CGGGA -23.8 UCCCU -22.4 AUUGG -13.2 
600 CUCUA -23.8 AUCUC -22.6 CCUAG -13.3 
601 CACUU -23.8 UUCAC -22.7 CCCGC -13.3 
602 CCUGA -23.9 GCUAG -22.7 CAUAG -13.3 
603 AAUAU -23.9 AGCGG -22.8 UGCCC -13.3 
604 CCGCU -24.0 CGUCC -22.9 AAUCU -13.4 
605 CCGAC -24.0 AUCAC -22.9 AGCCG -13.4 
606 GCCGA -24.1 UCUGA -23.1 AUCAC -13.5 
607 AUCUC -24.2 UCAAU -23.4 GGAUA -13.6 
608 ACUCU -24.2 GGGCG -23.4 AUCUC -13.9 
609 CACUG -24.3 GCAAC -23.4 CCAUA -13.9 
610 CCGGA -24.5 CGCCA -23.5 GACCU -13.9 
611 CAUUC -24.5 GAUAA -23.5 GACUA -13.9 
612 UACUC -24.5 GUUCC -23.6 ACUGC -14.1 
613 ACUGA -24.5 UUUAA -23.8 UGGCG -14.1 
614 CCAUA -24.6 UUUCA -23.8 AUGAG -14.3 
615 AUCAC -24.7 CUAGC -24.1 GCACC -14.3 
616 AUACC -25.0 AACGG -24.1 CGCCG -14.4 
617 UUAGA -25.1 GCUCA -24.2 ACCCU -14.4 
618 CUUAC -25.1 CAAUC -24.3 CCCUG -14.6 
619 UCGGG -25.2 GAUGA -24.4 CCCUA -14.6 
620 CUUAA -25.3 UUUGA -24.5 CGCCC -14.6 
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621 ACAUA -25.4 GCUCC -24.5 GUAGA -14.7 
622 CUACA -25.5 CCCGG -24.6 CCUUC -14.7 
623 GCACC -25.5 CUUUC -24.7 CUAGA -14.8 
624 UUACA -25.6 CACUU -24.8 GAGUG -14.8 
625 GGGGU -25.8 UACCA -24.9 CGGGA -14.9 
626 AUUGG -25.8 CCCCG -25.0 AGUAC -15.2 
627 GUAGA -25.8 GGGAU -25.0 AAUAU -15.3 
628 UCCCU -25.9 ACAGC -25.0 GCGGU -15.3 
629 AAGUG -26.2 CAAGU -25.1 UAGGA -15.4 
630 GAUAA -26.3 UUUCC -25.1 ACCCC -15.4 
631 AAACG -26.5 GGGCA -25.2 AUUAG -15.4 
632 UGCAG -26.5 UAAUA -25.3 CUUCC -15.5 
633 AGCGG -26.6 UAGUC -25.4 GGCGC -15.5 
634 GGAAU -26.6 UCCUU -25.4 UACAC -15.8 
635 GCUAG -26.7 UAGGC -25.4 GGAAU -15.8 
636 CCCGG -27.0 ACUAA -25.5 GUAAG -15.8 
637 GCCAU -27.0 GAAUU -25.6 UGCUC -16.0 
638 AUUCA -27.1 UAAUC -25.6 CCGAC -16.0 
639 UAAUA -27.2 CGGAA -25.7 ACACU -16.1 
640 CGCCC -27.2 CGAGG -25.8 AACAU -16.1 
641 UCACU -27.2 AUAAC -26.0 CCACC -16.1 
642 UCUGG -27.3 GUCCC -26.2 AAACG -16.2 
643 GUGGA -27.4 CUUCU -26.2 CCCGG -16.4 
644 UAAAU -27.5 GCCAU -26.2 AAGCG -16.5 
645 UAAUC -27.6 GGUCA -26.3 UACAA -16.6 
646 ACCGC -27.7 GUCAG -26.4 ACCUC -16.8 
647 CGGAG -27.7 CCCUU -26.5 CGGCC -16.8 
648 AAGUU -27.9 CACUG -26.5 UCACC -16.9 
649 ACAUC -27.9 UACUC -26.5 ACUAA -16.9 
650 UCCUG -27.9 CUACC -26.5 ACCCG -17.0 
651 CAUUA -28.1 AUUGG -26.6 UGGCC -17.0 
652 AACGG -28.1 AACAU -26.7 GGGGU -17.1 
653 GGUCU -28.1 CGGGG -26.7 UCAAU -17.1 
654 ACUAA -28.1 CCGCC -26.7 GAAUA -17.1 
655 UCUAA -28.2 UGGAC -26.9 GGGGG -17.2 
656 AACAU -28.2 GAUUC -27.0 UAGAG -17.2 
657 UCUCC -28.2 GUCAA -27.0 CAAUC -17.4 
658 AUAGC -28.2 CAACU -27.0 GAGUC -17.4 
659 UAAAC -28.3 UCAAC -27.1 AGGUA -17.6 
660 AGCCG -28.3 CCUGA -27.2 GCAGU -17.7 
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661 CAUCC -28.4 CUUAC -27.2 CCGAG -17.7 
662 GCAGU -28.6 UCCUA -27.2 GAACU -17.7 
663 UGGAC -28.7 AUCCC -27.3 GAGCU -17.7 
664 UGGCC -28.7 GUAGA -27.3 GACUC -17.8 
665 UCCCC -29.0 GCGGG -27.3 UCGGG -17.8 
666 AAAUU -29.2 UGGCC -27.3 AUGGC -17.8 
667 UCAAU -29.3 AUCCA -27.3 GAUAG -17.9 
668 AGUUA -29.4 CUCUA -27.4 CUCCC -18.0 
669 AGUCU -29.6 GGGGG -27.6 CCCAC -18.1 
670 UCAAC -29.6 GCUCU -27.7 GCUAC -18.1 
671 UAGAC -29.7 ACUAC -27.7 CAACU -18.2 
672 GAGCA -30.3 AAAUG -27.7 GGGUG -18.3 
673 UUAGG -30.3 ACCAU -27.7 AUUCA -18.5 
674 GGUAG -30.5 UAACA -27.8 GGACU -18.5 
675 ACUAC -30.7 UCUCC -28.0 UUACA -18.5 
676 CAGUG -30.8 GCCCU -28.0 GAAGU -18.6 
677 AACUG -30.8 GCCCA -28.1 GGUGC -18.6 
678 CACCU -30.8 AGUUG -28.1 AGAGU -18.7 
679 AUAAC -30.8 UAAAU -28.3 UUCCA -18.7 
680 UUCAG -30.9 GCAGC -28.3 CCGCC -18.8 
681 CUAGC -30.9 GGAUC -28.7 AUGAA -18.8 
682 CGGGC -31.0 CUCUC -28.7 AGCGC -18.9 
683 ACUUC -31.1 CCGGG -28.8 AUAGG -18.9 
684 UGACC -31.1 GGGUU -29.0 AAUAC -19.0 
685 CCCCC -31.3 AGUCU -29.1 AACUG -19.1 
686 CCUUC -31.3 GAGUU -29.2 AGUAG -19.1 
687 CUAAG -31.6 AAUGA -29.3 CUACA -19.1 
688 AGUAC -31.7 AGUAC -29.3 AGUAA -19.2 
689 CCGCC -31.7 CACAC -29.3 UGGAC -19.3 
690 UGGGC -31.7 GACCU -29.5 GGUUA -19.3 
691 CAACU -31.9 CCCCC -29.7 UGAGA -19.3 
692 AGGUU -32.2 GGCAC -29.7 CCGGA -19.4 
693 GGUAC -32.2 UCACC -29.8 UCCUC -19.5 
694 GACCU -32.3 ACACA -29.8 AUUAA -19.5 
695 GGGAU -32.5 UGGGG -29.9 CUCUC -19.6 
696 CUUCA -32.5 UUGGA -30.0 GCCGA -19.6 
697 GGCGA -32.6 AGAUG -30.0 UAGCC -19.7 
698 CACCC -32.8 UCUUA -30.1 AUACC -19.8 
699 CAAUC -32.9 GCCUC -30.1 UAAGC -19.8 
700 AAUUC -33.0 GACUU -30.3 AAACU -19.9 
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701 GAAGU -33.1 UUCUA -30.5 GAUGG -19.9 
702 CUUAG -33.2 GAACA -30.5 GGCGA -19.9 
703 UCUAG -33.3 CUAAG -30.5 CUGAG -20.0 
704 CGAGG -33.5 CUCCC -30.6 CCUCU -20.1 
705 CCCUA -33.8 UCUAA -30.6 ACGGG -20.2 
706 GGGGG -33.9 CCUUC -30.8 GGCUA -20.3 
707 AAUAC -33.9 CUUCA -30.8 GGGAU -20.3 
708 UCACC -33.9 GGUUA -31.1 CUAAG -20.3 
709 UACAA -34.0 AUAGG -31.2 UAAGA -20.4 
710 GCAAC -34.2 AGUUA -31.3 AUCCU -20.5 
711 CAAUU -34.3 AACCU -31.3 UAGAA -20.5 
712 CUAGA -34.4 AGCCG -31.3 AGAAU -20.6 
713 UAGGC -34.6 AGCUG -31.4 AGUGA -20.6 
714 AAAUG -34.6 CCAUU -31.6 UCCAC -20.6 
715 UACCA -34.7 AACAC -31.6 CCCUC -20.9 
716 CCUUA -34.7 CACUC -31.8 GAAUC -20.9 
717 GUCAC -34.7 AAUAC -31.9 UGAAG -21.0 
718 AAUCU -34.9 CUUCC -32.2 AGACU -21.1 
719 UGAAA -34.9 AUAGA -32.3 CGGAG -21.1 
720 AAGUA -35.1 CCCCU -32.3 AAAUG -21.1 
721 GCUGG -35.2 ACCCC -32.3 GGUCC -21.2 
722 GGUUA -35.2 AGCUA -32.3 AAGGU -21.2 
723 CCUAG -35.2 UCUGG -32.5 GACAC -21.2 
724 GAUAG -35.4 ACCUC -32.7 AACUA -21.2 
725 AUUCC -35.6 UCUUC -32.8 CGGGC -21.4 
726 UCCAC -35.8 GAGCU -32.8 ACAUC -21.4 
727 AGGUA -35.8 ACCAC -32.9 GCCGG -21.4 
728 AUAGG -36.0 CCUAG -32.9 GCCUC -21.4 
729 CACUA -36.2 CAGUU -33.0 CUAGC -21.5 
730 GAGUC -36.2 AACUU -33.0 UGAGC -21.6 
731 ACCCC -36.2 AUCAG -33.1 AAUGG -21.6 
732 CUCCC -36.4 GCAAG -33.1 CCAUC -21.7 
733 CUCUC -36.6 GGUGG -33.2 CAGAU -21.7 
734 ACCAU -36.7 GAUCC -33.3 AAUUA -21.8 
735 AUCCC -36.7 CACCU -33.4 UAGGG -21.8 
736 AGGCG -36.8 AAGUU -33.4 GGUAC -21.9 
737 AACUA -37.1 UGAGA -33.7 CGAGG -22.1 
738 CGGGG -37.2 CACUA -33.7 CCGCU -22.2 
739 GGUCC -37.3 GCCAC -33.8 GCCCC -22.2 
740 CUUCC -37.3 GGGUC -33.8 CAGUA -22.4 
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741 ACCCU -37.9 GAGAU -33.8 UAGCA -22.4 
742 GAUCC -38.4 ACUAG -33.9 GAGAU -22.5 
743 AACCU -38.4 CCAUC -34.1 AGGAU -22.6 
744 GCUCC -38.4 UCUAG -34.1 ACCGC -22.7 
745 GAAAU -38.8 ACUGA -34.3 CUCCU -22.8 
746 AUAAG -38.8 GAGUC -34.6 UCUCA -22.9 
747 AGUUC -38.9 UAAAC -34.7 CCUCC -23.1 
748 UCCUC -39.0 AAAGC -34.8 AUACA -23.2 
749 GCAGC -39.0 GAAUC -34.9 ACUAG -23.2 
750 CCAUC -39.0 AGGUG -34.9 AGAUC -23.3 
751 GACUC -39.1 GCCCC -34.9 CCUAA -23.3 
752 ACACU -39.2 GUCAC -35.0 GAAAC -23.3 
753 GGUGG -39.4 UCCAC -35.2 CACUC -23.5 
754 GAAUC -39.5 GGUCU -35.4 AAGUA -23.5 
755 GUCAG -39.6 CUAGA -35.4 UCCUG -23.5 
756 CACUC -39.8 UAGAC -35.4 ACACC -23.6 
757 CUCCU -39.8 AAGUA -35.4 UACCA -23.8 
758 AGUAA -39.9 GGUGA -35.7 AAGUC -23.9 
759 GCCUC -39.9 UGACC -35.7 AAGUG -24.0 
760 AAUGG -40.0 ACUCU -35.8 AGUCA -24.0 
761 CCACC -40.1 ACAAC -36.0 UGGCA -24.1 
762 GAGAU -40.1 GAACC -36.1 CCACU -24.2 
763 UGAGA -40.3 AAUUC -36.2 GUGGA -24.3 
764 CCAAU -40.9 GCUGG -36.3 GUGCA -24.5 
765 AUCCA -41.0 AGAUU -36.4 CCAAU -24.6 
766 ACCUC -41.1 GGUCC -36.5 GGCGG -24.6 
767 CAGUA -41.4 AACUA -36.6 AUAAC -24.6 
768 GUCCC -41.4 AAGCU -36.7 UUGCA -24.7 
769 AUUAG -41.4 UCACU -36.7 AACCU -24.9 
770 AGAUG -41.5 CCCUA -36.8 GCAAC -24.9 
771 AACAC -41.5 UACAA -36.9 CAAAU -25.0 
772 GAACU -41.6 CUGAG -36.9 UAGGC -25.1 
773 AGUAG -41.7 UCCUC -37.0 CAUUA -25.2 
774 CCUAA -41.7 GACUC -37.0 CAUUC -25.3 
775 GGUGA -41.8 GGCCC -37.0 UUCAA -25.3 
776 GAGCU -41.9 UCACA -37.0 ACAAU -25.3 
777 GCCCC -42.1 ACUUA -37.0 AGUGC -25.3 
778 GGGUC -42.3 UGAAA -37.2 AGGCU -25.4 
779 GCAAG -42.4 GGCUC -37.2 CAGUG -25.4 
780 CCACU -42.4 CACCC -37.3 AUAGA -25.4 
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781 CCGGG -42.7 GCCAA -37.5 UGGGC -25.4 
782 CAUAA -42.8 GAGAG -37.6 GGUGG -25.5 
783 AUAGA -42.9 CCUUA -37.7 CCAGU -25.6 
784 GCCCU -43.0 CUCUU -37.7 AAUCC -25.7 
785 UUCAA -43.1 GAAGU -37.7 CAGUC -25.8 
786 CAAGU -43.1 CAAUA -37.8 AAUAG -25.9 
787 ACACC -43.1 AAAUU -37.8 GACCC -26.0 
788 CACAC -43.2 GAUAG -37.9 GUCAG -26.3 
789 CUGAA -43.4 ACAGU -38.0 ACAGU -26.4 
790 GGUCA -43.4 CCUCC -38.0 ACAUA -26.5 
791 GAACA -43.5 UUGAA -38.1 GGACC -26.6 
792 UAGAG -43.5 CAGCU -38.2 AUCCC -26.9 
793 ACUAG -43.7 CUCCU -38.3 ACUCC -26.9 
794 AUCCU -44.1 UCCCC -38.3 CAUCC -27.1 
795 CAGAU -44.2 AGGUU -38.4 ACUGG -27.4 
796 GGAUC -44.3 GGCCU -38.6 CAUGA -27.5 
797 AAUUA -44.4 ACACU -38.9 GAUCC -27.6 
798 AGAAU -44.4 UGAAG -38.9 UGCAG -27.6 
799 CCUCC -44.6 AGCCU -39.0 GUGGG -27.9 
800 UAGAA -45.4 AUUAG -39.1 GCAAG -28.3 
801 GCUCU -45.5 UUCAG -39.2 AGUCC -28.3 
802 CCCUC -45.9 GACCA -39.3 GCCCU -28.4 
803 GAUGG -45.9 GCCAG -39.3 ACCAU -28.4 
804 ACAAC -46.0 AGAAU -39.3 AAAUC -28.6 
805 CAAGC -46.0 CAGUA -39.5 GAGGU -28.7 
806 CCUCU -46.0 AUUCC -39.5 GGGCU -28.7 
807 UGAAG -46.1 CUGAA -39.5 CAACC -28.8 
808 GCCAA -46.1 CAAAU -39.6 CAGCC -28.8 
809 AAUCC -46.2 CCACU -39.7 CACAU -29.1 
810 AGAUC -46.3 UUAGA -39.9 CGGGG -29.3 
811 AAGGU -46.4 AAUGG -39.9 AGGCG -29.3 
812 ACUGG -46.4 UCUCA -40.0 GGAUC -29.3 
813 UAAGA -46.6 CCUAA -40.0 CUCAA -29.4 
814 GGACU -46.6 UUAAG -40.1 GGCAC -29.4 
815 UAGCC -46.8 UCAGC -40.3 CUCAC -29.4 
816 UCUCA -47.2 ACACC -40.3 GCACA -29.6 
817 CAACC -47.3 ACAAG -40.3 AACAC -29.9 
818 UGGGG -47.4 CAAUU -40.6 UCCCA -29.9 
819 ACACA -47.4 CUUAA -40.6 GGCCU -30.2 
820 ACAGC -47.7 CCUCU -40.7 GACAA -30.2 
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821 CCCAC -47.8 CAGAU -40.8 UAAGG -30.3 
822 CCAGU -47.9 AGUAA -40.8 AACUC -30.3 
823 CUGAG -48.1 ACUUC -40.8 GCCAA -30.7 
824 AGGUG -48.2 CCAAU -40.9 GGGAC -30.8 
825 GCCCA -48.2 CAGUC -41.0 GAGAG -30.8 
826 CAGUC -48.2 AAUCU -41.0 AGCAU -30.8 
827 ACCAC -48.3 AGUAG -41.0 GGUGA -30.9 
828 CACCA -48.4 UAGCC -41.2 AUCCA -31.0 
829 GGACC -48.4 UACAG -41.2 AGCUA -31.0 
830 GAGAG -48.6 GACAA -41.2 UCACA -31.2 
831 AGUGA -48.6 AGUCC -41.4 AUCAG -31.4 
832 GGCAC -48.6 AUUAA -41.5 GGAGU -31.5 
833 AGUCC -49.0 CUCAC -41.5 CAUGC -31.6 
834 ACAAU -49.1 AUCCU -41.7 AGAUA -31.8 
835 AUCAG -49.1 GGGGC -41.8 CCUCA -31.9 
836 UUCCA -49.1 CUUAG -41.8 CAGGU -32.2 
837 CAAAU -49.3 CCAGC -41.8 ACAAC -32.4 
838 CAUCA -49.5 AGGUA -41.9 GGUCA -32.4 
839 GAGGU -49.5 AGUGA -42.0 CAUAC -32.6 
840 CAGCA -49.5 AGAUC -42.1 ACCAC -32.7 
841 UUAAA -49.6 GAGGU -42.1 GUGAG -32.9 
842 AAGUC -49.9 GCAAA -42.2 GGCAA -32.9 
843 ACAGU -50.1 CCCUC -42.2 AUAGC -33.1 
844 UAGGA -50.3 GGAGU -42.2 AUAAG -33.1 
845 AGAGU -50.3 CCAAC -42.3 CACCA -33.2 
846 AGGUC -50.4 GAAGC -42.5 CAAGU -33.3 
847 GACAC -50.6 AUCAA -42.5 GCCAC -33.4 
848 ACUCC -51.0 AGGUC -42.6 CCAAC -33.5 
849 GAAAC -51.1 AGAGC -42.6 GCUCC -33.7 
850 AGCCU -51.4 CACCA -42.7 CACAC -33.8 
851 AUUAA -51.4 CCUCA -42.9 ACCCA -33.8 
852 GGCCU -51.5 ACUGG -43.0 GCAGC -34.1 
853 GGGCA -51.8 GAGCC -43.0 CUAAA -34.3 
854 GGACA -52.1 AGAUA -43.0 GCAUC -34.6 
855 GCCAC -52.3 GCAGA -43.1 CAAUA -34.6 
856 CCAAC -52.3 ACCCU -43.1 GUCCC -34.6 
857 CUCCA -52.3 GACAC -43.2 GCUCU -34.8 
858 CUCAC -52.4 GGCUA -43.3 GCAAA -34.8 
859 GACAA -52.5 ACUCA -43.8 AGGAC -35.0 
860 AAUAG -52.6 UAAGG -43.9 ACUCA -35.1 
 80 
861 AGUCA -52.7 AAGUC -44.1 AGUGG -35.2 
862 AAGCU -52.8 AGCAC -44.3 CCGGG -35.3 
863 AGAUA -52.9 AAGAC -44.5 GCAUU -35.3 
864 UCACA -52.9 UCCAA -44.9 CUCCA -35.4 
865 GCCAG -53.4 ACAAU -45.1 GGACA -35.4 
866 AGCUG -53.5 CAGGU -45.1 GGGUC -35.4 
867 CCUCA -53.5 AGUUC -45.1 AAGCU -35.5 
868 GGCUA -53.6 GGUAG -45.2 CCCCA -35.5 
869 UACAG -53.8 GGACU -45.2 GGCCC -35.6 
870 AAGCA -53.8 AAGGC -45.3 UAAAG -35.6 
871 ACCCA -53.8 CUCCA -45.3 UGGGA -35.8 
872 CAGCU -54.0 AGAGA -45.5 AGCCU -35.8 
873 AACUC -54.0 GGCAA -45.5 CUAGG -35.9 
874 AAACU -54.2 GGACA -45.5 UCAGC -36.1 
875 GCUCA -54.2 UUCAA -45.6 AGCUG -36.1 
876 GGCCC -54.3 CAACC -45.8 GCCCA -36.3 
877 AACCC -54.6 AACCC -45.8 AGCAC -36.5 
878 GAACC -54.8 AAGCC -45.9 AGCCC -36.6 
879 UAAGG -54.9 UUCCA -45.9 AACCA -36.7 
880 AGACU -55.2 ACCAA -46.0 CUGGA -36.9 
881 AGGAU -55.3 UUCCC -46.2 AGAAC -37.0 
882 GACCC -55.6 AAUUA -46.2 UCAAG -37.1 
883 CCCCA -56.1 UAAGA -46.4 CAUAA -37.1 
884 UAGGG -56.1 UGGGA -46.9 ACCAG -37.1 
885 AGCUA -56.4 GACAG -47.0 GACAG -37.7 
886 GGAGU -56.4 UGAGG -47.2 ACAGC -37.7 
887 CCAGC -56.5 CUCAA -47.2 CCUGG -37.8 
888 CAAUA -56.9 GAACU -47.9 AACCC -37.9 
889 GGGAC -57.0 CCAGU -47.9 GACCA -38.1 
890 AGCCC -57.3 AGGGU -47.9 AGGGG -38.3 
891 GGCAA -57.6 GAGAC -48.0 UGGAA -38.4 
892 CUCAA -57.9 GGACC -48.1 GAACA -38.5 
893 AGAAC -58.3 CCACA -48.3 AGAGA -38.6 
894 UCAGC -58.4 AAGGU -48.3 CCAGC -38.7 
895 GGCUC -58.4 GGGAG -48.5 UCAGA -38.7 
896 CAACA -58.5 CAGAC -48.6 AGGUC -38.8 
897 UCAGA -58.6 GAAAG -48.6 CAACA -39.2 
898 GGGGC -58.8 AAAAA -48.8 AGGUG -39.2 
899 GAGCC -58.8 GAAGG -49.1 GAGAC -39.3 
900 CCUGG -59.0 UUAGG -49.1 ACACA -39.4 
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901 UGGGA -59.4 AGCCC -49.1 UCCAA -39.6 
902 AUCAA -59.7 CUAGG -49.1 AAAUA -39.6 
903 UGGAA -60.0 CACAA -49.1 UACAG -39.7 
904 CAGGU -60.4 GGGGA -49.2 GCUCA -39.8 
905 AGAGC -60.4 AGACC -49.2 CAGCU -40.1 
906 AGAGA -60.5 UAGGG -49.4 AUGGA -40.1 
907 UCCCA -60.9 GAUGG -49.5 AGGGC -40.2 
908 UCCAA -61.6 GGAGC -49.6 CAAGG -40.4 
909 GGGCU -61.8 ACUCC -49.7 AAAGU -40.4 
910 AGGGU -61.8 CAAAC -49.9 AAGAU -40.4 
911 GAAGG -62.0 CCACC -49.9 UGAGG -40.5 
912 ACUCA -62.0 AGACU -50.2 AGAUG -40.6 
913 UCAAG -62.2 UAGAG -50.3 AUGGG -40.6 
914 GCAAA -62.2 UGGAG -50.5 GCCAG -40.7 
915 AGCAC -62.3 AACUC -50.6 AGGGU -40.8 
916 UGAGG -62.6 GAAAC -50.6 AAUCA -40.9 
917 AAUCA -62.9 AAUCC -50.6 AGAGC -41.0 
918 GAGAA -63.0 CCUGG -50.7 GGCUC -41.1 
919 ACAAG -63.3 AAUAG -50.7 GAAGG -41.4 
920 GACAG -63.4 CAACA -50.8 UGGGG -41.7 
921 AACCA -63.7 AGUGG -50.9 GGGGC -41.7 
922 CUAAA -63.9 GGCCA -51.1 GGGCA -42.1 
923 AAAUC -63.9 AGAAC -51.1 UCAGG -42.2 
924 AGUGG -64.7 AGGAU -51.2 GGGCC -42.2 
925 GAGAC -64.8 UGGAA -51.5 AAAAU -42.2 
926 CAGAC -65.6 AGCUC -51.5 CAAAC -42.3 
927 CUAGG -65.7 GGGCC -51.9 AAGGG -42.5 
928 GACCA -65.9 AGAGU -51.9 GAGAA -42.7 
929 GGCCA -66.2 CCCAC -52.1 GGCAG -42.9 
930 GAAGC -66.6 AGGCA -52.2 GAACC -42.9 
931 AAAGC -66.6 CUAAA -52.3 CAUCA -43.2 
932 GGGAG -66.6 AGUCA -52.5 CAAGC -44.0 
933 AAAAA -66.7 GGAAC -52.5 GGAAC -44.3 
934 GGGCC -66.7 AGGCC -52.6 GGAGC -44.5 
935 AAGAC -66.8 AAUCA -52.8 CAAGA -44.6 
936 AGACC -67.1 AGGGG -53.1 AAACC -44.6 
937 GAAGA -67.4 CACAG -53.1 UCCAG -44.6 
938 ACAGG -67.5 UAGGA -53.2 GGGGA -44.8 
939 GGAGC -67.9 GAGAA -53.7 GGGAA -44.8 
940 CCCAA -68.0 UCAAG -53.8 AGGGA -45.1 
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941 GGAGG -68.1 CAGCC -54.2 AGACC -45.1 
942 GCAGA -68.2 GGCAG -54.4 ACAAG -45.7 
943 UCAAA -68.4 AAACC -54.9 UCAAA -45.7 
944 AGCUC -68.6 GGGAC -54.9 GAAAG -45.9 
945 AAACC -68.7 ACCCA -54.9 AAGCA -45.9 
946 CAAAC -68.7 CCAAG -55.2 CCACA -46.2 
947 CACAA -69.0 CCAAA -55.3 AAGGC -46.3 
948 ACCAG -69.1 GAGGG -55.3 CACAG -46.3 
949 AAGCC -69.7 UAGAA -55.3 GAGGG -46.3 
950 CUGGG -69.7 UCAGA -55.4 AAUAA -46.3 
951 CAGCC -69.8 AGGAC -55.4 CUGGG -46.3 
952 CAAGG -69.9 AACCA -55.4 GAAGA -46.5 
953 AACAG -70.6 UCCCA -55.4 CUGCA -46.6 
954 GGGGA -70.7 AAACU -55.5 GAGGA -46.7 
955 AUAAA -71.0 GGGCU -55.7 AACAA -46.8 
956 CUGGA -71.4 ACCAG -55.9 GAGCA -46.9 
957 AAUAA -71.5 GAAAU -56.7 GAAGC -46.9 
958 AGGAC -71.6 GGAGG -57.0 AAGCC -47.7 
959 GAGGG -71.6 AAAGU -57.2 GGCCA -47.9 
960 AAGGC -72.1 GACCC -57.2 GGCAU -47.9 
961 AAAGU -72.4 GAGGA -57.2 AUCAA -48.2 
962 AGGCU -72.5 CCCCA -57.4 UAAAA -48.3 
963 UAAAG -73.5 CAGGC -57.4 CCCAA -48.4 
964 AGGGC -73.6 AUAAA -57.6 ACAGG -48.5 
965 UCCAG -73.8 CCCAA -57.6 GGAAG -48.8 
966 ACCAA -74.1 CCAGA -57.6 CACAA -48.9 
967 AAAUA -74.5 AACAG -57.9 GCAGA -48.9 
968 GAGGC -74.8 ACAGG -58.2 GAAAA -49.2 
969 CCAAG -75.0 AGACA -58.3 UGGAG -49.4 
970 GGCAG -75.1 GAGGC -58.8 AAGAC -49.4 
971 GGGAA -75.2 CUGGA -59.0 AAAGC -49.5 
972 UCAGG -75.5 UCAGG -59.3 CAGGG -49.8 
973 CCACA -75.7 UAAAG -59.3 AGCAA -49.9 
974 UGGAG -76.5 GGAAG -59.4 AGCUC -50.2 
975 AGGGA -76.5 GGGAA -59.5 AACAG -50.3 
976 GGAAG -77.0 GCAGG -59.6 CAGGC -50.3 
977 AAGAU -78.6 AAUAA -59.6 AGCCA -50.5 
978 AGCAA -79.0 GGAGA -60.7 ACCAA -50.5 
979 AAACA -79.5 UUAAA -60.8 AAAAA -50.6 
980 GGAAC -79.5 AAAAC -61.2 GGGAG -50.6 
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981 AGAAG -80.2 AACAA -61.2 GAGCC -50.8 
982 AGGCC -80.2 AGAAG -61.7 CAUGG -50.8 
983 UAAAA -80.4 AGCAG -61.9 GGAGG -50.9 
984 AAAAU -80.6 CCCAG -62.0 CAGCA -51.3 
985 CACAG -80.9 AAAUC -62.0 AAGAA -51.4 
986 AAGAA -81.1 CUCAG -62.3 AGACA -51.6 
987 AAGGG -81.2 AGGGA -62.3 AAGGA -51.6 
988 AACAA -81.4 AGGCU -63.0 AUGCA -52.0 
989 GGAGA -81.4 CAGAG -63.6 GAGGC -52.3 
990 AGGAG -81.6 AGGGC -63.8 AUAAA -52.3 
991 GAAAG -81.6 AAGGG -64.6 CUCAG -52.5 
992 CAGGC -83.5 CAAAG -64.6 AAGAG -52.6 
993 GCAGG -84.3 CUGGG -64.8 GCAGG -53.0 
994 CAAAG -84.9 CAAAA -64.9 AGGAG -53.1 
995 CCAAA -85.3 GAAAA -65.2 GGAGA -53.6 
996 AAAAC -85.4 AAAUA -65.3 CCAAA -53.9 
997 AGGGG -85.8 GAAGA -66.0 CAGAC -54.1 
998 CAAGA -86.3 CCAGG -66.5 CAAAA -54.7 
999 AGCAG -86.4 AAGAU -66.6 CCAAG -54.7 
1000 CCCAG -86.4 AGCAA -67.9 AAACA -55.2 
1001 GAGGA -87.7 AAGAA -68.0 GCAUA -55.7 
1002 AGGCA -88.5 UCAAA -68.5 AAAAC -56.1 
1003 GGAAA -88.6 ACAAA -68.6 ACAAA -56.2 
1004 ACAAA -88.9 CAAGG -68.7 GGAAA -56.4 
1005 CCAGA -89.4 AGGAA -68.9 AGAAA -56.8 
1006 AGACA -89.7 UCCAG -69.3 AGGCC -56.9 
1007 AAGGA -89.9 AGCCA -69.7 CCAGA -57.8 
1008 AGCCA -90.0 AAAGA -70.0 AGAAG -58.7 
1009 CAGGG -90.5 AAAAG -70.1 ACAGA -59.1 
1010 ACAGA -90.7 AAACA -70.5 CCCAG -60.1 
1011 CAAAA -91.0 ACAGA -70.6 CAGGA -60.2 
1012 GAAAA -91.4 CAGGA -70.6 AGGAA -61.1 
1013 AAGAG -94.0 AGGAG -71.1 AAAGG -63.6 
1014 CAGAA -94.4 CAGAA -73.6 AAAGA -63.6 
1015 AAAGG -95.5 CAAGA -74.1 CAGAG -64.6 
1016 AGGAA -95.6 AGAAA -74.2 AGAGG -66.1 
1017 CUCAG -96.4 AGAGG -74.3 CCAGG -67.0 
1018 CAGAG -99.2 GGAAA -74.5 AGCAG -68.0 
1019 AAAAG -99.7 CAGGG -76.3 AAAAG -68.3 
1020 AGAGG -99.8 AAAAU -76.6 CAAAG -69.0 
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1021 AGAAA -102.8 AAGAG -78.1 AGGCA -69.6 
1022 AAAGA -103.8 AAGGA -80.8 CAGAA -72.0 
1023 CCAGG -103.8 UAAAA -82.5 GCAUG -101.5 
1024 CAGGA -109.4 AAAGG -93.9 UGCAU -108.8 
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Data S1. UCSC Genome Browser Views of the 
Scn8a, Gria3, Ppp3cb, Rtn3, Cnr1, Atp2b1, Camta1, and Aplp2 Genes, Related to 
Figure 2.   
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CHAPTER 3 
INTRODUCTION TO NON-RNA-BINDING LOW COMPLEXITY AND DISORDERED 
REGIONS IN RNA-BINDING PROTEINS 
 
RNA-binding proteins (RBPs) control RNA metabolism homeostasis from biogenesis 
to degradation in the cell. RBPs contain one or more RNA-binding domains (RBDs) that 
can recognize RNA in a sequence-specific manner. Multiple RBDs extend the surface, 
often β-sheet, contacting the RNA and hence confer higher binding affinities and 
specificities. RBDs consist of several different structural classes, including RNA 
recognition motif (RRM), hnRNP K-homology (KH), double-stranded RBD (dsRBD), Zinc 
finger domains and others. RRM is by far the most common and best-studied class of 
RBDs, and it is known to bind single-stranded RNA. The typical RRM is composed of 
about 90 amino acids that form a four-stranded anti-parallel β-sheet with two helices 
packed on each side, giving the domain βαββαβ topology. The dsRBD is a smaller 
proteins domain of 65-70 amino acids adopting an αβββα structure that binds to 
double-stranded RNA. Zinc fingers are generally considered as DNA-binding domains, 
however, several classes of zinc finger proteins, including the common C2H2 zinc fingers, 
exhibit RNA-binding activity. Structure determination of RNA:RBD interactions by 
co-crystallography and nuclear magnetic resonance (NMR) provides detailed information 
on residues in RBDs that are critical in interacting with RNA bases. Furthermore, 
functional characterization of RBDs has been benefited tremendously from the 
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development of technologies in identifying their binding targets and binding sequences. 
For example, CLIP-seq enabled us to discover numerous binding targets of RBPs and 
their binding sites globally in vivo (Ule et al., 2003).  
Besides the RNA-binding domains, RBPs also contain other domains that are less 
well characterized. These auxiliary domains are often composed of intrinsically 
disordered regions (IDRs) or of low amino acid complexity (LC), and both are highly 
enriched in the RBPs compared to non-RBPs (Calabretta and Richard, 2015; Kato et al., 
2012). Although disordered regions are historically viewed as hubs for protein-protein 
interaction networks (Haynes et al., 2006), the interacting partners and the nature of 
protein-protein interactions remain elusive for majority of the RBPs.  
The assemblies of RBPs and RNA can form RNP granules in the nucleus and the 
cytoplasm, which are microscopically visible membrane-less bodies. Recent 
observations of germ line P granules in C. elegans suggested a mechanism for 
structuring membrane-less bodies depending on the ability of proteins to transition 
between a soluble form and a condensed phase (Brangwynne et al., 2009). When the 
concentration of P granule components is high, these components are condensed to 
microscopically visible bodies. Conversely, lowering the concentration will cause the 
dissolution of P granules and the redistribution of protein throughout the cells. Together 
with the observations that P granules flowed off nuclei, dripped, and often fused into one 
larger drop, P granules were proposed to behave like liquid droplets, which diffuse, 
dissolve and condense during the cycles of assembly and disassembly of P granules 
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(Brangwynne et al., 2009). Multivalent interactions by repeated interaction domains, often 
seen in RNA-binding proteins and RNA, could yield sharp liquid-liquid-demixing phase 
separations, suggesting that multivalency may be a ubiquitous driving force for liquid 
droplet condensation (Li et al., 2012b). 
Work from McKnight’s group showed that many RNA-binding proteins precipitated by 
biotinylated isoxazole (b-isox) were components of RNP granules (Han et al., 2012; Kato 
et al., 2012). Many of them contain LC sequences. These LC sequences can undergo 
concentration-dependent phase transition in vitro into a hydrogel state, which consists of 
uniformly polymerized amyloid-like fibers (Kato et al., 2012). These observations suggest 
that LC sequences of RBPs are capable of driving RBPs compartmentalization into 
non-membrane bound structures. Among these LC sequences, repetitive tripeptide [G/S] 
Y [G/S] motif is highly enriched. Mutations of tyrosine to serine impair the ability to be 
retained in a preformed hydrogel (Han et al., 2012; Kato et al., 2012). Dysregulation of 
assembly and disassembly of LC sequence domains might result in pathogenic fibrillar 
inclusions of RBPs like FUS and TDP-43, seen in neurodegenerative disorders 
(Maekawa et al., 2009; Vance et al., 2009).  
A systematic survey of multiple RBPs containing IDRs or LC sequences suggested 
that disordered regions of RBPs have a propensity to form fibers or phase-separated 
liquid droplets in vitro, and this process could be triggered by low temperature, high 
protein concentration, low salt concentration or RNA-binding (Lin et al., 2015). Over time 
these structures mature to more stable higher ultra-structures, which often coincides with 
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formation of fibrous structures or hydrogel droplets wherein an amyloid-like cross-beta 
structure was observed (Kato et al., 2012; Lin et al., 2015). Different disordered domains 
could co-assemble into phase-separated droplets, suggesting coexistence of homotypic 
and heterotypic interactions.  
RNA strongly promotes assemblies of RBPs. RNA was trapped in the precipitates by 
b-isox via bounding by RBPs in the assemblies (Han et al., 2012). Moreover, RNA was 
shown to trigger higher-order assemblies of FUS (Schwartz et al., 2013) and promote 
liquid droplet formation (Lin et al., 2015). Post-translational modification of RBPs could 
also be utilized to regulate the propensity of higher-order assembly. Phosphorylation of 
the MEG proteins promotes granule disassembly and dephosphorylation of MEG 
promotes granule assembly (Wang et al., 2014). Phosphorylation of LC sequences in 
FUS impedes retention to a pre-formed hydrogel in vitro (Han et al., 2012), suggesting 
that phosphorylation disassembles FUS assembly. 
However, the role of IDRs and LC sequences in RBPs is poorly understood and the 
relationship between propensity of aggregation and their physiological function remains 
unresolved. Several studies reported that LC sequences allow localizing RBPs in and out 
of organized, membrane-free subcellular organelles like stress granules or RNA granules 
in the cytoplasm (Jain et al., 2016; Kato et al., 2012). A typical component of stress 
granules hnRNP A1, form liquid droplets, relying on its LC sequences. The phase 
separation promotes the fibrillization of disease-causing mutant hnRNPA1-D262V, 
probably by increasing local molecular concentration and hence nucleation (Molliex et al., 
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2015). Disease-causing mutations in LC sequences of FUS induce further phase 
transition into poorly soluble fibrillar hydrogels that trap other RNP granule components, 
disrupt RNP granule function and cause neurodegeneration (Murakami et al., 2015). 
Besides RNP granules, stress granules enriched in RBPs and RNA have been proposed 
to be dynamic, liquid-like structures. IDRs and LC sequences have been shown to 
contribute to the formation of stress granules.  
In addition to RNP granule and stress granule regulation, LC sequences have been 
shown to play roles in other biological processes. In yeast, the RNA-binding protein Rim4 
forms amyloid-like aggregates and mediates translational repression of numerous mRNA 
transcripts by binding to their 3’ UTR. Blocking the aggregation of Rim4 releases RNA 
transcripts for active translation (Berchowitz et al., 2015). When fused to a DNA-binding 
domain, LC sequences of the FET (FUS/EWS/TAF15) could interact with the carboxyl 
terminal domain (CTD) of RNA polymerase II through polymerization to activate RNA 
transcription (Kwon et al., 2013). Phosphorylation of CTD regulates its ability to bind to 
the hydrogel of FET protein in vitro, suggesting a new mechanism of how 
phosphorylation and dephosphorylation of CTD modulate the recruitment of RNA 
polymerase II to transcription start site. SR repeats of SRSF2 do not form hydrogels by 
themselves, but they bind to hydrogel droplets formed by the LC domains of hnRNPA2. 
SRSF2 with SR-to-GR mutations becomes trapped in the nucleoli at an early stage of 
nuclear speckles formation and impedes pre-mRNA splicing (Kwon et al., 2014). 
Understanding the physiochemical rules governing RNP granule assembly and 
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properties promises to shed light on the important but still poorly understood aspects of 
gene regulation in the cell.  
In the course of investigating the assembly of Rbfox with other LASR components, 
unexpectedly, we found that the LC sequence at the C-terminal part of Rbfox serves as 
an interface between Rbfox and LASR and mediates the higher-order assembly of Rbfox. 
Interestingly, as observed in many other RBPs like FUS and hnRNPA1, purified LC 
sequence of Rbfox is prone to aggregate and form hydrogel, thus proposing an intriguing 
question whether the assembly of Rbfox and LASR utilizes the aggregation property of 
LC sequence of Rbfox. Indeed, we found that tyrosine repeats similar to tripeptide motif 
[G/S] Y [G/S] are nearly evenly distributed across this domain and they are required for 
high-order assembly of Rbfox. We also found that the higher-order assembly is required 
for Rbfox-dependent splicing activation, but dispensable for splicing repression, which 
provides a clue for understanding a splicing factor as a dual actor. Our findings on how 
the LC sequences of Rbfox promote higher-order assembly with LASR to regulate 
alternative splicing are described in Chapter 4. 
 
References 
Berchowitz, L.E., Kabachinski, G., Walker, M.R., Carlile, T.M., Gilbert, W.V., Schwartz, 
T.U., and Amon, A. (2015). Regulated Formation of an Amyloid-like Translational 
Repressor Governs Gametogenesis. Cell.                  
Brangwynne, C.P., Eckmann, C.R., Courson, D.S., Rybarska, A., Hoege, C., Gharakhani, 
J., Julicher, F., and Hyman, A.A. (2009). Germline P Granules Are Liquid Droplets That 
Localize by Controlled Dissolution/Condensation. Science 324, 1729-1732. 
 95 
Calabretta, S., and Richard, S. (2015). Emerging Roles of Disordered Sequences in 
RNA-Binding Proteins. Trends Biochem Sci 40, 662-672. 
Han, T.W., Kato, M., Xie, S., Wu, L.C., Mirzaei, H., Pei, J., Chen, M., Xie, Y., Allen, J., 
Xiao, G., et al. (2012). Cell-free formation of RNA granules: bound RNAs identify features 
and components of cellular assemblies. Cell 149, 768-779. 
Haynes, C., Oldfield, C.J., Ji, F., Klitgord, N., Cusick, M.E., Radivojac, P., Uversky, V.N., 
Vidal, M., and Iakoucheva, L.M. (2006). Intrinsic disorder is a common feature of hub 
proteins from four eukaryotic interactomes. Plos Comput Biol 2, 890-901. 
Jain, S., Wheeler, J.R., Walters, R.W., Agrawal, A., Barsic, A., and Parker, R. (2016). 
ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. Cell 
164, 487-498. 
Kato, M., Han, T.W., Xie, S., Shi, K., Du, X., Wu, L.C., Mirzaei, H., Goldsmith, E.J., 
Longgood, J., Pei, J., et al. (2012). Cell-free formation of RNA granules: low complexity 
sequence domains form dynamic fibers within hydrogels. Cell 149, 753-767. 
Kwon, I., Kato, M., Xiang, S., Wu, L., Theodoropoulos, P., Mirzaei, H., Han, T., Xie, S., 
Corden, J.L., and McKnight, S.L. (2013). Phosphorylation-regulated binding of RNA 
polymerase II to fibrous polymers of low-complexity domains. Cell 155, 1049-1060. 
Kwon, I., Xiang, S., Kato, M., Wu, L., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, 
Y., and McKnight, S.L. (2014). Poly-dipeptides encoded by the C9ORF72 repeats bind 
nucleoli, impede RNA biogenesis, and kill cells. Science.                    
Li, P.L., Banjade, S., Cheng, H.C., Kim, S., Chen, B., Guo, L., Llaguno, M., Hollingsworth, 
J.V., King, D.S., Banani, S.F., et al. (2012). Phase transitions in the assembly of 
multivalent signalling proteins. Nature 483, 336-U129.?? 
Lin, Y., Protter, D.S., Rosen, M.K., and Parker, R. (2015). Formation and Maturation of 
Phase-Separated Liquid Droplets by RNA-Binding Proteins. Molecular cell 60, 208-219. 
Maekawa, S., Leigh, P.N., King, A., Jones, E., Steele, J.C., Bodi, I., Shaw, C.E., 
Hortobagyi, T., and Al-Sarraj, S. (2009). TDP-43 is consistently co-localized with 
ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in 
familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology 
29, 672-683. 
Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A.P., Kim, H.J., Mittag, T., and 
Taylor, J.P. (2015). Phase Separation by Low Complexity Domains Promotes Stress 
Granule Assembly and Drives Pathological Fibrillization. Cell 163, 123-133. 
 96 
Murakami, T., Qamar, S., Lin, J.Q., Schierle, G.S., Rees, E., Miyashita, A., Costa, A.R., 
Dodd, R.B., Chan, F.T., Michel, C.H., et al. (2015). ALS/FTD Mutation-Induced Phase 
Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels 
Impairs RNP Granule Function. Neuron 88, 678-690. 
Patel, S.S., Belmont, B.J., Sante, J.M., and Rexach, M.F. (2007). Natively unfolded 
nucleoporins gate protein diffusion across the nuclear pore complex. Cell 129, 83-96. 
Schwartz, J.C., Wang, X., Podell, E.R., and Cech, T.R. (2013). RNA seeds higher-order 
assembly of FUS protein. Cell reports 5, 918-925. 
Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, 
X., Smith, B., Ruddy, D., Wright, P., et al. (2009). Mutations in FUS, an RNA Processing 
Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science 323, 1208-1211. 
Wang, J.T., Smith, J., Chen, B.C., Schmidt, H., Rasoloson, D., Paix, A., Lambrus, B.G., 
Calidas, D., Betzig, E., and Seydoux, G. (2014). Regulation of RNA granule dynamics by 
phosphorylation of serine-rich, intrinsically-disordered proteins in C-elegans. eLife 3. 
 
 
 
 
 
 
  
 97 
CHAPTER 4 
LOW-COMPLEXITY SEQUENCE DOMAINS OF RBFOX FORM HIGHER-ORDER 
COMPLEXES WITH LASR TO REGULATE ALTERNATIVE SPLICING 
 
Introduction 
 
RNA-binding proteins (RBPs) control all aspects of RNA metabolism from biogenesis 
to decay. An RBP may have RNA-binding domains (RBDs) of several structural classes 
each recognizing short RNA element. Modern sequencing methods now allow relatively 
facile identification of large numbers of binding sites for these proteins across the 
transcriptome. However, these proteins frequently have auxiliary non-RNA binding 
domains, whose protein-protein interactions and functions are mostly not known. These 
auxiliary domains are often predicted to contain intrinsically disordered regions (IDR) and 
sequences of low amino acid complexity (LC) (Kato et al., 2012; Neelamraju et al., 2015).  
Recent studies have found that certain IDR and LC domains have a propensity to 
form fibers or phase-separated liquid droplets in vitro (Elbaum-Garfinkle et al., 2015; Lin 
et al., 2015; Molliex et al., 2015; Nott et al., 2015). Over time these structures mature into 
highly stable assemblies containing an amyloid-like cross-beta structure within a hydrogel 
matrix (Kato et al., 2012; Murakami et al., 2015; Patel et al., 2015). These aggregation 
properties and the formation of amyloid-like fibrils have garnered great interest from the 
recognition that in ALS and other neurological pathologies RNA-binding proteins such as 
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FUS and TDP-43 form very stable cellular inclusions containing amyloid-like structures. 
Recent work has also found that IDR or LC domains and their aggregation may function 
in normal mRNA metabolism to allow the reversible localization of RBPs in and out of 
membrane-free subcellular organelles such as cytoplasmic stress granules or RNP 
granules (Jain et al., 2016; Kato et al., 2012). The nuclear RBPs involved in splicing and 
other processes also have extensive LC sequences, but the roles for these sequences 
and their aggregation properties in normal function are not yet defined. 
The regulation of alternative pre-mRNA splicing involves a very large number of 
RBPs that bind nascent transcripts to alter spliceosome assembly and splice site choice. 
One important family of splicing regulators is the Rbfox proteins that control networks of 
spliced isoform expression in brain, muscle and during early embryonic development 
(Nakahata and Kawamoto, 2005; Underwood et al., 2005; Yeo et al., 2009b). The Rbfox 
proteins are of particular interest from their associations with neurological diseases. 
Rbfox1 in particular was found to be mutated in rare patients with autism spectrum 
disorders and epilepsy, and changes in Rbfox1 expression and Rbfox-dependent splicing 
have been observed in brains of ASD patients. There are three mammalian Rbfox genes 
(Rbfox1, Rbfox2, and Rbfox3) each containing a single highly conserved RBD of the RNA 
recognition motif type (RRM) that binds the short RNA element GCAUG or often 
UGCAUG (Auweter et al., 2006; Jin et al., 2003). Alternative promoters and alternative 
splicing diversifies the protein structures derived from each gene, including generating 
both nuclear and cytoplasmic isoforms (Damianov and Black, 2010; Lee et al., 2009). 
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The nuclear Rbfox proteins promote alternative exon inclusion when bound to a 
downstream UGCAUG element, or skipping of an exon when bound upstream or within 
the exon (Jin et al., 2003). The N and C terminal domains have segments of low amino 
acid complexity and presumably engage in protein-protein interactions (Figure 4.S 4.1A). 
The C terminal domain was found to be required for splicing regulation by an 
MS2-tethered protein (Sun et al., 2012). However, besides determining the subcellular 
localization, the extended N and C terminal domains flanking the RRM are of unknown 
function. 
Recently we showed that Rbfox proteins regulate splicing in association with the 
Large Assembly of Splicing Regulators, LASR, a multi-protein complex of RNA-binding 
proteins (Damianov et al., 2016). The interaction of Rbfox with LASR components was 
observed to affect their binding to nascent RNA and their activity in splicing. LASR 
contains eight proteins hnRNPs C, H, M, and UL, NF110, NF45, Matrin3, and DDX5, all 
approximately equimolar with Rbfox and each other. Virtually all of the intron-bound 
Rbfox was associated with LASR and could be extracted from the high-molecular-weight 
(HMW) material of cell nuclei by nuclease digestion. Despite extensive nuclease 
digestion, the Rbfox/LASR complex was found to sediment on density gradients at 55S 
and was thus forming complexes of a higher-order than a single Rbfox bound to a single 
LASR. The nature of the Rbfox/LASR contacts or the interactions leading to their 
higher-order assembly remained unresolved.  
 100 
Here we report that the Rbfox C-terminal domain mediates its interaction with LASR, 
and further that an LC sequence within this domain mediates higher-order assembly of 
Rbfox/LASR complexes. Examining the solution properties of this purified domain, we 
find that the LC region causes the protein to form soluble aggregates and to form fibrous 
structures and hydrogels. Mutations that specifically block the higher-order assembly of 
Rbfox but not its interactions with LASR also block Rbfox-dependent splicing activation 
and establish a link between the biophysical properties of Rbfox aggregation and its 
function in splicing regulation. 
 
Results 
 
The C-terminal domain of Rbfox mediates interaction with LASR and formation of 
higher-order assembly. 
To identify regions of Rbfox1 responsible for interacting with LASR, we generated 
Flp-In™ T-REx™ 293 cell lines stably expressing deletion mutants of Rbfox1 tagged with 
the HA-FLAG epitopes and the SV40 NLS (Figure 4.1A). We isolated Rbfox/LASR 
complexes from these cells by FLAG immunoprecipitation. The complete set of LASR 
proteins was co-immunoprecipitated with Rbfox missing either the N-terminal domain (NT) 
or the RNA-binding domain (RBD), indicating that these two regions are not essential for 
the LASR interaction (Figure 4.1B). Some LASR subunits were isolated in lower amounts 
in these samples, suggesting that NT and RBD, while not essential, may provide contacts 
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for particular proteins. In contrast, deletion of C-terminal domain (ΔCT) abolished the 
interaction with LASR, and the CT fragment alone co-immunoprecipitated the LASR 
subunits with similar efficiency to full-length Rbfox1 (Figure 4.1A). Thus the CT provides 
the primary contact with LASR. We previously found that Rbfox1 sediments on glycerol 
gradients as a larger assembly than predicted for a single Rbfox/LASR complex. Applying 
the glycerol density gradient assays to the mutant proteins, we found that the CT 
fragment sedimented as a higher-order complex similar to the full-length protein, while 
ΔCT remained at the top of the glycerol gradient as expected (Figure 4.1C). These 
results demonstrate that the Rbfox CT domain is necessary and sufficient both to interact 
with LASR and to form higher-order complexes. 
 
Repetitive tyrosine residues within the CT region are essential for higher-order 
assembly of Rbfox1 
We previously found that all the brain-expressed variants of the Rbfox proteins 
including Rbfox1, Rbfox2, and Rbfox3 form higher-order complexes seen in gradients. 
These were observed both endogenously in mouse brain and with ectopically expressed 
proteins in HEK293 cells (Damianov et al., 2016). Both Rbfox1 and Rbfox2 have 
muscle-specific variants derived from the inclusion of muscle-specific exon M43 instead 
of exon B40 (Nakahata and Kawamoto, 2005). Exon B40 was first described in neuronal 
cells although it was included in other non-neuronal cells as well. Exons M43 and B40 
encode related but not identical amino acid sequences within the CT domain (Figure 
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4.1D). We examined whether the M43 Rbfox variants also form higher-order complexes. 
Comparing the glycerol gradient sedimentation of these variants, we found that 
Rbfox1_M43 exhibited a similar sedimentation profile to Rbfox1_B40 and Rbfox2_B40, 
with a peak in the 55S region. Strikingly, Rbfox2_M43 did not form higher-order 
complexes, but instead sedimented as a much smaller species near the top of the 
gradient (Figure 4.1D). Rbfox2 exon M43 could also modify the behavior of Rbfox1. A 
hybrid protein (Rbfox1_2M43) also failed to form higher-order complexes (Figure 4.1D). 
These data suggested that Rbfox2_M43 might be missing residues needed for the 
higher-order assembly. Aligning the exon encoded amino acid sequences, it was notable 
that of three tyrosine residues present in both B40 and M43 exons, two were conserved 
in Rbfox1_M43 but all were missing from Rbfox2_M43.  
Looking more broadly in the CT region, we found additional tyrosine residues 
upstream and particularly downstream of exon B40, with the downstream residues more 
closely spaced and conserved across the Rbfox paralogs (Figure 4.1E). To examine the 
role of these tyrosines in the higher-order assembly, we created a series of mutant 
Rbfox1 proteins with increasing numbers of tyrosines changed to serine or alanine. A 
mutant Rbfox1 missing three tyrosine residues sedimented partially at 55S, but a 
substantial fraction of the protein shifted to the top of the gradient. For mutants with 
additional tyrosines changed to serine (6, 7, or 10 residues), higher-order assembly was 
nearly eliminated (Figure 4.1F). Mutations to serine showed a slightly stronger effect than 
alanine mutations. In contrast, changing three tyrosines to phenylalanine residues did not 
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impair the higher-order assembly of Rbfox1 (Figure 4.1F), suggesting that aromatic 
interactions mediate the assembly.  
Given that the CT domain was required for the Rbfox interaction with LASR, it was 
possible that the higher-order assembly involved interactions of LASR proteins and that 
the effect of the tyrosine mutations reflected a loss of the Rbfox1 and LASR interaction. 
This proved to not be the case. All the tyrosine-to-serine mutants as well as Rbfox2_M43 
retain their interaction with LASR, pulling down LASR in a FLAG immunoprecipitation 
assay with equal efficiency to wild type proteins (Figure 4.1G and data not shown). These 
data indicated that the property of higher-order assembly by Rbfox proteins could be 
separated from the LASR interaction.  
 
Multiple interfaces between the CT region of Rbfox1 and LASR 
To further define the interactions between Rbfox and LASR, we made additional 
mutations. We divided the CT domain into three fragments, C1, C2, and C3 (Figure 
S4.1A). C1 included the sequence upstream of the ten mutated tyrosines. C2 contained 
the mutated tyrosines. C3 included the sequence downstream of the mutated tyrosines. 
Each fragment was fused to HA-FLAG-SV40NLS-tagged Rbfox1 ΔCT which failed to 
interact with LASR (Figure 4.1B). Adding C1 to Rbfox1 ΔCT had little effect, with the 
protein pulling down only small amounts of LASR. This protein also did not form 
higher-order complexes (Figure 4.2B). In contrast, the proteins containing either C2 or C3 
pulled down LASR relatively efficiently (Figure 4.2A). C2 was more prone to aggregation 
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into higher-order complexes than C3 (Figure 4.2B). The medium-sized complexes in 
fraction 7 to 9 formed by C3 may result from tyrosines not tested by mutation. Mutation of 
the tyrosines in C2 eliminated the higher order assembly (Figure 4.2B), and unlike the full 
length protein also reduced the interaction with LASR (Figure 4.2A). 
These data indicate that C2 and C3 can independently interact with LASR. Unlike the 
full length CT domain, the interaction of the C2 fragment was dependent on the tyrosines. 
 
Aggregation of the CT domain alone 
A variety of self-aggregation properties have been reported for the LC domains of 
RNA-binding proteins, including the formation of hydrogels, amyloid-like fibrils, and 
phase-separated liquid droplets (Kato et al., 2012; Lin et al., 2015). The LC domain of the 
FUS protein contains the repeated tripeptide [G/S] Y [G/S] that mediates its assembly into 
an amyloid-like cross-beta structure (Kato et al., 2012). Although not exact matches to 
the FUS tripeptide motif, many of the tyrosines in the Rbfox1 C2 region are preceded or 
followed by glycine or serine. Hot spots of aggregation in polypeptides of the CT domain 
were identified by AGGRESCAN (Conchillo-Sole et al., 2007) (Figure S4.1A). We 
examined whether the Rbfox CT domain exhibited similar aggregation properties to FUS 
and other RBPs. We purified bacterial recombinant 6xHis-tagged wildtype CT domain 
and the CT mutant with ten tyrosines changed to serines (CT-YS), each fused to mCherry. 
Wild type mCherry-CT fusion protein eluted in the void volume of a size-exclusion column 
as large soluble nucleic-acid-free aggregates. In contrast, a portion of the CT-YS mutant 
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eluted as monomeric protein, indicating that it is less prone to aggregation (Figure 
S4.1B). 
We used a fluorescent liquid-liquid droplet assay to examine aggregation of the 
wildtype and mutant proteins. CT or CT-YS was fused to the SNAP tag which was 
fluorescently labeled with SNAP-surface 649. Protein solutions containing 2% of 
fluorescently labeled proteins were used in droplet assembly assays as described (Lin et 
al., 2015). Changes in phase were monitored by fluorescence microscopy. The labeled 
solutions remained monophasic and clear at room temperature in 150 mM NaCl. 
However, when the NaCl concentration was dropped to 37.5 mM, the CT protein at 12 
µM was seen to form fluorescent fibrous structures by epifluorescent microscopy after 21 
hours. Less concentrated solutions of the CT protein (6 µM) also formed fibrous 
structures with longer incubation (48 hours). In contrast, the CT-YS mutant remained in 
solution for days under same conditions (Figure 4.3A). The CT formed more fibrous 
structures than the round liquid droplets reported with the FUS protein. Fluorescent 
aggregates were only observed by reducing the salt concentration from the 150 mM used 
in purification, although it is possible that smaller aggregates of protein eluted in the void 
from the size exclusion column may seed the larger visible structures forming in low salt.  
To test this possibility, we carried out similar experiments using the monomeric 
fractions of the C2 and its ten-tyrosine-to-serine mutant C2-YS (Figure S4.1B). 
Performing the same droplet assembly assay, we observed that C2 but not C2-YS 
formed fibrous aggregates in low salt (Figure 4.3B). 
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We also tested the crowding reagent polyethylene glycol (PEG) to promote phase 
separation of proteins at low concentration. In the presence of 10% PEG, SNAP-C2 
labeled with SNAP-surface 549 formed spherical fluorescent structures of 0.5-1 µM in 
150 mM NaCl (Figure S4.1D). An equivalent solution of SNAP-C2-YS remained clear 
(Figure S4.1D). The SNAP-surface 549 labeled C2 or C2YS were incubated with C2 or 
C2-YS fused to monomeric EGFP (mEGFP). mEGFP-C2 but not mEGFP-C2-YS was 
found to label the SNAP-surface 549 labeled C2 droplet as well as form droplets on its 
own (Figure 4.3C), indicating that homotypic interactions of the C2 region require the 
tyrosines. 
In other assays we compared C2 and C2YS for their ability to form hydrogels and 
fibers. After incubation at room temperature for 5 days, the concentrated mEGFP-C2 (1 
mM) formed hydrogel droplets, whereas the mEGFP-C2-YS did not (Movie S1). The 
large fibrous structures formed by the C2 protein were observed by both fluorescent 
microscopy and transmission electron microscopy (Figure S4.1EF). These structures 
were stained with Thioflavin T, possibly indicated an amyloid-like assembly (Figure 
S4.1E). The assembly of pure Rbfox protein or the CT domain required the tyrosine 
residues. This homophilic assembly may serve to concentrate Rbfox/LASR in structures 
larger than the unit complex of one Rbfox and one LASR complex.  
 
The Rbfox Tyrosine-rich domain is required for GCAUG-dependent exon activation 
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In earlier work, we showed that nearly all intron bound Rbfox protein was in complex 
with LASR. Rbfox proteins affected the splicing activity of the LASR component hnRNP M, 
and conversely hnRNP M affected Rbfox activity on some exons. The identification of 
mutations in Rbfox that eliminate its interaction with LASR, or alter its higher-order 
assembly allowed us to test the requirement for these interactions in Rbfox mediated 
splicing. We used two Rbfox-regulated minigene reporters in in vivo splicing assays: 
Dup-E33 and Dup-E9* (Tang et al., 2009). Dup-E33 contains CaV1.2 exon 33, which has 
a downstream UGCAUG site required for Rbfox enhanced exon inclusion. Dup-E9* 
contains a modified CaV1.2 exon 9*, which has an upstream UGCAUG site and is 
repressed by Rbfox (Figure 4.4AB). These reporters were transiently expressed in a 
HEK293 cell line that has had endogenous Rbfox2 expression eliminated by CRISPR 
knock-out. As seen previously, E33 is largely skipped in Rbfox2-/- HEK293 cells, but its 
splicing is strongly stimulated by coexpressed wildtype Rbfox1. Conversely, E9* is 
spliced into the DUP-E9* mRNA in the Rbfox2-/- HEK293 cells and this splicing is strongly 
repressed by Rbfox1. In contrast, the ΔCT mutant of Rbfox1 neither activated E33 nor 
repressed E9* (Figure 4.4B). Note that the ΔCT protein carries the SV40 T antigen NLS 
to replace C-terminal nuclear localization signal of Rbfox1, and the ΔCT protein has not 
lost its nuclear localization (Figure 4.1B). The CT domain, which is required for LASR 
association, is also required for splicing regulation by Rbfox. 
To test the requirement for the Rbfox tyrosine residues in splicing regulation, we 
expressed the minigene reporters in cells with series of mutant Rbfox proteins. 
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Interestingly, splicing repression and splicing activation showed different responses to 
these mutations. Activation of E33 was reduced by the tyrosine to serine mutations, and 
this effect depended on the number of tyrosines altered. Loss of three tyrosines led to a 
partial loss of activity, but the protein missing 10 or more tyrosines was only slightly more 
active than the F126A mutation that knocks out RNA binding by Rbfox1 (Figure 4.4D). In 
contrast, the repression of E9* splicing was only minimally affected by the tyrosine 
mutations; the protein missing 13 tyrosines was still much more active that F126A (Figure 
4.4E and 4.1E). For these minigenes, the higher-order assembly of the Rbfox1/LASR 
complexes is needed for splicing activation, but dispensable for splicing repression.  
To assess the effects of the tyrosine mutations on a larger number of exons and on 
exons expressed from endogenous genes, we applied RASL-seq (RNA-mediated 
oligonucleotide annealing, selection and ligation with next-generation sequencing) (Li et 
al., 2012a) to profile 5530 alternative splicing events in Rbfox2-/- HEK293 cell lines 
expressing Rbfox1 and its mutants. RNA was isolated from three biological replicates of 
cells expressing wildtype Rbfox1 (WT), the ten-tyrosine-to-serine mutant (10Y), the 
RNA-binding-defective F126A mutant (FA), and control cells (Ctrl). For each assayed 
alternative splicing event, the ratio of included isoform to excluded isoform (In/Ex ratio) 
was calculated. For all the exons assayable in HEK293 cells, these ratios were compared 
between the different cell lines and replicates. Exons exhibiting greater than a 1.5-fold 
change in In/Ex ratio between WT and control (p<0.05), and less than a 1.5-fold change 
between FA and control were defined as Rbfox1 regulated. By these criteria, 206 
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cassette exons were regulated by Rbfox1 (Figure 4.5A, Table S4.1). The In/Ex ratios for 
each exon across all the cell lines were subjected to unsupervised hierarchical clustering. 
As expected, replicates of cells expressing the same protein were most similar and the 
values for the FA cells were most similar to the control. The cells expressing WT protein 
were most different from the other cells. The cells expressing the 10Y protein showed the 
most variability across replicates. Looking at individual exons across the different cell 
lines, the exons clustered into three groups with distinct splicing behavior. Exons in 
Group 1 (29) were repressed by Rbfox1, while the 49 exons in Group 2 and the 128 
exons in Group 3 were activated by Rbfox1 (Figure 4.5A and S4.2B, Table S4.1). As 
seen for DUP-E9*, the group 1 exons that were repressed by wildtype Rbfox1 are also 
largely repressed by the 10Y mutant proteins. For exons activated by Rbfox1, those in 
group 3 lost regulation by the 10Y mutation, as seen for DUP-E33 (Figure 4.5A). With 
some variation between replicates, exons in Group 2 were at least partially activated by 
10Y, and many were activated to a similar level as by WT (Figure 4.5A). The median fold 
change of In/Ex ratio of WT to 10Y for exons in group 2 is close to 1, while there is more 
than 1.5-fold change between WT and 10Y for exons in group 3 (Figure 4.5B). As seen 
with the reporter gene exons and many endogenous exons (Figure 4.4DE, 4.5 and 
S4.2B), splicing repression and splicing activation showed different dependencies on the 
tyrosine residues of the CT domain. Exons repressed by Rbfox were not strongly affected 
by the Y-S mutations, but a substantial subset of exons activated by Rbfox requires these 
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residues and presumably the higher-order assembly of the Rbfox/LASR for splicing 
regulation. 
 
DISCUSSION 
 
Repetitive tyrosine residues in LC domains trigger higher-order assembly of Rbfox 
proteins with LASR 
We showed that C-terminal tail of Rbfox proteins containing conserved LC 
sequences interact with LASR and this interaction is required for maintaining Rbfox 
activity in splicing regulation. A series of repetitive tyrosine residues within this LC domain 
could serve as one of the interfaces interacting with LASR, but more importantly, they are 
required in high-order assembly of Rbfox proteins. Tripeptide motif [G/S] Y [G/S] has 
been reported to be involved in forming amyloid-like fibers with cross-beta sheet 
structures (Kato et al., 2012). Not all the tyrosine residues in the repeats that we identified 
follow this pattern, but most of them either match or partially match. We also noticed an 
interesting spacing pattern of repetitive tyrosine residues, which might play a role in 
maintaining β-sheet structures. Structural determination of this domain will help to 
determine the role of tyrosines in forming such structures and spacing effect of these 
residues.  
We find that many proteins in LASR consist of LC domains or disordered domains 
and all the major LASR subunits were in the core subset of proteins precipitated by b-isox 
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(Kato et al., 2012). Since we found that LASR could exist and form higher-order assembly 
by itself without Rbfox proteins, we would suspect that the mechanism we discovered for 
Rbfox1 higher-order assembly could be applied to other RNA-binding proteins to 
assemble LASR.  
 
Association of Phase-separable and fiber forming properties with higher-order 
assembly 
We demonstrated that polymerization of Rbfox1 through repetitive tyrosine residues 
in CT region in vivo correlates with its capability of forming fibers at high protein 
concentration and phase-separable droplets at low protein concentration with crowding 
reagent in vitro. We also observed that Rbfox1 LC domain could fibrillize over time and 
form phase-separable droplet structures, while its ten-tyrosine-to-serine mutant could not. 
The droplets formed at the condition with crowding reagent were able to from fibers when 
incubated for longer time. LC domain of Rbfox proteins could form fibrous structures 
without forming liquid droplets. However, phase-separation at low protein concentration 
promoted by crowding reagent could increase the local concentration of protein, leading 
to fiber formation ultimately.  
We found that short RNA fragments protected by Rbfox-LASR complexes, which 
turned out to be the binding sites for Rbfox and other RNA-binding proteins in LASR 
(Unpublished, Ying, Y. & Black, D.L.). After nuclease digestion, these RNA were trimmed 
to short fragments, which are not likely to be the organizer of the complexes. However, 
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RNA could potentially initiate the assembly process to bring proteins closer, as it could 
promote phase separation and fibrous structure formation in vitro (Lin et al., 2015). 
Meanwhile, traditional protein-protein interactions as well as potential fiber-like 
polymerization by disordered and LC domains could occur to form higher-order 
complexes.  
 
Higher-order assembly of Rbfox1 in alternative splicing regulation 
Most studies of RBPs primarily focus on the RBD and their RNA recognition 
properties. Little is known about the role of non-RBD regions. Here we showed that 
non-RBD region at C-terminal of Rbfox proteins modulates the splicing activity of Rbfox 
proteins by interacting with LASR. Interestingly, the splicing activation activity could be 
further tuned by the capability to form higher-order assembly of Rbfox proteins. 
Specifically, Rbfox proteins fully capable of higher-order assembly activate splicing 
potently, mutants mildly impeded in higher-order assembly activate to an intermediate 
level, and mutants that are incapable of higher-order assembly fail to activate. 
The observations from minigene reporter assays hold true in general for many exons 
that identified by RASL-seq. This add-on tunable layer of splicing regulation by 
higher-order assembly could precisely control the ratio of transcript abundance between 
different splice variants. Dysregulation of the higher-order assembly and disassembly 
might result in aberrant splicing regulation. 
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EXPERIMENTAL PROCEDURES 
 
Plasmids 
Rbfox1 and its mutants were cloned into destination vector 
pcDNA5-FRT/TO-3xHA-3xFLAG (a gift from James A. Wohlschlegel, UCLA) via the 
Gateway cloning system (Life Technologies) for expression in Flp-InTM T-RexTM 293 cells. 
Tyrosine-to-serine mutations were introduced by QuickChangeTM site-directed 
mutagenesis. CT or C2 domain of Rbfox1 and their tyrosine-to-serine mutants tagged 
with an N-terminal SNAP (NEB), mCherry or mEGFP were cloned into pET28aTev vector 
for expression in E. coli. Details are available in the Supplemental Experimental 
Procedures. 
 
Cell culture  
Flp-InTM T-RexTM 293 cells stably expressing 3xHA-3xFLAG-SV40NLS-Rbfox1 and its 
deletion mutants, 3xHA-3xFLAG-Rbfox1 and its tyrosine mutants, 3xHA-3xFLAG-Rbfox1 
and Rbfox2 B40 or M43 variants, were generated using the Flp-InTM system (Life 
Technologies) according to the manufacturer’s instructions. All cell lines were cultured in 
Dulbecco’s Modification of Eagle’s Medium (Mediatech) containing L-glutamine and 10% 
FBS. Protein expression was induced with 500 ng/ml doxycycline for two days.  
 
Antibodies 
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Primary antibodies used for western blot were as follows: FLAG (Sigma, F3165-1MG), 
GAPDH (Ambion, AM4300), snRNP70 (Sharma et al., 2005). The secondary antibodies 
were goat anti-mouse or anti-rabbit IgG conjugated with cy3, cy5 (GE Healthcare) or 
IRDye 680LT, 800CW (LI-COR). Typhoon imager 9410 (GE Healthcare) and Odyssey 
Infrared Imaging System (LI-COR) were used for detection.   
 
Protein complexes analysis 
Subcellular fractionation from cells was performed as described (Damianov et al., 2016). 
HMW protein fractions were subjected to glycerol gradient ultracentrifugation or 
FLAG-immunoprecipitation as described (Damianov et al., 2016). Proteins were analyzed 
by western blot or stained by SYPRO Ruby protein gel stain (Life Technologies).   
 
Recombinant protein purification 
Proteins were expressed in E. coli Rosetta2 (DE3) and purified with a HisTrap HP 5ml 
column (GE Healthcare), followed by a Hiload Superdex 200 column (GE Healthcare). 
Purified proteins were concentrated and frozen at -80 °C. Details are available in 
Supplemental Experimental Procedures. 
 
Droplet Assembly 
Droplet assembly was performed as describe previously (Lin et al., 2015). Proteins were 
fluorescently labeled with SNAP-Surface 549 or SNAP-Surface 649 (NEB) according to 
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the manufacturer’s protocols. Purified bacterial protein solutions (2% of the proteins are 
fluorescently labeled) were diluted to 37.5 mM NaCl, 50 mM Tris (pH 7.5), and 1mM DTT. 
Reactions were placed in 96-well glass bottom plate (MatTek) coated with 3% BSA for 15 
minutes and sealed with PCR plate film (USA scientific) to minimize evaporation. Images 
were acquired on LSM 510 Meta Confocal Microscope (Zeiss) or Eclipse TE2000 
(Nikon). 
 
Hydrogel formation 
Hydrogel droplets of mEGFP-C2 of Rbfox1 were prepared as described previously (Kwon 
et al., 2013). In brief, proteins were concentrated to 1mM in gelation buffer (50 mM Tris 
pH 7.5, 150 mM NaCl, 1 mM DTT). A droplet (2 µl) of protein solution was placed on a 
glass-bottomed dish (MatTek) sealed with parafilm and incubated at room temperature 
for 5 days.  
 
Transmission Electron Microscopy 
The protein solutions (5 µl) were loaded onto a glow-discharged TEM grid (Electron 
Microscopy Sciences, FCF400-Cu-SB) and stained with 0.8% uranyl formate. TEM 
images were obtained at 120 kV on T12 quick cryoEM and cryoET (FEI). 
 
In vivo splicing assay 
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Transfections were performed with BioT (Bioland Scientific) according to the 
manufacturer's protocol. 48 hours after transfection, RNA was extracted from cells using 
Trizol (Life Technologies), and reverse transcribed with random hexamers and 
Superscript III (Life Technologies) according to manufacturer’s instructions. Minigene 
reporter spliced products were amplified by PCR (22 cycles) and separated by denaturing 
urea-PAGE. Endogenous gene splice products were amplified by PCR (22-25 cycles) 
with addition of SYBR Green I dye (Bio-rad) in the reaction and resolved by native PAGE. 
The amplified splice products were detected by Typhoon imager 9410 (GE Healthcare) 
and quantified by ImageQuantTM TL. Primer sequences are listed in Table S1. 
 
RASL-seq splicing analysis 
RASL-seq was performed as described with modifications (Li et al., 2012a). In brief, 
ligated oligos were subjected to two rounds of PCR amplification to include adapters 
compatible with the flow cell on Miseq. The library was sequenced on Miseq using 
custom sequencing primers. Sequenced reads were mapped to the oligo sequence pool 
by Blat (Kent, 2002) allowing two mismatches. Significantly changed splicing events were 
identified by average fold change and t-test (p < 0.05, comparing wildtype Rbfox1 to 
control). Details are available in Supplemental Experimental Procedures. 
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FIGURE LEGENDS 
 
Figure 4.1: Repetitive tyrosine residues in CT domain of Rbfox mediate its 
higher-order assembly. 
(A) Schematic diagram of Rbfox1 and its deletion mutants.  
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(B) Immunoprecipitation of HA-FLAG-SV40NLS-Rbfox1 deletion mutants with LASR. 
Soluble and HMW nuclear fractions were prepared from Flp-In T-REx 293 cells stably 
expressing HA-FLAG-SV40NLS-Rbfox1 deletion mutants. Protein extracts were 
immunoprecipitated with antibodies to FLAG. Immunoprecipitates were separated by 
4-12% SDS-PAGE and stained by SYPRO Ruby. Arrowheads indicate 
HA-FLAG-SV40NLS-Rbfox1 deletion mutants. LASR subunits are indicated on the 
right.  
(C) Sedimentation of Rbfox1 deletion mutants through 10-50% glycerol density 
gradients. HMW fractions prepared from Flp-In T-REx 293 cells stably expressing 
HA-FLAG-SV40NLS-Rbfox1 deletion mutants were loaded onto 10-50% glycerol 
density gradients. Gradient fractions from top to bottom run from left to right. Proteins 
from odd gradient fractions were immunoblotted with antibody to FLAG. 40S and 60S 
markers are indicated below.  
(D) Amino acid sequences encoded by exon B40 and M43 in Rbfox1 or Rbfox2 (top). 
Sedimentation of Rbfox1 and Rbfox2 splice variants through 10-50% glycerol density 
gradients (bottom). HMW fractions prepared from Flp-In T-REx 293 cells stably 
expressing HA-FLAG-Rbfox1 and HA-FLAG-Rbfox2 splice variants were loaded onto 
10-50% glycerol density gradients. Gradient fractions from top to bottom run from left 
to right. Proteins from odd gradient fractions were immunoblotted with antibody to 
FLAG. 40S and 60S markers are indicated below. 
(E) Amino acid sequence alignments of CT domain in Rbfox1, Rbfox2 and Rbfox3 variant 
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with exon B40 included. Tyrosine residues that have been examined by mutagenesis 
are shown in red.  
(F) Sedimentation of Rbfox1 tyrosine mutants through 10-50% glycerol density 
gradients. HMW fractions prepared from Flp-In T-REx 293 cells stably expressing 
HA-FLAG-Rbfox1 tyrosine mutants were loaded onto 10-50% glycerol density 
gradients. Gradient fractions from top to bottom run from left to right. Proteins from 
odd gradient fractions were immunoblotted with antibody to FLAG. 40S and 60S 
markers are indicated below. 
(G) Immunoprecipitation of HA-FLAG-Rbfox1 tyrosine-to-serine mutants with LASR. 
Soluble and HMW nuclear fractions were prepared from Flp-In T-REx 293 cells stably 
expressing HA-FLAG-Rbfox1 tyrosine-to-serine mutants. Protein extracts were 
immunoprecipitated with antibody to FLAG. Immunoprecipitates were separated by 
4-12% SDS-PAGE and stained by SYPRO Ruby. HA-FLAG-Rbfox1 
tyrosine-to-serine mutants and LASR subunits are indicated on the right.  
 
Figure 4.2: Rbfox1 interacts with LASR through multiple interfaces of CT domain. 
(A) Schematic diagram of Rbfox1 CT mutants (top). Immunoprecipitation of 
HA-FLAG-SV40NLS-Rbfox1 CT mutants with LASR (bottom). Soluble and HMW 
nuclear fractions were prepared from Flp-In T-REx 293 cells stably expressing 
HA-FLAG-SV40NLS-Rbfox1 CT mutants. Protein extracts were immunoprecipitated 
with antibody to FLAG. Immunoprecipitates were separated by 4-12% SDS-PAGE 
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and stained by SYPRO Ruby. Arrowheads indicate HA-FLAG-SV40NLS-Rbfox1 CT 
mutants. LASR subunits are indicated on the right. Asterisks mark non-specific 
bands.  
(B) Sedimentation of Rbfox1 CT mutants through 10-50% glycerol density gradients. 
HMW fractions prepared from Flp-In T-REx 293 cells stably expressing 
HA-FLAG-SV40NLS-Rbfox1 CT mutants were loaded onto 10-50% glycerol density 
gradients. Gradient fractions from top to bottom run from left to right. Proteins from 
odd gradient fractions were immunoblotted with antibody to FLAG. 40S and 60S 
markers are indicated below. 
 
Figure 4.3: LC domain of Rbfox1 form fibrous aggregates in vitro. 
(A) Schematic diagram of SNAP-tagged Rbfox1 CT domain with a C-terminal 6xHis tag 
and its ten-tyrosine-to-serine mutant (top). Fluorescence microscopy images of the 
macroscopic structures formed by SNAP-CT and SNAP-CT-YS in 37.5 mM and 150 
mM NaCl (bottom). 2% of proteins were labeled with SNAP-surface 649. Images 
were taken 21 hours and 48 hours after the initiation of phase separation by lowering 
the salt concentration. Scale bar: 5 µm. 
(B) Schematic diagram of SNAP-tagged Rbfox1 C2 fragment with a C-terminal 6xHis tag 
and its ten-tyrosine-to-serine mutant (top). Confocal fluorescence microscopy 
images of the macroscopic structures formed by SNAP-C2 and SNAP-C2-YS in 37.5 
mM and 150 mM NaCl (bottom). 2% of proteins were labeled with SNAP-surface 
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549. Images were taken 24 hours after the initiation of phase separation by lowering 
the salt concentration. Scale bar: 5 µm. 
(C) Schematic diagram of SNAP or mEGFP-tagged Rbfox1 C2 fragment with a 
C-terminal 6xHis tag and its ten-tyrosine-to-serine mutant (top). Confocal 
fluorescence images showing the co-partitioning of C2 into spherical fluorescent 
droplets (bottom). 0.5 µM of each protein were mixed with addition of 10% PEG8000. 
Images were taken 24 hours post-incubation. Scale bar: 5 µm. 
 
Figure 4.4: The tyrosine-rich region in CT domain of Rbfox1 is required for 
GCAUG-dependent exon activation. 
(A) Schematic diagram of DUP-E33 and the modified DUP-E9* minigene reporters. The 
downstream UGCAUG site and its mutation of E33 are indicated. The exonic and 
downstream UGCAUG from the original DUP-E9* were mutated to generate the 
modified DUP-E9* with upstream UGCAUG intact. This modified DUP-E9* minigene 
was used in this study. 
(B) In vivo splicing assays with Rbfox1 CT deletion mutant on E33WT, E33mt and 
E9*WT, E9*mt minigene reporters. Denaturing gel electrophoresis of RT-PCR 
products for minigene reporters upon co-expression with 
HA-FLAG-SV40NLS-Rbfox1 deletion mutants. Spliced products are indicated on the 
right. A graph showing PSI (percentage spliced in) calculated from four independent 
experiments is shown above each gel. Error bar dictates SEM. **** p < 0.0001 by 
 128 
unpaired, one-tailed Student's t test between Rbfox1 CT deletion (ΔCT) and full 
length Rbfox1 (FL). 
(C) Representative western blot of protein expression level in splicing assays in (B). 
Whole cell lysates were prepared from Flp-In T-REx 293 cells transiently expressing 
HA-FLAG-SV40NLS-Rbfox1 deletion mutants and probed with antibodies to FLAG 
and snRNP70. 
(D) In vivo splicing assays with Rbfox tyrosine mutants on E33WT and E33mt (right) 
minigenes. Denaturing gel electrophoresis of RT-PCR products for E33WT and 
E33mt minigenes upon co-expression with HA-FLAG-Rbfox1 tyrosine-to-serine 
mutants. Spliced products are indicated on the right. A graph showing PSI calculated 
from three independent experiments is shown above each gel. Error bar dictates 
SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001 by unpaired, one-tailed 
Student's t test between each Rbfox1 tyrosine-to-serine mutant and wildtype Rbfox1. 
(E) In vivo splicing assays with Rbfox tyrosine mutants on E9*WT and E9*mt minigenes. 
Denaturing gel electrophoresis of RT-PCR products for E9* WT and E9*mt minigenes 
upon co-expression with HA-FLAG-Rbfox1 tyrosine-to-serine mutants. Spliced 
products are indicated on the right. A graph showing PSI calculated from three 
independent experiments is shown above each gel. Error bar dictates SEM. n.s., not 
significant by unpaired, one-tailed Student's t test between each Rbfox1 
tyrosine-to-serine mutants and wildtype Rbfox1. 
(F) Representative western blot of protein expression level in splicing assays in (D) and 
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(E). Whole cell lysates were prepared from Flp-In T-REx 293 cells transiently 
expressing HA-FLAG-Rbfox1 tyrosine mutants and probed with antibodies to FLAG 
and GAPDH. 
 
Figure 4.5: Higher-order assembly of Rbfox1 is needed for splicing activation of 
many endogenous exons. 
(A) Heatmap was generated by hierarchical clustering of cassette-exon splicing (206 
events) significantly changed by Rbfox1 from RASL-seq. 
(B) Boxplot showing the fold change of WT In/Ex ratio versus 10Y In/Ex ratio in Group 1, 
2 and 3, respectively. Each dot represents a cassette-exon splicing event. 
 
Supplementary Figure 4.1: CT domain of Rbfox1 aggregated in vitro. 
(A) Plots of “hot spots” of aggregation in CT of Rbfox1 predicted by AGGRESCAN. 
Wildtype Rbfox1 CT and its ten-tyrosine-to-serine mutant were shown in red and 
blue, respectively. Amino acid sequences of Rbfox1 CT domain were shown below. 
Low complexity sequences predicted by SEG program were shaded in grey. 
Sequences in red were “hot spots” for aggregation. Ten tyrosine residues examined 
by mutagenesis were underlined in C2. 
(B) Chromatographs of recombinant proteins purified from E. coli. Molecular weight 
markers are indicated on top of the graphs. 
(C) Protein gels of recombinant proteins purified from E. coli stained by Coomassie blue. 
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(D) Confocal fluorescence microscopy images of SNAP-Surface 549 labeled SNAP-C2 
but not SNAP-C2-YS forming droplets at low protein concentration in the presence of 
10% PEG 8000. Scale bar: 5 µm. 
(E) Fluorescence microscopy images of SNAP-C2 forming fibrous structures stained with 
Thioflavin T.  
(F) Transmission electron micrograph of fibrous structures formed by SNAP-C2. 
 
Supplementary Figure 4.2: Significantly changed cassette exons identified from 
RASL-seq, related to Figure 4.5. 
(A) Western blot showing protein expression level of 12 samples used in RASL-seq. 
Whole cell lysate were probed with antibodies to FLAG and GAPDH. 
(B) RT-PCR validation of exons in Group 1, 2 and 3 identified from RASL-seq. Spliced 
products are indicated on the right. PSI values were shown below the gels. 
 
Table S4.1: related to Figure 4.4 and 4.5, Supplementary Figure 4.2. 
(A) RASL-seq sequencing reads mapping information. 
(B) Splicing of cassette exon significantly changed by Rbfox1 from RASL-seq. 
(C) PCR Primers used in in vivo splicing assays. 
 
Supplemental Experimental Procedures 
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Plasmids 
The SNAP-pET28aTev, mCherry-pET28aTev or mEGFP-pET28aTev vectors were 
constructed by two-step cloning. First, the thrombin cleavage site of the original pET28a 
vector (Novagen) was replaced with a Tev cleavage site by QuickChange mutagenesis 
generating the pET28aTev vector. Then, the SNAP tag (NEB), mCherry, or mEGFP was 
inserted into the vector pET28aTev before the Tev cleavage site by Gibson Assembly 
(NEB). CT or C2 domain of Rbfox1 and their ten-tyrosine-to-serine mutants were cloned 
into the SNAP-pET28aTev, mCherry-pET28aTev or mEGFP-pET28aTev vectors after 
the Tev cleavage site. All constructs contain an N-terminal SNAP, mCherry or mEGFP 
tag and a C-terminal 6xHis tag. The monomeric mutation (A206K) was made for EGFP. 
The sequences of all resulting vectors were confirmed by DNA sequencing. 
 
Recombinant protein purification 
The proteins were expressed in E. coli strain Rosetta2 (DE3). Bacteria were cultured in 
LB medium supplemented with 50 µg/ml Kanamycin and 34 µg/ml chloramphenicol at 
37 °C and induced at OD600 of 0.6–0.8 with 0.5 mM IPTG at 25 °C for 4 hours. The 
harvested cells were resuspended in equilibration buffer (50 mM Tris-HCl pH 7.5, 500 
mM NaCl) and lysed by sonication. After centrifugation, the soluble fractions of the cell 
lysates were loaded onto a HisTrap HP 5ml column (GE Healthcare) equilibrated with 
equilibration buffer. The columns were washed with equilibration buffer containing 50 mM 
imidazole, and the target proteins were eluted with a linear gradient of equilibration buffer 
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containing 50-500 mM imidazole. The proteins were further purified by a Hiload Superdex 
200 column (GE Healthcare) equilibrated in the buffer containing 50 mM Tris-HCl pH 7.5, 
and 150 mM NaCl. The purified proteins were concentrated with Amicon Ultra centrifugal 
filters (Millipore), and stored at -80 °C. The purities of purified proteins were confirmed by 
SDS-PAGE, and the concentrations were determined by absorbance at UV280. 
 
RASL-seq splicing analysis 
RASL-seq was performed as described with modifications (Li et al., 2012a). Total RNA 
from Flp-In T-REx 293 cells stably expressing Rbfox1 mutants were extracted with Trizol 
(Life Technologies) and treated with DNase I. RASL-seq oligos were annealed to 1 µg of 
total RNA. After ligation, 5 µl eluted ligated oligos were used for 10 cycles of PCR 
amplification using primers F1: 5’-CCGAGATCTACACTCTTTCCCTACACGACGGCGA 
CCACCGAGAT-3’ and R1: 5’- GTGACTGGAGTTCAGACGTGTGCGCTGATGCTACGA 
CCACAGG-3’. Half of the resulting PCR products were used in the second round of PCR 
amplification (10-15 cycles) using primers F2: 5’- AATGATACGGCGACCACCGAGATC 
TACACTCTTTCCCTACACG-3’ and D701-D712 adapters (Illumina). The indexed PCR 
products were pooled and sequenced on Miseq with a custom sequencing primer 5’- 
ACACTCTTTCCCTACACGACGGCGACCACCGAGAT-3’ and a custom index 
sequencing primer 5’-TAGCATCAGCGCACACGTCTGAACTCCAGTCAC-3’. 
Sequencing data were mapped to RASL-seq oligo pool sequences with Blat allowing for 
two mismatches. On average, 1.3 million reads were obtained for each sample. Splicing 
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events were filtered for a minimum of 5 reads averaged across all samples. Ratios of the 
counts of long to short isoforms (In/Ex ratio) were calculated. The significantly changed 
events were identified by average fold change and the t-test (p-value < 0.05, comparing 
wildtype Rbfox1 to control). Heatmaps were generated by hierarchical clustering using R. 
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Figure 4.1 
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Figure 4.2 
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Figure 4.3 
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Figure 4.4 
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Figure 4.5 
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Supplementary Figure 4.1 
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Table S4.1A. RASL-seq sequencing reads mapping information. 
 
Sample Ctrl1 Ctrl2 Ctrl3 
raw reads  2,107,845   2,302,560   1,883,733  
blat mapped(2 mismatches)  1,851,866   1,943,012   1,531,724  
%mapped  88   84   81  
    Sample WT1 WT2 WT3 
raw reads  2,125,022   1,628,396   1,642,182  
blat mapped(2 mismatches)  1,700,616   1,250,668   1,315,270  
%mapped  80   77   80  
   
 Sample 10Y1 10Y2 10Y3 
raw reads  1,705,217   1,597,497   1,299,457  
blat mapped(2 mismatches)  1,414,190   1,247,133   1,063,517  
%mapped  83   78   82  
   
 Sample FA1 FA2 FA3 
raw reads  1,630,762   1,050,440   943,323  
blat mapped(2 mismatches)  908,078   789,440   621,655  
%mapped 56  75   66  
 
 
 
 
 
  
 142 
Table S4.1B. Splicing of cassette-exon significantly changed by Rbfox1 from 
RASL-seq. 
event_
ID 
gene_s
ymbol 
Ctrl_ 
mean 
WT_ 
mean 
YS_ 
mean 
FA_ 
mean 
pval FDR group 
6731 MELK 3.71 8.42 2.93 5.01 0.041340 0.045299 3 
6729 MATR3 9.99 17.88 10.30 14.52 0.038940 0.043596 3 
6703 RREB1 0.77 3.58 0.81 0.90 0.013520 0.026680 3 
6684 IQCK 1.17 2.11 1.39 0.83 0.009125 0.021999 3 
6654 MLL5 0.55 1.21 0.70 0.48 0.000478 0.008626 3 
6587 PRUNE 1.33 2.85 1.99 1.52 0.035640 0.040956 3 
6524 SETD5 0.11 0.36 0.23 0.09 0.005347 0.017767 3 
6478 ZNF131 26.48 61.43 34.75 24.09 0.021136 0.032638 3 
6417 hMLH1 0.24 0.82 0.45 0.21 0.033420 0.039687 3 
6397 FSD1L 0.17 0.34 0.11 0.25 0.029057 0.036722 3 
6388 C1orf58 22.09 37.15 19.49 24.40 0.007594 0.020056 3 
6348 ZNF221 0.26 0.51 0.32 0.33 0.004045 0.015637 3 
6231 PCM1 0.58 1.21 0.67 0.42 0.011661 0.025554 3 
6004 DDB2 0.62 1.87 0.99 0.90 0.024293 0.034182 3 
5933 MDM2 0.04 0.09 0.06 0.04 0.006571 0.019223 3 
5928 HAUS2 7.85 12.88 12.31 6.55 0.004466 0.016385 3 
5869 
C14orf1
79 
0.02 0.05 0.02 0.03 0.013215 0.026680 3 
5868 
C20orf7
2 
2.19 5.74 2.57 3.09 0.023114 0.033531 3 
5853 
BC0378
84 
0.30 0.70 0.47 0.43 0.003811 0.015394 3 
5847 ZMYM1 0.26 0.42 0.36 0.18 0.012398 0.026359 3 
5826 C5orf32 14.21 27.98 18.93 11.66 0.042437 0.045532 3 
5796 HELLS 0.02 0.03 0.02 0.01 0.017316 0.029975 3 
5778 
CDKN2
A 
0.00 0.00 0.00 0.00 0.001427 0.010543 3 
5601 UBE2F 0.01 0.06 0.05 0.01 0.045999 0.047617 3 
5507 TANK 0.08 0.23 0.12 0.08 0.010964 0.024549 3 
5501 
HMBOX
1 
1.50 2.69 1.73 1.58 0.013867 0.026831 3 
5458 ZNF384 0.04 0.19 0.05 0.05 0.001795 0.010877 3 
5406 
METT5
D1 
0.11 0.25 0.11 0.12 0.040843 0.044993 3 
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5306 CARS 60.99 203.06 85.91 45.26 0.006625 0.019223 3 
5278 VAP 0.20 0.56 0.35 0.19 0.005087 0.017761 3 
5129 LCLAT1 0.13 0.46 0.19 0.15 0.005826 0.018606 3 
5064 CHD1L 55.28 128.00 97.00 61.00 0.042797 0.045679 3 
3661 RAB6A 1.30 8.29 5.25 0.89 0.000486 0.008626 3 
3646 FIP1L1 0.21 0.37 0.24 0.17 0.006936 0.019572 3 
3645 FNBP1 0.03 0.11 0.07 0.03 0.003253 0.015216 3 
3608 MARK3 0.09 3.34 0.90 0.12 0.042132 0.045455 3 
3603 SENP6 1.90 3.41 2.08 1.46 0.021269 0.032638 3 
3601 RBM5 0.30 0.68 0.49 0.35 0.003646 0.015394 3 
3539 FHL1 0.04 0.11 0.03 0.04 0.045680 0.047525 3 
3530 MICAL3 0.00 0.07 0.00 0.00 0.035221 0.040956 3 
3500 TPIP 60.17 137.33 67.33 58.33 0.021864 0.032638 3 
3469 FSTL4 0.39 0.69 0.50 0.33 0.019797 0.031879 3 
3403 
LOC400
927 
0.44 1.04 0.44 0.38 0.023000 0.033531 3 
3394 RBM16 0.10 0.15 0.08 0.10 0.026894 0.035743 3 
3359 PRKDC 20.73 37.22 25.49 29.25 0.040274 0.044666 3 
3356 RORA 0.08 0.29 0.15 0.09 0.001087 0.010543 3 
3333 KIF21A 0.03 0.72 0.14 0.04 0.000303 0.008560 3 
3329 DIAPH1 0.08 1.52 0.79 0.10 0.019826 0.031879 3 
3287 NGLY1 15.09 34.26 18.87 12.33 0.000798 0.010272 3 
3228 EXT2 136.50 322.00 99.72 158.00 0.047159 0.048092 3 
3189 NF2 1.64 11.87 8.21 1.18 0.026006 0.034787 3 
3188 USP47 0.10 1.20 0.28 0.11 0.001537 0.010543 3 
3168 MACF1 0.04 0.07 0.04 0.05 0.032579 0.039020 3 
3121 USO1 0.02 0.06 0.03 0.03 0.012623 0.026359 3 
3114 CSDE1 0.01 0.03 0.02 0.01 0.018988 0.031801 3 
3055 LPHN2 0.01 0.03 0.01 0.01 0.003324 0.015216 3 
2935 KIF23 0.86 1.46 1.03 0.67 0.019312 0.031879 3 
2903 NOVA1 19.18 49.33 27.06 26.83 0.029751 0.037370 3 
2881 MSI1 6.53 13.11 5.42 9.33 0.035526 0.040956 3 
2864 GOLIM4 0.00 0.04 0.02 0.01 0.034650 0.040556 3 
2843 EIF4G1 4.43 12.20 5.20 5.44 0.014751 0.026950 3 
2806 RAD17 0.13 0.25 0.19 0.13 0.014500 0.026910 3 
2793 CHTF8 0.74 1.60 1.13 0.52 0.014066 0.026831 3 
2715 PDGFC 0.05 0.08 0.05 0.04 0.045469 0.047525 3 
2660 BM009 1.03 1.71 1.45 0.76 0.032093 0.038889 3 
2646 PBX3 0.82 1.29 1.05 0.80 0.032351 0.038972 3 
2564 MARK2 0.92 1.90 1.23 0.94 0.012843 0.026359 3 
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2559 PHF20 0.02 0.05 0.03 0.02 0.006267 0.018985 3 
2514 TPM3 0.16 0.47 0.23 0.23 0.031349 0.038439 3 
2477 
STRAD
A 
0.20 0.65 0.26 0.18 0.004099 0.015637 3 
2465 
SMARC
A2 
4.68 7.43 5.30 5.51 0.002802 0.014429 3 
2436 FIP1L1 2.57 4.13 3.55 3.14 0.004534 0.016385 3 
2369 USP37 2.49 6.72 3.02 2.63 0.046850 0.048015 3 
2329 PTBLP 0.13 0.58 0.21 0.09 0.045422 0.047525 3 
2294 
DCUN1
D5 
1.64 2.53 1.08 1.81 0.011436 0.025332 3 
2065 CAST 0.01 0.05 0.03 0.01 0.003133 0.015060 3 
2018 TJP2 6.82 13.71 11.97 5.19 0.023637 0.034050 3 
1959 RBM27 0.15 0.33 0.24 0.15 0.000526 0.008626 3 
1950 HMGN3 0.01 0.03 0.01 0.00 0.001419 0.010543 3 
1878 MPRIP 0.00 0.05 0.04 0.00 0.003765 0.015394 3 
1858 ST7 0.01 0.26 0.06 0.01 0.038239 0.043045 3 
1766 NUMB 0.01 0.02 0.01 0.01 0.001137 0.010543 3 
1733 NACA 0.00 0.01 0.00 0.00 0.001569 0.010543 3 
1683 KIF21A 0.07 0.12 0.05 0.11 0.001470 0.010543 3 
1603 PLCH1 0.01 0.28 0.02 0.01 0.021416 0.032638 3 
1596 CASP8 0.12 0.43 0.26 0.18 0.005339 0.017767 3 
1549 
DKFZp5
66L241 
0.34 1.40 0.76 0.38 0.000047 0.002408 3 
1525 VEGFA 0.45 1.13 0.50 0.58 0.006001 0.018660 3 
1513 
TSC22D
2 
0.03 0.37 0.09 0.04 0.009364 0.022173 3 
1483 
LRRFIP
2 
0.06 0.23 0.10 0.04 0.024145 0.034182 3 
1438 OSBPL9 1.37 3.35 2.51 1.49 0.013440 0.026680 3 
1362 NF2 1.64 11.87 8.21 1.18 0.026006 0.034787 3 
1333 SPTAN1 0.31 0.58 0.39 0.25 0.021441 0.032638 3 
1314 DAZAP1 3.17 6.71 4.91 3.86 0.000632 0.008677 3 
1311 
TCERG
1 
0.49 1.66 0.96 0.52 0.002716 0.014348 3 
1266 DPP8 0.19 0.34 0.19 0.17 0.010130 0.023240 3 
1201 RSRC2 0.02 0.05 0.01 0.03 0.033669 0.039687 3 
1185 BCAS3 0.06 0.13 0.07 0.06 0.004001 0.015637 3 
1172 EIF4G1 2.74 4.72 3.70 1.87 0.025169 0.034386 3 
1139 MYO6 0.00 0.04 0.01 0.01 0.001001 0.010543 3 
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1065 EIF4A2 0.39 0.79 0.66 0.51 0.004964 0.017631 3 
1051 DST 15.34 33.70 18.59 13.30 0.001183 0.010543 3 
1045 
CDK5R
AP2 
0.45 0.78 0.56 0.36 0.022914 0.033531 3 
1034 SNX14 0.37 0.75 0.55 0.36 0.008130 0.020935 3 
1020 TSR1 7.58 19.76 8.33 8.50 0.001309 0.010543 3 
1010 SLMAP 0.07 0.12 0.08 0.09 0.042145 0.045455 3 
992 MTA1 0.58 1.06 0.89 0.57 0.015791 0.027803 3 
876 EIF4H 0.09 0.44 0.22 0.06 0.002275 0.012667 3 
843 EHBP1 4.09 6.48 6.17 6.11 0.035803 0.040956 3 
785 CHTF8 0.74 1.60 1.13 0.52 0.014066 0.026831 3 
767 RP5 0.43 1.99 0.79 0.32 0.001746 0.010877 3 
743 
PPFIBP
1 
0.04 0.11 0.02 0.05 0.043726 0.046431 3 
730 IQCH 15.87 42.56 17.00 14.64 0.036767 0.041615 3 
627 
ARHGA
P21 
25.75 55.00 31.50 19.22 0.020335 0.031978 3 
574 
GOLGA
2 
0.01 0.13 0.05 0.02 0.000419 0.008626 3 
504 BRD4 0.06 0.21 0.08 0.06 0.005814 0.018606 3 
432 DNM1L 0.00 0.08 0.02 0.00 0.013599 0.026680 3 
421 
SORBS
1 
0.33 0.74 0.55 0.42 0.016466 0.028746 3 
414 
NCAPD
2 
11.24 19.00 10.75 14.00 0.028219 0.036706 3 
400 DOCK9 0.04 0.20 0.08 0.04 0.022866 0.033531 3 
388 BNIP2 0.03 0.27 0.11 0.03 0.014914 0.026950 3 
333 UHRF2 82.74 171.67 108.00 102.33 0.015754 0.027803 3 
325 TIAM1 11.82 35.68 14.24 10.75 0.024721 0.034386 3 
266 MYO9A 0.01 0.03 0.01 0.00 0.017927 0.030520 3 
265 JMJD6 0.03 0.09 0.05 0.04 0.005288 0.017767 3 
162 ANGEL2 0.25 0.44 0.28 0.25 0.003143 0.015060 3 
152 
PLEKH
M2 
1.53 6.25 2.56 1.73 0.020118 0.031879 3 
141 FUBP1 0.02 0.06 0.02 0.02 0.025947 0.034787 3 
6907 TSC1 14.27 23.56 36.29 14.02 0.008517 0.021397 2 
6504 
FGFR1
OP 
2.63 5.27 4.43 2.14 0.001633 0.010543 2 
6326 
CSNK1
G2 
0.38 0.89 0.93 0.51 0.012924 0.026359 2 
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6067 WDR20 0.05 0.20 0.17 0.04 0.009139 0.021999 2 
5860 KLC1 2.75 4.70 3.80 3.61 0.006564 0.019223 2 
5751 
RNF216
L 
0.32 0.85 0.92 0.36 0.028331 0.036706 2 
5331 RPS24 0.58 2.43 2.83 0.74 0.049633 0.049633 2 
3482 SRPK2 12.23 19.18 21.71 13.85 0.007430 0.020056 2 
3475 
CCDC8
8A 
2.09 5.60 3.06 1.46 0.007373 0.020056 2 
3397 IMAA 0.65 1.16 1.17 0.81 0.018902 0.031801 2 
3220 
UBQLN
1 
10.29 24.66 22.69 8.21 0.002517 0.013643 2 
3154 RNPS1 1.53 2.66 2.54 1.07 0.014429 0.026910 2 
3024 MAPT 0.20 0.48 0.35 0.18 0.008974 0.021999 2 
3005 ZNF195 0.33 0.62 0.66 0.37 0.000025 0.002408 2 
2964 CNOT10 24.76 100.07 88.18 22.88 0.017480 0.030007 2 
2331 SLMAP 5.31 11.06 9.27 4.14 0.000128 0.004378 2 
2314 PHF21A 1.56 3.15 2.68 1.28 0.031163 0.038439 2 
2195 MBTD1 2.41 3.70 3.88 2.08 0.004469 0.016385 2 
2179 SMAD9 0.41 0.90 0.64 0.31 0.006931 0.019572 2 
2106 MAX 0.32 0.55 0.47 0.35 0.003599 0.015394 2 
1998 ZNF507 0.16 0.26 0.24 0.16 0.009798 0.022936 2 
1956 FOXM1 0.01 0.04 0.03 0.01 0.007986 0.020825 2 
1917 
MRPS1
8A 
526.33 854.81 1068.83 362.48 0.024392 0.034182 2 
1890 ST7 0.36 1.13 1.19 0.35 0.029011 0.036722 2 
1875 GNAS 1.00 1.52 1.46 1.21 0.007536 0.020056 2 
1796 MAP4K4 1.59 3.64 2.93 1.28 0.009184 0.021999 2 
1744 EPB41 0.02 0.43 0.30 0.01 0.008432 0.021397 2 
1701 ATXN2 6.64 22.49 29.89 4.87 0.000586 0.008626 2 
1648 PROM1 0.04 0.16 0.13 0.03 0.001425 0.010543 2 
1569 
FBXW1
1 
0.21 0.32 0.33 0.28 0.024943 0.034386 2 
1300 
CAMK2
G 
0.05 0.17 0.19 0.05 0.044241 0.046736 2 
1268 
RAD51L
3 
1.27 2.08 1.93 1.48 0.021607 0.032638 2 
1252 ODF2 3.35 7.31 6.85 4.88 0.002877 0.014454 2 
1074 BCLAF1 0.13 0.26 0.26 0.14 0.010432 0.023616 2 
943 ATXN2 1.43 2.55 2.38 1.63 0.006069 0.018660 2 
755 ROBO1 0.09 0.13 0.12 0.09 0.025205 0.034386 2 
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736 
FGFR1
OP2 
1.89 4.53 4.08 2.55 0.012793 0.026359 2 
672 
KIAA018
2 
3.80 8.92 11.61 3.95 0.027351 0.036117 2 
658 CIP29 0.31 3.63 3.02 0.46 0.015562 0.027803 2 
550 UBE2L3 38.35 92.12 91.96 53.14 0.035985 0.040956 2 
538 KLF6 0.01 0.04 0.03 0.01 0.049295 0.049535 2 
531 
C1orf14
9 
0.10 0.17 0.16 0.14 0.028952 0.036722 2 
454 
FAM126
B 
0.18 1.67 1.49 0.21 0.046581 0.047979 2 
407 UTRN 0.06 0.37 0.29 0.08 0.010153 0.023240 2 
377 ECT2 0.25 1.51 1.14 0.27 0.033714 0.039687 2 
373 ZRANB2 0.03 0.06 0.06 0.03 0.001319 0.010543 2 
361 PDLIM7 0.09 0.22 0.23 0.07 0.019485 0.031879 2 
329 
HNRNP
D 
0.03 0.08 0.09 0.04 0.001254 0.010543 2 
23 FMNL2 1.42 3.36 3.22 2.00 0.001955 0.011185 2 
6605 ERCC2 14.55 8.70 12.51 11.52 0.019972 0.031879 1 
6263 SRRM2 1.26 0.52 0.68 1.83 0.012609 0.026359 1 
6185 DBF4B 2.97 1.67 1.75 2.02 0.000109 0.004378 1 
5988 
QTRTD
1 
4.27 1.42 2.01 4.82 0.003811 0.015394 1 
5905 6-Sep 8.31 3.74 3.08 7.79 0.030452 0.037789 1 
5622 
CDC42S
E2 
9.91 2.78 1.23 7.68 0.012073 0.026179 1 
5455 MASTL 0.18 0.09 0.09 0.15 0.014374 0.026910 1 
5378 ING3 0.13 0.06 0.13 0.09 0.048149 0.048621 1 
5356 
KIAA124
5 
49.35 32.38 38.86 40.67 0.000045 0.002408 1 
5261 NBPF10 49.35 32.40 39.01 40.67 0.000020 0.002408 1 
5258 
KIAA072
3 
0.10 0.05 0.11 0.13 0.001303 0.010543 1 
5204 NBPF8 0.02 0.01 0.01 0.01 0.032078 0.038889 1 
3716 
LOC728
855 
21.68 3.55 3.69 18.30 0.040330 0.044666 1 
3213 NUMB 1.13 0.36 0.83 1.15 0.001863 0.010965 1 
2996 
JAKMIP
2 
20.58 7.94 13.73 17.66 0.001638 0.010543 1 
2917 MCL1 129.64 55.17 78.58 120.28 0.023946 0.034182 1 
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2697 ATP2B4 151.56 30.78 85.06 104.67 0.030308 0.037789 1 
2379 RICTOR 0.54 0.33 0.30 0.45 0.000332 0.008560 1 
2363 ADD3 62.36 13.15 20.57 49.04 0.027922 0.036636 1 
2327 RAI14 1.47 0.71 0.94 1.50 0.005871 0.018606 1 
2321 
FAM184
A 
1.83 0.99 0.87 2.21 0.021837 0.032638 1 
2174 BAZ2B 14.79 4.14 8.58 14.31 0.007453 0.020056 1 
1933 STX2 15.97 8.83 8.86 16.98 0.019508 0.031879 1 
1149 ING4 35.28 21.61 28.80 42.02 0.047610 0.048314 1 
1120 PBRM1 6.82 1.55 1.49 5.87 0.041657 0.045403 1 
652 
ERBB2I
P 
2.19 1.05 0.93 2.03 0.000561 0.008626 1 
472 EP400 3.73 2.48 3.38 3.89 0.028535 0.036722 1 
254 BNIP1 0.06 0.03 0.05 0.05 0.003426 0.015343 1 
10 ANK2 0.61 0.32 0.26 0.45 0.014841 0.026950 1 
 
 
  
 149 
Table S4.1C. PCR Primers used in in vivo splicing assays. 
 
 
 
 
  
minigene 
reporter 
Primer 
Name Sequence Comment 
Forward primer DUP8 GACACCATGCATGGTGCACC 
FAM 
labelled 
Reverse primer DUP3 AACAGCATCAGGAGTGGACAG   
    endogenous 
exons 
Gene 
Name Sequence 
Goup  
Forward primer 
PBRM1 
TGTGATTAAGGCCCAACACC 
1 
Reverse primer CTACCATAGGGGCCACTCCT 
Forward primer 
FAM184A 
AAAGGGCCCAAGACATTTTT 
1 
Reverse primer ATGTGAAGTACCGGGCAAAC 
Forward primer 
QTRTD1 
CAGAACATCATGAAGTCTTGACAG 
1 
Reverse primer ACTGGAACCAGTCTGGCTGA 
Forward primer 
RAI14 
GCAGGAATTCAAAGCCTTCT 
1 
Reverse primer GAAGGGTGGTTCAGCAAAAA 
Forward primer 
FAM126B 
CGGACTGCAATTACAACAGC 
2 
Reverse primer AGCCCCTGATGAAAATCCTT 
Forward primer 
ST7 
GCTACACAGCTGCTTTGCTC 
2 
Reverse primer TTTTGGCACATGAGGATTGA 
Forward primer 
RNF216L 
TCACCAGAAACCAGTGGAAA 
2 
Reverse primer CCTGGTGGTAATCGAGCAGT 
Forward primer 
MARK3 
CATGAAGCCACACCATTGTC 
3 
Reverse primer CCCTCATATCTCCCGTTCCT 
Forward primer 
USP47 
AACCAACTGGTCCCGAAAG 
3 
Reverse primer TCCGTTCATTCACTGTCTTTG 
Forward primer 
KIF21A 
TGGAAGGTCGACTCAAACAA 
3 
Reverse primer TGGGCTGTTTAAAGGAGCAT 
Forward primer 
RREB1 
GATCACCTGTCCCCACTGTC 
3 
Reverse primer GTCCCGTGAGGTGAGGTCTA 
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CHAPTER 5 
CONCLUDING REMARKS AND FUTURE DIRECTIONS 
 
Concluding Remarks 
 
Rbfox protein family is one of the important splicing regulators, which has been 
associated with many human diseases. Remarkable progress has been made towards 
understanding the role of Rbfox proteins since being discovered more than a decade ago. 
The RNA-binding properties have been well-characterized by SELEX experiments that 
identified the RNA sequence (U)GCAUG recognized by Rbfox RRM motif (Jin et al., 
2003), and the structure of this motif bound to short RNA sequence was resolved by NMR 
(Auweter et al., 2006). Earlier work on a limited number of model exons and minigene 
reporters suggest that the Rbfox proteins could act as both splicing activators and 
repressors depending on their binding position relative to the alternative exon (Baraniak 
et al., 2006; Kuroyanagi et al., 2007; Mauger et al., 2008; Ponthier et al., 2006; Sun et al., 
2012; Tang et al., 2009; Zhou et al., 2007; Zhou and Lou, 2008). Although much effort 
has been made to uncover the mechanism of Rbfox regulation, little is known about the 
underlying molecular mechanisms. Thanks to the recent modern high-throughput 
sequencing technology, numerous Rbfox-regulatory targets were identified in different 
tissues and cell lines (Weyn-Vanhentenryck et al., 2014; Yeo et al., 2009a). Rbfox 
proteins regulate many targets that are critical for proper development. The 
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transcriptome-wide binding profiles of Rbfox proteins revealed by CLIP-seq provided 
tremendous amount of information on the spatiotemporal binding of Rbfox proteins on 
their targets and RNA sequence specificities of Rbfox proteins. These new findings 
corroborate and extend our understanding of Rbfox proteins from earlier work. However, 
the molecular basis of how Rbfox proteins promote or suppress splicing in a 
position-dependent manner is poorly understood. This is the initial big question we asked. 
For long time, our lab and many others could not recapitulate the Rbfox-dependent 
splicing regulation in in vitro system using recombinant purified Rbfox protein and 
minigenes containing known Rbfox-dependent exons, a strategy that has been utilized 
successfully for many other splicing regulators. We hypothesized that some components 
critical for Rbfox-dependent splicing may be missing in the in vitro splicing reaction 
carried out with nuclear extract. Therefore, identifying protein partners of Rbfox proteins 
was the first step towards answering the big question of this dissertation. 
To identify potential protein partners of Rbfox proteins, we started by carefully 
assessing the protein profiles of Rbfox proteins in the cell. Rbfox proteins have diverse 
variants showing tissue-specific expression and different localization. Particularly, the 
inclusion or exclusion of exon 19 of Rbfox1 results in two isoforms with different C-termini: 
FAPY and TALVP. The variant ending in FAPY is predominantly nuclear, while the 
TALVP isoform is localized to the cytoplasm (Lee et al., 2016; Lee et al., 2009). Since 
splicing occurs in the nucleus, we focused on the FAPY variant. Splicing could happen 
while the transcripts are still attached with chromatin, or after their release from chromatin. 
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The splicing regulatory complexes might be different in these two processes, thus we 
isolated and fractionated nuclei, and examined the protein profiles of Rbfox proteins in 
the obtained fractions. Strikingly, the Rbfox proteins were among the few splicing 
regulators we found residing predominantly in the high molecular (HMW) nuclear material 
containing the chromatin. Moreover, Rbfox proteins within the HMW fraction were 
engaged in a very large multi-protein complex, which we termed a Large Assembly of 
Splicing Regulators, LASR. The discovery of LASR and its potential role in 
Rbfox-dependent splicing regulation laid the foundation for this dissertation. 
We characterized the protein content of the LASR complex described in Chapter 2, 
and found that it contains eight RNA/DNA-binding proteins with approximately equal 
stoichiometry: hnRNP M, hnRNP H, Matrin3, NF110, hnRNPU-like2, hnRNP C, DDX5, 
NF45. Many of these proteins were also implicated as splicing regulators in many other 
studies. The LASR complex has three distinct features compared with other known 
RNA-binding protein complexes. First, LASR is exclusively associated with the high 
molecular weight fraction material containing chromatin, despite the fact that all the 
protein subunits except Rbfox could be found in soluble nucleoplasm as well. Since 
LASR acts as a potential splicing regulatory protein complex, it is understandable that it is 
primarily associated with nascent transcripts that are attached to the chromatin, yet the 
actual factor controlling the recruitment of LASR is not defined. Second, LASR is an 
RNA-independent protein complex, because LASR was extensively treated with 
nucleases during purification. In contrast, many RNA-binding protein complexes are 
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dependent on RNA. Nevertheless, we found very short RNA fragments (~30nt) retained 
within LASR, which were presumably protected from nuclease digestion. Sequencing 
data from these RNA fragments suggested them to be the binding sites of LASR since 
they are enriched in sequence motifs recognized by the Rbfox proteins as well as by 
other RNA-binding members of LASR. Third, LASR sedimented around 55S in glycerol 
gradients. Among all the subunits of LASR, the Rbfox proteins are almost completely 
engaged in this complex, whereas all the other proteins are abundant in other gradient 
fractions, suggesting that these protein subunits also exist as free proteins, or participate 
in other protein complexes. However, the other subunits could form similar protein 
complexes sedimenting at ~ 55S in absence of Rbfox expression, indicating that the 
Rbfox proteins are not the organizers of this large complex. Taken together, the nuclear 
Rbfox proteins are associated with other RNA binding proteins within LASR and are 
recruited to intronic sequences on pre-mRNA. 
The average weight the 55S LASR complex is expected to be in the megadalton, 
which is much larger than the sum of one copy of each of the subunits. Understanding 
this higher-order assembly of LASR, particularly the interactions between Rbfox and the 
other proteins, will help to understand Rbfox-dependent splicing regulation. We find that 
the C terminal region of Rbfox1, but not the N terminus or the RRM, is both necessary 
and required for interacting with LASR and assembling into higher-order complexes. The 
C terminus of Rbfox1 does not have any defined protein domain structure. Instead it is 
computationally predicted to have low complexity sequences. Although understanding 
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the role of low complexity sequences in RNA-binding proteins is still in its infancy, a burst 
of studies coming out in recent years suggest that these low complexity sequences and 
intrinsic disordered domains could polymerize to assemble into higher-order structures 
and play a role in protein functions (Kato et al., 2012; Kwon et al., 2013; Lin et al., 2015; 
Molliex et al., 2015; Patel et al., 2015). We find that LC sequence of Rbfox1 is required 
for the higher-order assembly of Rbfox1, but it is dispensable for interacting with LASR. 
Indeed, multiple interfaces were found in the C terminal part of Rbfox1. Repetitive 
tyrosine residues are distributed throughout the LC domain of Rbfox1, which are required 
in higher-order assembly of Rbfox1. These repetitive tyrosine residues match or closely 
resemble the tripeptide motif [G/S] Y [G/S] reported in other RNA binding proteins such 
as FUS (Kato et al., 2012). Due to the alternative splicing of Rbfox proteins, two naturally 
occurring tissue-specific mutually exclusive alternative exons B40 and M43 were located 
within the LC domain (Nakahata and Kawamoto, 2005). Interestingly, exons B40 and 
M43 within Rbfox1 and Rbfox2 encoded related but not identical sequences. The Rbfox2 
M43 has three tyrosine residues altered, resulting in its incapability of supporting 
higher-order assembly.  
We also examined the LC domain of Rbfox1 in vitro to see whether the high-order 
assembly of Rbfox1 can be related to amyloid-like aggregation like other RNA-binding 
proteins reported. Hydrogel formation and droplet assembly assays were performed with 
purified LC domain of Rbfox1 and its ten-tyrosine-to-serine mutant. The wild type LC 
domain of Rbfox1 formed droplets and fibrous structures that can be stained by Thioflavin 
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T. Thioflavin T is a dye that stains β-sheet structures (Khurana et al., 2005), suggesting 
that the structure formed by LC domain is likely to be β-sheets. Over time, the fibrous 
structures become more stable and form hydrogels. In contrast, the mutant protein 
stayed in the solution for days under the same experimental conditions. These results 
suggest that the tyrosine residues in the LC domain of Rbfox1 conferred these properties 
and established a link between fiber formation in vitro and higher-order assembly in vivo. 
These structural findings motivated us to ask whether the interaction between Rbfox 
and LASR, as well as the higher-order assembly of the complexes, have a functional role 
in Rbfox-mediated alternative splicing regulation. As expected, the interaction between 
Rbfox and LASR is required in both splicing activation and repression, suggesting that 
Rbfox proteins regulate alternative splicing with the help of LASR. However, strikingly, 
differential requirements of higher-order assembly were observed in splicing activation 
and repression. Results from well-characterized Rbfox-regulated minigene reporters and 
large-scale splicing profiling by RASL-seq indicate that higher-order assembly is largely 
required in Rbfox-dependent splicing activation, while dispensable in splicing repression.  
In summary, the primary goal of this dissertation is to understand the molecular 
mechanism of how Rbfox proteins regulate alternative splicing. The discovery of LASR 
led us to study the role of Rbfox proteins under the context of LASR. Indeed, results from 
this dissertation showed that Rbfox proteins regulate alternative splicing via its interaction 
with LASR. Differential requirements of higher-order assembly of Rbfox proteins for 
splicing activation and repression were revealed unexpectedly. In addition, we showed 
 156 
that both higher-order assembly in vivo and fiber-like aggregation in vitro require 
repetitive tyrosine residues at the C terminus of Rbfox proteins, suggesting a possible 
mechanism of higher-order assembly by fiber-like aggregation.  
 
Future directions 
 
These results have provided a clearer picture of how Rbfox proteins work to 
inference splicing choice, but have left many interesting questions unanswered.  
In this dissertation, we figured out the interface of Rbfox proteins with LASR, but the 
proteins directly interacting with Rbfox proteins and the interfaces on other proteins are 
unknown. Chemical crosslinking coupled with mass spectrometry allows identifying the 
interaction and interfaces of proteins, which can be applied on LASR. Information on the 
interaction between different subunits will also help understand the assembly of the 
complex and figure out the core components or the organizers of the complex. It will be of 
interest to determine the structure of LASR, although it will be a tough project to purify 
large quantity LASR from cells and obtain pure homogenous protein complexes for 
cryo-EM.  
The higher-order assembly of LASR is required in splicing activation by Rbfox 
proteins. Altering the tyrosine residues in Rbfox proteins will impair the assembly of Rbfox 
with LASR. But how are the LASR assembly and disassembly regulated in vivo? One 
attractive hypothesis is that phosphorylation and dephosphorylation might regulate this 
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process. Indeed, we found the higher-order assembled Rbfox is hypophosphorylated 
(data not shown). However, whether the tyrosine phosphorylation of Rbfox proteins is the 
driving force of assembly and disassembly needs further investigation. When such 
regulatory activities are identified, we would be able to modulate the splicing activity of 
Rbfox proteins via these factors. 
Many subunits of LASR act as splicing regulators individually. They recognize 
different RNA sequences, bind to different pre-mRNA target transcripts and regulate 
alternative splicing by distinct mechanisms. Thus, how would they coordinate to work as 
a team when they come together as one protein complex?  
LASR is a beautiful representative of combinatorial regulation by many different 
splicing factors. We found short RNA fragments retained in LASR, which were 
sequenced to be the binding sites of many subunits in LASR (data not shown). Analyses 
of these sequences might be a good starting point to understand how the RNA binding 
and splicing regulation are orchestrated by LASR. 
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